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Abstract  
Hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX) is a synthetic toxic explosive compound 
which was introduced into the environment during the Second World War. 
Microorganisms have adapted to degrade RDX and the enzymes involved include an 
unusual cytochrome P450, termed XplA, that is N-terminally-fused to a flavodoxin 
domain, and a flavodoxin reductase partner, XplB.  
To discover new RDX-degrading enzymes, selective enrichments were performed on 
explosive-contaminated soil samples from the United Kingdom, Belgium, Germany, 
Czech Republic, Ukraine and Moldova. Thirteen RDX-degrading bacteria were isolated 
and all identified as Rhodococcus spp. The xplA gene was identified in all isolates and 
TNT found to inhibit RDX-degradation. 
The evolutionary origin of xplA was analysed in eleven aerobic RDX-degrading bacteria 
belonging to four different genera: Rhodococcus spp., Microbacterium, Gordonia and 
Williamsia. Only six single nucleotide polymorphisms were found in the xplA/xplB 
region, emphasising the recent evolution of these genes. Additionally, genes flanking 
xplA/xplB were nearly identical between the four genera and together comprise a 
genomic island approximately 36 kbp in size which has been transmitted horizontally 
within a transposable element.  
In Gordonia sp. KTR9 several gene re-arrangements were found on the xplA/xplB-
containing plasmid, including the fusion of xplB to glnA. The XplB portion of the fusion 
was found to be inactive due to a serine to tryptophan substitution, whereas the GS 
portion, encoded by glnA, has activity, despite missing 15 % of the C-terminal region. 
Finally, the evolutionary origin of xplA was investigated by characterising three putative 
cytochromes P450: Gt-XplA from Gordonia terrae strain NBRC 100016; and CYPA 
and CYPB from Gordonia polyisoprenivorans NBRC 16320. Although purified Gt-
XplA, CYPA and CYPB did not have activity towards RDX, activity was detected 
following the substitution of amino acids into the putative active site of GT-XplA and 
truncated-CYPA. 
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1.1 Microbial adaptation to xenobiotic compounds  
 
Since the industrial revolution, massive amounts of “xenobiotic” organic compounds 
have been chemically synthesised and released into the biosphere. These compounds 
often have structures or properties that do not exist in nature [1], and many are toxic, 
such as explosives, antibiotics, disinfectants, fungicides, herbicides or insecticides  [1, 
2]. It is estimated that 150 x 10
6
 tonnes of xenobiotics are released annually into the 
environment [3],  producing considerable pollution in the biosphere and effecting the 
wildlife and human health [2, 4, 5]. 
Bacteria have been on our planet for more than 3.8 billion years [6], and are renowned 
for their extraordinary variation in metabolic properties, cellular structure and lifestyle; 
for instance Escherichia coli, Shigella flexneri, Salmonella enterica, Klebsiella 
pneumonia, Serratia marcescens and Yersinia pestis are all belong to a small taxonomic 
group of enteric bacteria, however their morphology, cellular metabolism and life style 
are remarkably diverse, depending on the ecological niche, as is shown in Figure 1.1 
[7]. 
 
Figure 1.1: Physiological and lifestyle diversity of number of enteric bacteria. 
Reproduced from Ochman et al. (2000) [7]. 
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Such metabolic diversity amongst bacteria reflects the genomic plasticity of these 
organisms, in which the “flexible” gene pool, carrying additional beneficial traits for the 
host under special environmental circumstance, can be rapidly manipulated through the 
processes of evolution and adaptation [8]. This feature has made it possible for bacteria 
to survive in almost every environment on the planet, from extremely high to extremely 
low temperatures, in various acidic or alkaline environments, and even in the dark, cold 
abyssal zone at the bottom of oceans, under extreme hydrostatic pressure and nutrient 
limitation [9]. 
Given that most xenobiotic compounds are rich in carbon and/or nitrogen, it is perhaps 
no surprise that bacteria have evolved catabolism pathways for many of these toxic 
compounds, including those which have been relatively recently introduced (within the 
last 50 years) to the environment [10]. Humans have taken advantage of this bacterial 
“evolutionary greenhouse” to detoxify and recycle xenobiotic pollutants in the 
biosphere [1] by using bacteria themselves, or the enzyme(s) responsible for 
metabolism of the xenobiotic [2]. 
1.2 Molecular mechanisms of microbial evolution 
Three factors contribute towards the diversity of bacterial genomes; firstly, the ability to 
produce small changes in the existing sequence through substitution, inserting or 
deleting a few nucleotides.  Secondly through DNA rearrangement and intragenomic 
reshuffling of the genomic content, and thirdly, via the acquisition of foreign DNA from 
another organism through horizontal gene transfer [6, 11].  
1.2.1 Microbial evolution through small scale mutation in existing 
DNA  
The concept of molecular evolution as a result of small genetic mutations was 
developed by Motoo Kimura and Tomoko Ohta (Figure 1.2). With “Neutral Theory of 
Molecular Evolution”, Kimura [12] developed a mathematical calculation to estimate 
nucleotide substitution rates, and proposed that most mutations are neutral or nearly 
neutral and these spread through genetic drift. Ohta [13] expanded the concept and 
proposed a relationship between random genetic drift and selection in the so called 
“nearly neutral theory of molecular evolution”. Ohta suggested slight deleterious 
mutations play an important role in molecular evolution. 
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Figure 1.2: Photos of the pioneer scientists of modern molecular evolution - Motoo 
Kimura (left) and Tomoko Ohta (Right). The photos are reproduced from History of 
Recent Science and Technology (http: //authors.library.caltech. edu/5456/1/hrst.mit.edu 
/index.html). 
  
Overall, mutations can be silent or neutral, not affecting the fitness of the organism, 
have a deleterious or lethal effect, or be advantageous and improve the fitness of the 
organism within an environmental niche.  In most cases, mutations have either a 
deleterious or lethal effect on the fitness of the organism [6, 7, 14, 15], however the 
gene which carries the deleterious mutation can disappear after a few generations 
through natural selection [15]. In silico sequence analysis of the 3,595 groups of 
homologous sequences in public databases, identified 17 groups of genes in different 
organisms which have potentially evolved through adaptation mutations, mainly 
through nonsynonymous mutations [15]. The melamine-degrading enzyme (melamine 
deaminase, TriA) was proposed to have been evolved from atrazine chlorohydrolase 
(AtzA). TriA was identified in melamine-degrading Pseudomonas sp. strain NRRL B-
12227 and has 98 % sequence identity to AtzA from the atrazine-degrading 
Pseudomonas sp. strain ADP. Each enzyme is 475 amino acids long differing by only 
nine amino acids. Both atrazine and melamine are xenobiotics; as melamine has existed 
in the environment for a longer period, it may have potentially contributed to the rapid 
evolution of AtzA from TriA [16]. Resistance to penicillin in Streptococcus 
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pneumoniae was proposed to originally evolve via point mutations in the pbp genes in 
the commensal penicillin-sensitive strain S. mitis. The mutated pbp genes then 
transformed in S. pneumoniae, by homologous recombination, to form a mosaic of pbp 
blocks. These mutations are responsible for the alteration of penicillin-binding proteins 
(PBP), target proteins of penicillin. The modified PBPs have less affinity for the drug 
and thus enhance the fitness of the bacteria in the presence of the drug [17]. Moreover, 
spontaneous mutations in the N-terminal cap domain of haloalkane dehalogenase (dhlA) 
were shown to play an important role in the modification of enzyme specificity, and 
subsequently contribute to the evolution of Xanthobacter autotrophicus to degrade the 
xenobiotic 1,2-dichloroethane [18].  
1.1.2 Large scale cellular DNA manipulation 
Bacterial genomes frequently undergo processes of reduction, re-arrangement, 
duplication and inversion, as mechanisms to adapt to their ecological niche [19]. 
Several enzymes including transposases and intergrases, which are usually related to 
mobile DNA elements, mediate these processes in the cell. Sequence rearrangement is 
also regarded as an important step in the acquisition of foreign genetic material through 
horizontal gene transfer  [5, 20].   
For instance, the small genome size found in members of the genus Mycoplasma is not 
indicative of primitivity of the organisms, but is rather due to the shrinkage of the 
bacterial genome and loss of non-essential genes through bacterial adaptation [21]. In 
2002 Moran proposed that a reduction in bacterial genome size, a particularly common 
phenomenon in parasite bacteria, can have adaptive advantages for the organism in 
terms of accelerating growth rate and maintenance within the host, although examples 
of several remaining non-functional or pseudogenes in the small genomes of Rickettsia 
and Buchnera could argue against the hypothesis [21].  
Plasmid reduction has had an important role in increasing the pathogenicity of Shigella 
sp. and another enteroinvasive Escherichia coli, changing the lifestyle of these strains; a 
region including the cadA gene (identified on a plasmid of an ancestral commensal E. 
coli) is deleted in these strains.  The gene encodes a lysine decarboxylase (LDC), the 
product of which, cadaverine, was found to greatly inhibit Shigella enterotoxin activity 
[22]. 
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In bacteria, DNA rearrangement is another mechanism in the process of evolution [7]. 
For example large chromosomal inversions in the genome of pathogenic Pseudomonas 
aeruginosa has boosted bacterial speciation and colonisation in the lungs of cystic 
fibrosis patients [23]. Conversely, an experimental attempt to investigate the effects of 
artificial large chromosomal inversion in Lactococcus lactis found varied impact on 
bacterial cell fitness, but mainly disadvantageous effects [24].  
Bacterial genome reduction and re-arrangement can also occur through transposable 
elements; discrete DNA segments that are able to move, without need of sequence 
homology, between donor and target sites. These mobile elements themselves also play 
an important role in microbial adaptation, and there are several xenobiotic-degrading 
activities which have been traced to products of transposable elements [10, 25].  
There are three classes of transposable element based on a genetic element and 
transposition mechanism [10, 25, 26]: Class-I, Class-II, and conjugative transposons.   
Class-I type transposons include simple insertion elements (IS s), in which short DNA 
sequences carry the genetic materials for transpositional recombination only [26, 27],  
and composite transposons, in which genes for the various beneficial traits including 
xenobiotic degradation are located between two nearly identical copies of ISs, in direct 
or invert orientations. The majority of ISs contain a short, ten to 40 bp terminal 
inverted-repeat sequence, flanked by direct-repeated sequences (DRs) [10, 25, 27]. In 
Pesudomonas sp. strain P51, genes involved in chlorobenzene degradation, tcbA and 
tcbB, are located on a 12 kbp composite transposon, Tn5280, flanked by two insertion 
elements IS1066 and IS1067 on the p51 plasmid [28]. Additionally, the benzene 
catabolic genes on plasmid pHMT112 from Pseudomonas putida ML2 are located on 
the Class I composite transposon Tn522, flanked by two directed repeated ISs  
IS1489v1 and IS1489v2 [29]. 
Class II transposons, are also known as Tn3 family type transposons. These elements 
usually carry two genes involved in their transposition: tpnA encoding a transposase, 
and tpnR encoding a resolvase. Transposition in this class occurs through two steps in a 
replicative pathway: in the first step the entire donor replicon is integrated into a target 
site by the action of transposase to produce both cointegrate and direct-repeat sequence 
of two transposons (Figure 1.3).  In the second step, the cointegrate is broken down by 
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the action of resolvase, through site-specific recombination, to produce a target 
sequence carrying transposon and regenerated donor replicon (Figure 1.3) [10, 25, 26, 
30]. 
 
Figure 1.3: Two step replicative process of Class II (Tn3) transposition. Entire donor 
replicon is inserted into a target site to form a cointegrate by the action of transposase 
enzyme encoded by tpnA.  This cointegrates then breaks down to the target sequence with 
the transposon and regenerated donor. Reproduced from Grindley (1983) [30]. 
 
The third class of transposons are called Conjugative Transposons or Integrative 
Conjugative Elements (ICEs), and historically called Genomic Islands and Integrative 
Plasmids [1, 10, 31]. The ICEs are self-transmissible blocks of DNA elements, usually 
located on chromosomes, and frequently near to a gene encoding tRNA. These elements 
carry genes which give beneficial traits to the host, as well as genes for their 
transmission, regulation and maintenance [32]. They can be found in both gram positive 
and gram negative bacteria, and differ from Class I and II transposons in that they are 
able to transfer horizontally between unrelated microorganisms through conjugation [8, 
31, 33]. Generally, ICEs are larger than both Class-I and Class-II transposons, 
sometimes reaching up to 200 kbp [8, 34]. Although it has been proposed that the GC 
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composition of ICEs differs compared with the rest of the genome [8, 11], computation 
analysis for the 95 characterised ICEs revealed that this is not usually the case, with < 
30 % of the tested ICEs differing (higher or lower) in GC content when compared with 
the rest of the genome. However, dinucleotide bias is found to be a key feature of ICEs, 
with 62 % exhibiting dinucleotide bias. Importantly, most novel genes are predicted to 
be associated with ICEs [34].  
These elements are excised from the chromosome through the site-specific 
recombination and take circular form, replicated from the host chromosome and can be 
transferred to recipients by conjugation. The transferred DNA can then be integrated 
into the bacterial chromosome through recombination between a specific site of the 
circular form and a site in the genome of their host, whereas the remaining ICE in the 
host cells is then integrated back to the chromosome (Figure 1.4) [1, 8, 10, 31-33]. Thus 
transposition of these elements has phage and plasmid life cycle, in which they integrate 
into, and excise from, the chromosome as phage, and transfer by conjugation as a 
plasmid [31-33].   
 
Figure 1.4: Transposition of the ICEs. The ICE is excised from the host genome and 
circularises, then can be transferred to recipient cells by conjugation and lastly integrate into 
the host genome. Reproduced from Wozniak and Waldor (2010) [33].  
Considering that unique transposition features of this class of transposons, Burrus et al. 
(2002) [31] suggested the term “Integrative and Conjugative Elements, ICEs” for this 
group of mobile elements, rather than “Genomic Islands”. The authors argued that the 
term “genomic island” for these mobile elements, which was initially used to coin 
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pathogenicity islands, would be rather a generalised name and functional classification 
of these elements. Additionally, genomic islands could also refer to wider groups of 
mobile elements with very different structures, and they could belong to either class of 
transposons or even statllite phage-like elements [31]. Despite these facts, different 
names are still in use for this group of mobile elements.  
Dobrindt at al. (2004) [11] proposed that ICEs might have originally derived from 
integrating plasmids or phages, that can go through successive evolution over time. The 
ICEs can became immobile through reduction evolution and lose the genes required for 
this process, or other mobile elements such as insertion elements and transposons, can 
be added before excision to the new host (Figure 1.5). 
 
Figure 1.5: Hypothetical Intergrative and Conjugative Elements (ICEs) lifecycle. ICEs 
carry genes with beneficial traits for the host (Gene x), as well as genes for autonomous 
replication (ori), transfer (tra), and intergration (int). These mobile elements integrate into a 
host’s chromosome through site-specific integration (1), which then can either immobile by 
losing the gene(s) involve in their mobility (2), or other mobile elements like insertion 
elements (IS) or transposable elements (Tn) can be added (3). To be transferred into a new 
host, genomic islands need to excise from chromosome and transfer to another bacterial cell 
chromosome. Reproduced from Dobrindt at al. (2004) [11]. 
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The best-characterised xenobiotic degrading ICE is the 105 kbp self-transmissible clc 
element involved in chlorobenzene degradation in Pseudomonas sp. strain B13 [35, 36]. 
Other examples include the 55 kbp Tnbph element involved in biphenyl and 4-
chlorobiphenyl degradation on the transposable element Tn4371 [37] and the 90 kbp 
bph–sal element involved in biphenyl and salicylate degradation in Pseudomonas 
putida KF715 [38]. More recently a 232 kbp phn island in the phenanthrene-degrading 
bacterium Delftia sp. Cs1-4 [39] has also been reported. 
1.1.3 DNA acquisition through horizontal gene transfer 
Acquisition of the DNA sequences from a close, or distantly related, organism through 
horizontal gene transfer is considered be a main strategy in bacterial evolution and 
adaptation [5, 7, 8, 20]. The systematic examination of 116 prokaryotic total genome 
sequences showed that 14 % of the 324,563 genes in these organisms were acquired 
through recent horizontal gene transfer. The number of the acquired genes was found to 
vary between bacterial species, for instance 21 % of E. coli genes are thought to be 
acquired by horizontal gene transfer, compared with only 2 % in the total genome of 
Mycoplasma genitalium G-37 (Figure 1.6) [40].  
 
Figure 1.6: Example of distribution of the horizontally acquired genes amongst the 
genome of various bacteria. Each bar represents the number of genes in the corresponding 
bacterium; the red part of the bar represents the ratio of horizontally acquired genes in the 
genome. Graph produced using data publish by Nakamura at al. (2004) [40].  
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Successful horizontal gene transfer has three requirements; firstly, a method to deliver 
DNA sequence from the donor to the recipient genome. Secondly, the acquired 
sequence must integrate in the recipient genome. Thirdly, expression of the new DNA 
segment must in some way result in beneficial traits in the cell [7]. The first two steps 
occur through three possible mechanisms: transformation, transduction or conjugation 
[7, 32].  
Natural transformation is the process of the active uptake and inheritable integration of 
the naked exogenous DNA fragment from the environment into the bacterial genome [7, 
41]. Given the difference in the cell wall structure of gram negative and gram positive 
bacteria, mechanisms of DNA uptake from extra cellular milieu into the cytoplasm is 
also different between these two groups of bacteria. In gram negative bacteria, a DNA 
fragment should pass through the outer membrane then the cell wall and finally, 
cytoplasmic membrane, whereas in gram positive bacteria, the outer membrane barrier 
does not exist [41, 42]. In addition to this, the natural competence, a physiological state 
allowing bacteria to naturally uptake DNA from the environment, is also different 
amongst bacteria. At least 40 bacterial species have been identified as naturally 
competent and able to uptake DNA from the environment [43], while other bacteria 
become competent to take up DNA only under certain physiological conditions [42, 43]. 
In both gram positive and gram negative bacteria, only one of the two DNA strands is 
transformed into the cytoplasm in order to integrate into host genome, the other strand is 
degraded into nucleotides then released either outside of the cell (in gram positive 
bacteria) or into the periplasmic space (in gram negative bacteria) [41].  The advantage 
of the natural transformation in terms of bacterial adaptation is not well understood. 
Two hypotheses have been proposed to explain the natural competency in bacteria; 
firstly, that transformation of DNA occurs mainly to provide DNA as a nutrient by the 
transformed cells, or the imported DNA is used by the cell to repair damaged DNA 
[44]. The second hypothesis is that transformation provides the genetic diversity and 
increased fitness of the bacteria in the so-called “sex hypothesis” [44]. Johnborg at al. 
(2007) assessed both models in a review paper based on many experimental data [44]. 
The authors argued that natural genetic transformation occurs to enable DNA to be used 
as a nutrient by bacteria, particularly in Streptococcus pneumonia. In this bacterium 
only the sense-strand of imported DNA is transferred into the cytoplasm, whereas the 
complementary strand is degraded outside the cell; a rather wasteful way of gathering 
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food [44]. Natural competencies of streptococcal species have been shown to increase 
the fitness of the bacterium, the best example is acquiring resistance to the beta-lactam 
antibiotic penicillin by S. pneumonia from the evolved commensal S. mitis [17, 44]. 
Moreover, use of DNA as a nutrient can also be considered to contribute towards the 
fitness of naturally competent bacterial enabling their survival in ecological niches 
when compared to non-competent bacteria.    
Bacteria can acquire new genetic materials from bacteriophage in the process of 
transduction [7]. In general, infection of the bacterium cell with the phage can be either 
multiplication of phage particles and then release to the environment after lysis of the 
host cell, or integration of the phage genome into the host chromosome as a prophage in 
the process of lysogenization. Transduction has also been shown to play an important 
role in the genome diversity of bacteria and several prophages have been identified in 
the genome sequence of bacteria [45]. In addition to introducing the bacteriophage 
DNA into the bacterial genome as a “generalised transduction”, bacteriophage can also 
work as a vehicle to transfer DNA material from previously infected hosts into the new 
bacterial chromosome in a process called “specialised transduction” [7, 45].  The latter 
type of transduction mainly occurs when the prophage imprecisely excises from 
bacterial chromosome, resulting in the package of a small fragment of the bacterial 
genome within the DNA phage [46]. The evolutionary advantage of lysogenic bacteria 
has been described for some strains of bacteria. In one of the earliest examples, Edlin et 
al. (1977) [47] reported that  P1, P2 and Mu prophages provided a reproductive fitness 
for the host E. coli strains; the growth rates of lysogens strains of E. coli were much 
faster than nonlysogen strains in glucose limited conditions, however both lysogen and 
non-lysogen strains had the same growth rate in non-nutrient limitation conditions [47]. 
Moreover, phages are also important in the dissemination of genomic islands. The gene 
encoding toxic shock toxin (tst) in Staphylococcus aureus is carried by a 15 kbp 
pathogenicity island, SaPI1, which is located on the chromosome and flanked by 17 bp 
direct repeats. It has been shown that, upon infection of the bacterium cell with the S. 
aureus phage 80α, SaPI1 is excised from the chromosome; it replicates autonomously, 
and is encapsulated into its own DNA into phage particles. Upon transfer into a new 
host, the SaPI1 integrates into the recipient cell using intergrase encoded by the gene on 
SaPI1 [48].  
Chapter 1 
29 
 
Conjugation is the direct transfer of the single stranded DNA from a donor to recipient 
cells through a multi-protein apparatus called conjugation or mating apparatus [33, 41, 
49]. Conjugation has been shown to play an important role in the quick adaptation of 
microorganisms to the new environment through acquiring genetic material from 
evolved strains. Several genes involved in xenobiotic degradation are found in self-
transmissible catabolic plasmids, which usually have several insertion and transposon 
elements [10].  Naphthalene catabolism genes, nahAC, have shown to be located on the 
self-transmissible plasmid and can be transferred from the naphthalene-degrading 
bacteria to their cured progeny via filter mating [50]. Moreover, genes involved in the 
mineralisation of the xenobiotic melamine in Rhodococcus sp. strain Mel [51] and 
mercury resistance genes [52] have also been shown to be located on self-transmissible 
plasmids. 
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1.3 Explosives as xenobiotic compounds   
1.3.1 Overview of explosives    
Explosives are a group of organic compounds that under thermal, chemical or physical 
effect decompose extremely rapidly, creating a large amount energy in the form of heat 
and gas.  
Blackpowder (gunpowder) was the first formulated explosive which was accidently 
discovered by Chinese alchemists during the process of separating gold from silver in 
low temperature reactions in 220 BC. The composition of blackpowder was made up by 
mixing charcoal and sulphur, with potassium nitrate as an oxidiser. Blackpowder was 
only discovered in Europe in the 13
th
 century by the English monk Robert Bacon [53].  
Nitroglycerine (Glyceroltrinitrate, GTN) a nitrate ester, was discovered by an Italian 
Professor Asanio Sobrero in 1846, and a few years later manufactured by a Swedish 
inventor, Immanuel Nobel, by mixing glycerol with a cooled mixture of nitric and 
sulphuric acids [53]. Although GTN was a more powerful explosive than blackpowder, 
the liquid physical state and chemical instability made the process of production 
extremely hazardous. Currently explosive compounds can be grouped into three main 
categories: nitrate esters, nitroaromantics, and nitramines [53].  
Nitrate esters are a group of explosives which are characterised by nitro groups linked to 
carbon atoms via ester bonds, with examples such as GTN and 
pentaerythritoltetranitrate (PETN). Both GTN and PETN are also medically important 
compounds; the release of nitric oxide as a result of enzymatic action have made these 
compounds useful as vasodilators during some medical condition, coronary angina 
being one example [54].  
Nitroaromatic explosives are characterised by several nitro groups (-NO2) on an 
aromatic structure, examples for this group include 2,4,6-trinitrotoluene (TNT), and the 
propellant 2,4-dinitrotoluene (2,4-DNT). Nitroamines contain one or more N-nitro 
groups on aromatic rings, examples for this group of explosives are hexahydro-1,3,5-
trinitro-1,3,5-triazine (RDX, Research Department eXplosive or Royal Demolition 
eXplosive) and octahydro-1,3,5,7-tetranitro-1,3,5,7-tetrazocine (HMX; High Melting 
Point eXplosive or Her Majesty's eXplosive) (Figure 1.7) [54, 55].  
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Figure 1.7: Examples of explosives and explosives transformation products of the 
explosives which usually find in explosive contaminated sites. The structures are drawing 
using ChemSketch version 12.0 [56] by Chong (2011) [57]. 
 
Both TNT and RDX are amongst the most commonly used explosives around the world 
and their toxicity has raised serious environmental concerns. The rest of this chapter 
will focus on these two compounds as explosive xenobiotic compounds.  
TNT was first discovered by German scientist Julius Wilbrand in 1863 [53] and it was 
the main explosive used during the first World War [53, 58] and is still considered to be 
the most widely used and important military compound [54, 58, 59].  Several factors 
contribute in the wide usage of TNT around the world including cheap raw materials, 
easy manufacturing processes, moderate stability for physical impact, relatively high 
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explosive power, and good compatibility with other explosives. Moreover, TNT has 
thermal stability, low volatility and low hygroscopicity; providing stability in moist 
conditions and detonatation in water (Table 1.1) [53].   
RDX was first prepared by a German scientist Georg Friedrich Henning in 1899 for 
medicinal purposes (Table 1.1). It was first used as an explosive by Herz in 1920 and 
has extensively been used since the Second World War for both military and industrial 
purposes [53]. It has a high explosive power, nearly 40 % higher than TNT. This feature 
has made RDX an important high explosive compound currently in use [54] and it is 
mainly used as a mixture with either TNT or HMX [60, 61]. 
Table 1.1: Properties of TNT and RDX [53, 61] 
Characteristics TNT RDX 
CAS Number  3808-89-2 00121-82-4 
Chemical formula  C7H5N3O6 C3H6N6O6 
Molecular weight  227.1 222.1 
Colour Pale yellow crystalline  White crystal  
Melting temperature/ ºC 80.8 204 
Thermal ignition temperature/ ºC 300 260 
Crystal density at 20 ºC/g cm
-3
 1.654 1.82 
Energy of formation/ kJ kg
-1
 -184.4 + 417 
Enthalpy of formation/ kJ kg
-1
 -261.5 + 318 
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1.3.2 Environmental contamination by explosives  
Production, use, storage and decomposition of explosives have resulted in large scale 
contamination worldwide. The precise scale of contamination is not clear, however in 
United States alone it is estimated that 24.6 million acres has been contaminated with 
munitions and the cost of the cleaning is estimated to be $16- $165 billions [62].  
Distribution of explosive compounds in contaminated sites is highly heterogeneous and 
it depends on the type of training range and munition used [55, 60, 63]. In a study to 
investigate the distribution of energetic compounds in 23 military training ranges in 
United States and Canada, the concentrations of RDX and TNT were found in hand 
grenades ranges to span between <0.01 to 51 mg/kg and <0.01 to 36 mg/kg for RDX 
and TNT, respectively. HMX was mainly found in anti-tank rocket range impact areas 
with concentrations ranged between  < 23 to 987 mg/kg [63], whereas the primary 
residue at the artillery and mortar firing points are the 2,4- and 2,6-dinitrotoluene (DNT) 
isomers [64]. The most extensive contaminated site in the training ranges was found 
near low-ordered, partial detonations artillery ranges with grams of pure soil explosive 
[63]. Similarly, the concentration of RDX, HMX, TNT, 2-amino-4,6-dinitrotoluence (2-
ADNT), and 4-amino-2,6-dinitrotoluence (4-ADNT) were found to be vary at the Camp 
Edwards Impact Area in United States, including detection of RDX in the ground water 
in the area [60]. 
TNT is recalcitrant to degradation in the environment; the three nitro groups of TNT 
withdraw electrons from the benzene moiety and make it difficult for electrophilic 
attack by microbial oxygenases [55]. In the case of RDX, in addition to the structure, 
which is also recalcitrant to degradation, RDX is also highly mobile in soil, so 
contamination of ground water from leaching is higher than for other explosives [60, 64, 
65].  
Both TNT and RDX are toxic and potential carcinogenic compounds [66]. TNT has 
been shown to be mutagenic in Vibrio fischeri [67, 68], Salmonella typhimurium 
(strains TA 98 and TA 100), mammalian cell line of hamster lung (V79 cells) [69], and 
to cause chlorosis in plants [70]. Humans exposed to TNT have suffered liver damage, 
toxic hepatitis and blood cell abnormality such as anaemia and jaundice [71].  
Chapter 1 
34 
 
The toxicity of RDX is mainly due to its effect on the central nervous system as well as 
renal and gastrointestinal systems. The toxicity of this compounds has been 
demonstrated in humans [72], mice, rats, dogs [73] and plants [74]. Accidental ingestion 
of RDX by humans showed several symptoms including several seizure, nausea, 
vomiting, postictal coma and abdominal tenderness [72].  
1.3.3 Microbial transformation of TNT  
There are a number of mono-nitroaromatic compounds like chloramphenicol, aureothin, 
phidolopin, nitropyoluteorin, oxypyrrolnitrin and 3-nitropropionic acid that exist in 
nature [54, 58]. However most nitroaromatics are substituted with multiple nitro groups 
and these are novel in the environment. These xenobiotic compounds have been 
intensively produced in the last century as explosives, pesticides, dyes, and 
polyurethane foams [58]. Microorganisms have evolved to tolerate the toxicity of these 
xenobiotic compounds and in some cases metabolise them.     
Mineralisation of mono- or di-nitro group compounds can occur in nature, though 
microbial degradation of the tri-nitro substituted compound TNT is particularly 
challenging and has not yet been clearly reported [55, 75]. However, several species of 
bacteria have been isolated and identified for their ability to transform TNT under 
aerobic and anaerobic condition using one of the two pathways shown in Figure 1.8 [76-
80].  
Type I oxygen-insensitive nitroreductases reduce nitro group of TNT through (pathway 
A, Figure 1.8). These are soluble flavoproteins found in many enteric bacteria and can 
reduce nitro groups on many different nitroaromatic compounds, including TNT, 
accompanied by oxidation of either NADP or NADPH.  The TNT reduction by type-I 
oxygen-insensitive nitroreductase is followed by the production of 
hydroxylaminodinitrotoluene (HADNT), aminodinitrotoluene (ADNT) and 
diaminonitrotoluene (DANT) and then diarlymine (only in bacteria) [81]. Examples of 
Type I nitroreductases with activity toward TNT are PnrA from Pseudomonas putida 
JLR11 [79] and nitroreductase (NR) from Enterobacter cloacae strain 96-3[82] 
Some members of the Old Yellow Enzyme family of flavoproteins can transform TNT 
by pathway B (Figure 1.8). These enzymes can also transform TNT via direct ring 
reduction and hydride addition to form monohydride-Meisenheimer or dihydride-
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Meisenheimer complexes [81]. Examples of this family of enzymes are Pentaerythritol 
tetranitrate reductase (PETNr) reductase and XenB from Enterobacter cloacae PB2 [77] 
and Pseudomonas fluorescens I-C [78], respectively.  
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Figure 1.8: Biotransformation pathways of TNT. In Pathway A, transformation of TNT 
occurs via reduction of a nitro group to form HADNT and ADNT. In Pathway B, TNT is 
transformed by hydrogenation of the aromatic ring structure to produce a Meisenheimer 
complex, which goes on to produce nitrite and diarylamine [75, 81, 83, 84]. The structures 
are drawing using ChemSketch version 12.0 [56] by Chong (2011) [57].  
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1.3.4 Microbial degradation of RDX 
The explosive compound RDX is considered to be strictly xenobiotic in the biosphere, 
as unlike the nitro aromatic TNT, natural nitramine compounds have not been identified 
in nature [54]. Structurally, RDX is not as stable as TNT and enzymatic attack to one of 
the three nitro groups or the -CH2- group is enough to destabilise the ring structure and 
initiate spontaneous decomposition [85].  
Reports of microbial degradation of RDX started in the 1980s [86], and three pathways 
have since been described for RDX biodegradation: anaerobic RDX-degradation 
through successive reduction [86], anaerobic denitratation of RDX through the 
formation of methylenedinitramine [87], and aerobic denitration of RDX [88, 89]. 
The biodegradation of RDX via successive reduction was proposed by McCormick et 
al. (1981) [86].  In this pathway, RDX is sequentially reduced to form hexahydro-l-
nitroso-3,5-dinitro-1,3,5-triazine (MNX), hexahydro-1-3-dinitroso-5-nitro-1,3,5-triazine 
(DNX), hexahydro-1,3,5-trinitroso-1,3,5-triazine (TNX), and then produce 
formaldehyde (HCHO) and methanol (CH4O) (pathway A, Figure 1.9) [86]. Hawari et 
al. (2000) [87] suggested this pathway occurs via a two-electron reduction of RDX by 
type I oxygen-insensitive nitroreductase. Indeed, purified type I nitroreductase from 
Enterobacter cloacae strain 96-3 was shown to reduce RDX, however the metabolite 
products of RDX reduction were not identified in that study [90]. RDX-degradation 
through a two-electron reduction was also reported for a nitrate reductase (EC 1.6.6.2) 
from Aspergillus niger  [91]. This enzyme reduced RDX anaerobically to MNX and 
then, differing from the previous pathway, the ring structure of MNX is broken down to 
produce an intermediate metabolite methylenedinitramine (similar to pathway B, Figure 
1.9), which then produced nitrous oxide (N2O), formaldehyde (HCHO), and an 
ammonium ion (NH4
+
) [91]. Several anaerobic bacterial species have also been 
identified as being able to degrade RDX by this pathway [86, 92, 93]. 
A second RDX-degradation pathway was proposed by Hawari et al. (2000) [87] after 
identifying two novel metabolite products, methylenedinitramine [(O2NNH)2CH2] and 
bis(hydroxymethyl)nitramine [(HOCH2)2NNO2], from anaerobic RDX-degradation by 
municipal anaerobic sludge in a phosphate-buffered (pH 7) mineral salt medium using 
glucose as a carbon source [87]. The authors suggested that RDX degradation occurs via 
an initial ring structure cleavage of RDX to produce the above mentioned intermediate 
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products, which are then converted to nitrous oxide, formaldehyde, formic acid and 
methane by the action of different indigenous organisms in the sludge (pathway B, 
Figure 1.9). The enzyme responsible for the initial N-C-N bond cleavage of the RDX 
ring was not identified [87], however later it was proposed that the ring cleavage of 
RDX could be occurring via a single electron reduction by oxygen sensitive type-II 
nitroreductase. This enzyme converts RDX to an unstable radical anion, and subsequent 
denitratation cleaves the intermediate product to form methylenedinitramine [89]. 
Klebsiella pneumoniae strain SCZ-1, a gram negative facultative anaerobic bacterium, 
was also found to degrade RDX mainly through the (pathway B, Figure 1.9). 
Additionally, the aerobic RDX- transformation by XenA and XenB mainly occurs 
through this pathway [94].       
Biodegradation of RDX can also occur via denitration. In this pathway, the denitration 
of RDX results in the cleavage of the ring structure and produces 4-nitro-2,4-
diazabutanal (NDAB, NO2NHCH2NHCHO), methylenedinitramine (MEDINA, 
NO2NHCH2NHNO2), and formamide. NDAB is the dead end product, which is mainly 
produced from di-denitration and di-hydration of RDX. MEDINA is an intermediate 
product of mono-denitration and mono-hydration of RDX which, with formamide, are 
further transformed abiotically to N2O, NH3, and CO2 (Figure 1.10)[88]. Interestingly, 
although this pathway was described in aerobic bacteria, oxygen is not involved in 
microbial degradation of RDX [89].  
Three enzymes have been identified that denitrate RDX via this pathway; an eukaryotic 
cytochrome P450 2B4 (EC 1.14.14.1) from rabbit liver [85], a cytochrome P450 from 
Rhodococcus rhodochrous 11Y called XplA [95, 96] and a flavoprotein diaphorase (EC 
1.8.1.4) from Clostridium kluyveri [97]. 
Bhushan et al. (2003) [85] has shown that the cytochrome P450 2B4 can degrade RDX 
in the same pathway (Figure 1.10) with the production of nitrite, formaldehyde and 
NDAB. Interestingly, the activity of cytochrome P450 2B4 toward RDX was three fold 
faster than the activity of the enzyme towards its reported standard substrate 
pentoxyresorufin in pH 7.2 at 37 °C. Additionally, enzyme activity was strongly 
inhibited by oxygen which reduced reaction rates three fold. Moreover, for the first 
time, it was proposed that a cytochrome P450 might be involved in RDX-degradation 
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by Rhodococcus sp. DN22 before the identification of XplA in R. rhodochrous 11Y 
[85].  
The XplA protein is an unusual cytochrome P450 as it has a flavodoxin domain N-
terminally fused with to a heme domain [96]. RDX degradation pathway by XplA from 
R. rhodochrous 11Y was described by Jackson et al. (2007) [95]; interestingly, 
denitration of RDX by XplA is not oxygen-dependent but the presence of oxygen 
determines the nature of the end products. Under aerobic condition, RDX is double 
denitrated and double hydrated to produce NDAB, two molecules of nitrite and one 
molecule of formaldehyde. Under anaerobic conditions, RDX is single denitrated and 
hydrated to produce MEDINA, one molecule of nitrite and one molecule of 
formaldehyde [95]. The dentritation activity of XplA towards RDX was also reduced by 
two folds in aerobic conditions compared to anaerobic conditions (Figure 1.10) [98].  
Diaphorase (EC 1.8.1.4) from Clostridium kluyveri transforms RDX anaerobically via 
the mono denitration pathway. Similar to the anoxic denitration of RDX by XplA, the 
RDX ring structure is cleaved after the first denitration and hydration to produce 
MEDINA, which is then converted to nitrite, formaldehyde, ammonium, and nitrous 
oxide (Figure 1.10). Likewise XplA and cytochrome P450 2B4, the activity of this 
enzyme was inhibited by oxygen and reduced activity by 92 % under aerobic condition 
[97].  
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Figure 1.9: Biodegradation of RDX under anaerobic conditions. In Pathway A, RDX is 
degraded via a two electron reduction to form MNX, DNX and TNX [86]. In Pathway B, the 
ring structure of RDX is cleaved via a single electron reduction by Type I reductase to 
produce methylenedinitramine and bis(hydroxymethyl) nitramine, which is then converted to 
nitrous oxide, carbon dioxide, and methane [87]. The structures are drawing using 
ChemSketch version 12.0 [56] by Chong (2011) [57]. 
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Figure 1.10: Aerobic denitration pathway of RDX in Rhodococcus sp. DN22. The 
intermediate products I and II are the result of single and double denitration processes, 
respectively. Reproduced from Annamaria et al. (2010) [88].  
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1.3.5 RDX denitration by cytochrome P450 XplA 
Although diaphorase (EC 1.8.1.4) [97], cytochrome P450 2B4 (EC 1.14.14.1) [85], 
XenA, XenB [94], Type I nitroreductase [90] and nitrate reductase (EC 1.6.6.2) [91] can 
all transform RDX, research has mainly focused on XplA as a potential enzyme to clean 
up RDX-contaminated sites as it degrades RDX in both aerobic and anaerobic 
conditions and the rate of the RDX-removal is faster than by other reported enzymes.   
The gene xplA encoding XplA was first identified by Seth-Smith et al. (2002) in the 7.5 
kbp pHSX1 genomic library of R. rhodochrous 11Y, an RDX-degrading bacterium 
isolated from explosive contaminated soil of the UK. When the pHSX1 fragment of 
11Y was transferred into non-RDX-degrading bacterium R. rhodochrous CW25, the 
transformed CW25 acquired RDX-degradation capacity. Sequencing of pHSX1 showed 
that the region encodes a flavodoxin reductase, a flavodoxin domain fused to 
cytochrome P450 and an acetyl CoA synthase (Figure 1.11) [96]. To identify the key 
enzyme responsible of RDX-degradation capacity in the pHSX1 region, the pHSX1 
region was sub-cloned into 3.5 kbp pHSX1a and 2.3 kbp pHSX1b (Figure 1.11). Each 
sub-clone was transferred into R. rhodochrous CW25, and transformed CW25 with 
either sub-clone acquired the ability to degrade RDX.  It was therefore concluded that 
XplA is an essential enzyme for RDX degradation and indigenous reductase from the 
host cell can supply electrons to XplA when the reductase partner is missing [96].  
 
 
 
 
 
 
Figure 1.11: The 7.5 kbp fragment flanking the xplA/xplB region from R. rhodochrous 
11Y responsible for conferring the ability to degrade RDX in R. rhodochrous CW25. 
The region was found to encode three proteins; ferredoxin reductase (XplB), a flavodoxin 
domain fused N-terminally to the cytochrome P450, and acetyl CoA synthase. Reproduced 
from Seth-Smith et al. (2002) [96]. 
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The XplA from R. rhodochrous 11Y was recombinantly expressed and characterised. 
Spectrophotometric analysis of purified XplA showed the peak of the protein at 420 nm, 
and this peak shifted to 408 nm upon reduction with sodium diothionate, and then 
shifted back to 448 nm, a characteristic Soret peak of cytochrome P450, when the 
reduced XplA was bubbled with carbon monoxide (Figure 1.12) [98]. 
 
Figure 1.12: Spectrophotometric analysis of the purified XplA protein in oxidised form, 
reduced form with sodium diothionate, and reduced with CO. Reproduce from Rylott et 
al. (2006) [98]. 
 
Digestion of the purified protein with trypsin and mass spectrometry (MS/MS) 
identification of the peptides revealed that the P450 domain of XplA is fused to a 
flavodoxin protein; a unique arrangement which was not previously known for 
cytochrome P450 proteins. Moreover, it was shown that the flavodoxin domain of XplA 
is active and has an FMN cofactor [98]. Interestingly, RDX denitritation by XplA is not 
an oxygen-dependant reaction, different from most other cytochromes P450 which 
usually have oxygenase activity [95]. The crystal structure of the XplA-heme revealed 
the oxygen-independent activity of this protein is due to the replacement of highly 
conserved residues Glu/Asp-Thr/Ser in other P450s, required for oxygenase activity, 
with Met-394 and Ala-395 in the active site of XplA. The importance of Ala-395 for 
denitration activity of the enzyme was shown by mutating the residue to threonine: this 
dramatically reduced the kcat/KM of the enzyme by approximately 200-fold (More 
details on crystal structure of XplA-heme is on Chapter 6) [99].  
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Intriguingly, since the identification of xplA in R. rhodochrous 11Y, the gene has been 
identified in a number of RDX-degrading bacteria around the world with > 99 % 
sequence identity. Homologues of xplA were found in 18 RDX-degrading Rhodococcus 
spp isolates from the UK [100]; Rhodococcus sp. DN22 isolated from Australia [100]; 
Rhodococcus sp. YH1 [100], Rhodococcus sp. T7, and Rhodococcus sp. T9N isolated 
from Israel [101] Gordonia sp. KTR9, Williamsia sp. EG1 [102], and Microbiacterium 
sp. MA1 isolated from United States [103].  
The presence of nearly identical xplA in RDX-degrading bacteria isolated from distinct 
geographical locations suggests the recent evolution of the gene. Interestingly, sequence 
comparison of the 52.2 kbp partial sequence of the plasmid carrying xplA in 
Microbiancterium sp. MA1 with the 7.5 kbp sequence of the pHSX1 library of R. 
rhodochrous 11Y revealed that in addition to xplA/xplB, there is a ~4 kbp flanking 
region that is also nearly identical (> 99%) between these two phylogenetically distant 
related bacteria [103]. Therefore, it was suggested that the gene was acquired by 
horizontal gene transfer prior to its global distribution. Furthermore, the conjugal 
transfer of plasmid pGKT2, which carries xplA and xplB, from Gordonia sp. KTR9 to 
Gordonia polyisoprenivorans, Rhodococuss jostii RHA1 and Nocardia sp. TW2 has 
been reported, which further supports this proposal [104].  
Similar to XplA, its partnering reductase XplB from R. rhodochrous 11Y has been 
recombinantly expressed and characterised [95]. XplB is a flavoprotein, containing one 
molecule of FAD as a co-factor. The protein was expressed recombinantly fused with a 
GST tag. Cleavage of the GST-tag from XplB resulted in precipitation of the protein. 
Soluble XplB was shown to actively transfer electrons from NADPH to the heme centre 
of XplA to degrade RDX; suggestion XplB is a reductive partner to XplA. Additionally, 
xplB has been also found alongside xplA in all aerobic RDX-degrading bacteria that 
have been tested to date. However, in Gordonia sp. KTR9, xplB is naturally fused to 
glnA which encodes glutamine synthetase [105].   
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1.3.6 Application of XplA and XplB for environmental remediation  
Pollution by explosives has risen in recent years as a major environmental concern. 
Methods like incineration and composting have been applied to de-contaminate polluted 
areas, however these methods can be expensive and some in some cases produce 
additional environmental problems.  
The XplA and XplB enzymes have also been intensively studied for their potential 
ability to remediate RDX. For this purpose, transgenic lines of Arabidopsis thaliana 
expressing xplA, were initially created and tested for RDX-removal capacity in axenic 
liquid cultures. The transgenic lines rapidly removed all the RDX whereas 
untransformed plant lines had no significant uptake of RDX during the same time 
course [98].  
The plant line with the highest rate of RDX removal (35S::XPLA-10) was selected for 
further studies using soil contaminated with 50, 250, 500 and 2,000 mg/kg of RDX. In 
addition to the fact the transgenic plants did not show any sign of suffering from the 
phytoxic effect of RDX, the shoot and root biomasses of these plants were nearly three 
times bigger than the wild-type. Moreover, three times less RDX was detected in the 
transgenic line compared to wild-type. Thus, xplA in A. thaliana confers resistance to 
RDX toxicity. That the transgenic line produced greater shoot and root biomasses in the 
presence of RDX compare to plants grown on pristine soil suggests that xplA also 
confers the ability to use RDX as a source of nitrogen [98] (Figure 1.13).  
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Figure 1.13: (A) Growth of eight week old transgenic (XPLA-10) line and wild-type 
plants in uncontaminated and soil contaminated with 50, 250, 500 and 2000 mg/ kg 
RDX. (B) Shoot and root biomass of wild-type and transgenic plants. Fwt– fresh 
weight. Reproduced from Rylott et al. (2006) [98]. 
 
Homozygous XPLAB transgenic lines was created by transforming 35S::XPLA-10 with 
xplB gene. Transferring xplB to XplA-expressing lines remarkably improved the RDX-
removal capacity by the xplA transgenic line. RDX-removal by the eight-week old 
XplAB-2 and XplAB-27 lines in a soil leachate was four times higher than 35S::XPLA-
10 transgenic plant; all RDX (180 µM) was disappeared from by XplA/XplB expressing 
lines, whereas just 25% of RDX removed by 35S::XPLA-10 transgenic line, and no 
RDX removal were detected with wild-type [95].  
Although these transgenic plants were shown to actively remove RDX in soil 
contaminated with RDX, one obstacle to the application of transgenic plants in the real 
world would be the inhibitory effect of the co-contaminant explosive TNT towards 
XplA in the contaminated site. It has been shown that TNT strongly inhibits the RDX-
denitration activity of XplA [95], as well as RDX-degradation activity by Rhodococcus 
sp. YH1 [106]. 
To overcome this barrier, the XplAB-2 transgenic line was re-transformed with the nfsI 
gene from Enterobacter cloacae, encoding a TNT-transforming enzyme. The transgenic 
plants could not only degrade RDX, but could also withstand the phytoxicity and 
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inhibitory effects of TNT.  Currently, Professor Neil Bruce’s group, and collaborators, 
are studying switchgrass (Panicum virgatum) transgenic lines expressing xplA/xplB and 
nfsI, and field trials of RDX phytoremediation by transgenic plants are underway at an 
explosive-contaminated site in the U.S. 
1.3.7 Aims of the project 
The explosive RDX is a strictly xenobiotic compound and has been in the environment 
for a relatively short period of time. To date XplA has only been identified in bacteria 
from explosive contaminated sites, and no close homologues or natural substrates have 
been identified for XplA. These findings lead to intriguing questions about the origin of 
XplA, thus, the aims of this study are to:  
1- Isolate new bacteria harbouring similar XplA or different enzymes with activity 
towards RDX allowing the construction of an evolutionary map for xplA, as well 
as an attempt to discover a new RDX-degrading enzyme not affected by TNT.  
2- Investigate the mechanism by which xplA-carrying bacteria survive in explosive 
contaminated sites, in which TNT is a co-contaminant. 
3- Compare xplA-flanking regions in RDX-degrading bacteria isolates that have 
originated from distinct geographical locations in order to characterise the 
mobile element carrying the gene.  
4- Investigate the potential evolutionary advantage of the natural fusion of XplB to 
glutamine sysnthetase (XplB-GS) protein in RDX-degrading bacterium 
Gordonia sp. KTR9.  
5- Shed light on the evolutionary origin of the xplA gene by characterising three 
putative cytochromes P450 whose sequences have been recently released and 
share sequence similarity to XplA.    
 
 Chapter 2: Materials and Methods 
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2.1 Chemicals and reagents  
All chemicals, reagents and DNA modification enzymes used in this study, unless 
specified, were purchased from Bio-Rad Laboratories Ltd., Invitrogen, New England 
Biolabs, Promega, Sigma-Aldrich and Thermo Fisher Scientific.   
The explosives RDX and TNT (both > 95% purity) were kindly provided by the 
Defence Science and Technology Laboratory, Fort Halstead, U.K. 
Oligonucleotide primers for routine PCR were designed using an online service 
(http://primer3.ut.ee/) [107, 108]. Primers for cloning were designed based on the In-
Fusion® HD cloning (Clontech Laboratories) website (http://bioinfo.clontech.com/infus 
ion/convertPcrPrimersInit.do). For site directed mutagenesis studies, primers with 
substituted nucleotides were designed manually following the criteria detailed by the 
QuickChangeII Site-Directed Mutagenesis method. All primers were synthesised either 
by Sigma-Aldrich or Integrated DNA Technologies. A list of the primers used in this 
study, unless otherwise specified, can be found in Table 2.1. 
2.2 Bacterial strains 
The aerobic RDX-degrading bacteria used to characterise the RDX-genomic island 
belonged to four different genera and originated from different geographical locations 
(Table 2.2). Gordonia terrae strain NBRC 100016 and Gordonia polyisoprenivorans 
NBRC 16320 were supplied by The Biological Resource Centre (NBRC), National 
Institute of Technology and Evaluation (NITE) in Japan.  
Escherichia coli DH5α (Invitrogen) was supplied from NCB group socks. E. coli BL21 
(DE3) was supplied by Invitrogen, E. coli Rosetta 2 (DE3) by Novagen-Merck and E. 
coli ArtricExpress by Agilent Technologies.  
2.3 Plasmids 
The gene expression vectors used in this study were pET-16b (Novagen-Merck), pET-
28a (+) (Novagen-Merck) and pGEX2T (GE Healthcare Life Sciences).  
The pET-16b vector has an ampicillin/carbenicillin selective marker and is used to 
express genes as N-terminally His-tagged proteins (Figure 2.1). pET-28a(+) has a 
kanamycin selective marker and is used to express genes as either N-terminally or C-
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terminally His-tagged proteins (Figure 2.2). pGEX2T also has a carbenicillin/ampicillin 
selective marker and is used to increase the solubility of the protein tagging the coding 
region N-terminally with a glutathione S-transferase (GST) peptide (Figure 2.3). 
 
Figure 2.14: Vector map of pET-16b.  The vector has an ampicillin (shown as Ap in the 
figure) resistance gene and is designed to express heterologous genes as His-tag proteins 
using a T7 promoter. Multiple cloning sites in the vector are shown as a black arrow. 
 
Chapter 2 
51 
 
 
Figure 2.15: Vector map of pET-28a(+).  The vector has a kanamycin (shown as Kan) 
resistance gene and is designed to express heterologous genes as N-terminal or C-terminal 
His-tag proteins using a T7 promoter. Multiple cloning sites in the vector are shown as a 
black arrow. 
 
 
Figure 2.16: Vector map of pGEX-2T. The vector has ampicillin/carbenicillin resistance 
gene and is designed to express heterologous genes with an N-terminally fused glutathione 
S-transferase (GST) peptide using the tac promoter.   
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Table 2.1: List of the primers used in this study: 
Primer used to amplify RDX-degrading genomic island amongst RDX-degrading 
bacteria (Chapter 4)  
Name 
Primer binding 
sequence 
Sequence 5′-3′ 
Product 
size (bp) 
A-F GAF-F  CGATTCCGTATCCGACCTC 
1,426 
A-R TranscRp-504R GATGTTCTCCGGTTGATCG 
B-F RegulatoryPrt-89F       GGTTCACATGGCTTTTCACC 
886 
B-R SensorK-935R CTATCGCATCGCTCAGGAGT 
C-F SensorK-1078F CATTCCGTCTATTCCGGTTC 
958 
C-R SensorK-123R CGTGGTCGTGACAGTCATCT 
D-F Sensork-337F CGTCATCAGTACGAGCTGGA 
1,295 
D-R Carbesterase-167R AGAGTCGGGCACATGACAC 
E-F HypoPrt-453F GGTCTCGCAACACACTGAAC 
1,274 
E-R MarR-194R GCACTGTTGAGTCCGAGATG 
F-F HypoPrt-453F ACGTCGGAATTCAGTGTCGGGCGGACC 
1,351 
F-R Permease-6R GAGTCGAAGAGGGCACTCAG 
G-F Permease-7F CTGTGTGGTGTGGTGATGGT 
1,038 
G-R Permease-7R CTACTCCCCGGTCTTCTTCGGAAT  
H-F Permease-8F ACTACATCGTGCTGCTGTCC 
1,078 
H-R Dihydro-8R GTCGAGCATATGCACGTCGGGGATACG 
I-F Dihydro-9F GATGTCAACGAATGGACGAT 
1,049 
I-R xplB-9R GTCGATCCGAAGTGGAACAC 
J-F xplB-10F CGGTGATGATGCGTGAACT 
900 
J-R XplA-192R CAGTTCACCCTCTCCGTAGGTGGAGGTGAC 
K-F xplB-11F ACCCGAACACCCGAGATGGAGTGTGGAGA 
1,065 
K-R xplA-11R TCAGATAGCCGAAAGCGACT 
L-F xplA-12F CACGCGTCCTACAACTACCC 
1,073 
L-R SSD12R AACAGCTCCTCACGGTAAGC  
M-F xplA13F ATCGTCCTGTCCTGAAAACC 
977 
M-R AMP13R GTTGTGGCAGGTGTTGAGTT 
N-F AMP14F ATCAGCGATGGGACGATAC 
1,143 
N-R AMP14R ATGCCCAGGTGAACGTGT 
O-F AMP15F GTGATGTACGAGGGCAAGC 
981 
O-R AMP486dwnR GACGGCATACAAGACGAACA 
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Primers to amplify the internal region of the xplA (Chapter 3) 
Name  Sequence 5′-3′ 
XplA-513F AGAGTTTGATYMTGGCTCAG 
XplA-1033R TCAGATAGCCGAAAGGGACT 
Primers to amplify 16S rRNA [109] (Chapter 3 and 4) 
Name  Sequence 5′-3′ 
7F AGAGTTTGATYMTGGCTCAG 
1510R ACGGYTACCTTGTTACGACTT 
Primers to sequence inserts in expression vectors (Chapter 4, 5 and 6)  
Name Sequence 5′-3′ 
T7 Promoter TAATACGACTCACTATAGGG 
T7 Terminator GCTAGTTATTGCTCAGCGG 
pGEX 3′ GGGCTGGCAAGCCACGTTTGGTG 
pGEX 5′ CCGGGAGCTGCATGTGTCAGAGG 
Primers to clone xplB-glnA into pET-28a(+) and pGEX2T (Chapter 5)  
Name Sequence 5′-3′ 
pET-28-xplB-glnA-F TCGCGGATCCGAATTCATGAGTACATCCGCGCTCG 
pET-28-xplB-glnA-R GGTGGTGGTGCTCGAGTCAGCAGACCGATTCGGCCG 
pGEX-xplB-glnA-F GGTTCCGCGTGGATCCATGAGTACATCCGCGCTCG 
pGEX-xplB-glnA-R GTCGACCCGGGAATTCTCAGCAGACCGATTCGGCCG 
Primers to mutate Trp-386 to Ser in XplB from R. rhodochrous 11Y, and mutate Ser-
385 to Trp in XplB-GS (Chapter 5) 
Name Sequence 5′-3′ 
XplB(W386S)-F GTCGATTTCGACGGCTCGATGCGGATCG 
XplB(W386S)-R  CGTCGATCCGCATCGAGCCGTCGAAA 
XplB(S385W)-GS-F GTCGATTTCGACGGCTGGATGCGGATCG 
XplB(S385W)-GS-R CGTCGATCCGCATCCAGCCGTCGAAA 
 
 
 
 
 
Chapter 2 
54 
 
Primers used to clone cytochromes P450 into expression vectors (Chapter 6) 
Name  Sequence 5′-3′ 
pET-28GtP450-F TCGCGGATCCGAATTCATGACCCTGATCCATGTCTGGTA 
pET-28GtP450-R   GGTGGTGGTGCTCGAGTCAGCTCAAGGAGATGGGCAT 
PET-16bCYPA-F TCGAAGGTCGTCATATGATGAGCGACATACAAGCTGC 
pET-16bCYPA-R GTTAGCAGCCGGATCCTCAGGGAATCAGGCGTAGAG 
pET-16bCYPB-F TCGAAGGTCGTCATATGATGACAACCACTGACACACTGT 
pET-16bCYPB-R GTTAGCAGCCGGATCCTCATGACAGGCGGACAGTA 
pET-28-CYPA-F AGGAGATATACCATGGCAATGAGCGACATACAAGCTC 
pET28-CYPA-R CCGCAAGCTTGTCGACGGGAATCAGGCGTAGAGG 
pET-16b-turnCYPA-F TCGAAGGTCGTCATATGGCAACGTCAACCAGTCCC 
pET-16b-turnCYPA-R TCGAAGGTCGTCATATGACGTCAACCAGTCCCGCA 
Primers used for site directed mutagenesis in the cytochrome P450 (CYPA) in Gordonia 
polyisoprenivorans NBRC 16320 (Chapter 6) 
Name  Sequence 5′-3′ 
CYPA-D256A-F GGGCACATGGCCGTCGGGTACCTGATCGCAGC 
CYPA-D256A-R ATCAGGTACCCGACGGCCATGTGCCCGAGGC 
CYPA-E299Q-F CGATCCACCACAACTGTGTTTCTACCGGGT 
CYPA-E299Q-R GTTAGCAGCCGGATCCTCAGGGAATCAGGCGTAGAG 
CYPA-P184L-F GAGACCATGCTGATGCTGGCCG 
CYPA-P184L-R GCCAGCATCAGCATGGTCTCGAA 
CYPA-L252V-F GATGCTTTACAGCGTCGGGCACATG 
CYPA-L252V-R GCCATGTGCCCGACGCTGTAAAG 
CYPA-M248V-F CGTGCGACAGCGCTGGTGCTTTACAG 
CYPA-M248V-R CGACGCTGTAAAGCACCAGCGCTGTC 
CYPA-I100L-F GTGCGAGACACGGTCCTCGGCAAGGA 
CYPA-I100L-R GCAGGTCCTTGCCGAGGACCGTGTCTC 
Primers used for site directed mutagenesis in the cytochrome P450 from Gordonia 
terrae NBRC 100016 (Chapter 6) 
Name  Sequence 5′-3′ 
GtP450-N396A-F GGTGCACCCGCCCCCGCCTA 
GtP450-N396A-R GGTAGGCGGGGGCGGGTGCA 
GtP450-P395M-F GTCCGGTGCAATGGCCCCCGCCTAC 
GtP450-P395M-R GAGGTAGGCGGGGGCCATTGCACCG 
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Table 2.2: List of RDX degrading bacteria used to study the RDX degrading genomic 
island (Chapter 4) 
 
2.4 Media 
2.4.1 Minimal medium 
Minimal medium was made up of 50 mM potassium phosphate buffer (pH 7.2) 
containing glycerol (10 mM), glucose (5 mM), and succinate (5 mM) as a carbon 
source, trace elements [115], and 100 µM RDX from a 1 M stock of RDX dissolved in 
DMSO, unless otherwise specified, as a sole source of nitrogen.  
2.4.2 Luria Bertani Broth (LB) medium   
Luria Bertani Broth (LB) medium was prepared by dissolving tryptone (10 g/L), yeast 
extract (5 g/L) and NaCl (10 g/L) in distilled water. Luria-Bertani Agar (LA) was made 
by adding 15 gram of agar into 1 L of LB prior of autoclaving.   
Bacterial strains 
16s rRNA Accession 
number 
Country of 
isolation 
Source 
R.  rhodochrous 11Y AF439261.1 UK [110] 
Rhodococcus sp. Bl-1 KF700363 Belgium 
Isolated by 
Dr. Astrid Lorenz 
Rhodococcus sp. DS1 KF933858 Belgium In this study 
Rhodococcus sp. 9UK      KJ566615 UK 
Isolated by 
Dr. Cyril Bontemps 
Rhodococcus sp. 5U KJ566616 Ukraine In this study 
Rhodococcus sp.YH1 AF103733.1 Israel 
Provided by 
Prof Zeev Ronen[111] 
Rhodococcus sp. DN22 X89240.1 Australia [112] 
Rhodococcus sp. EG2 KF571869.1 US 
Provided by  
Dr. Peter Andeer [113] 
Williamsia sp EG1 KF571870.1 US 
Provided by  
Dr. Peter Andeer [113] 
Microbacterium sp. MA1 FJ357539 US 
Provided by 
Dr. Peter Andeer [103] 
Gordonia sp. KTR9 DQ068383 US 
Provided by 
Dr. Karl Indest [114] 
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2.4.3 MacConkey Broth 
MacConkey broth was prepared by disolving 40 g/L of MacConkey powder (Oxoid) in 
water.  
2.4.4 SOC media   
SOC (Super Optimal broth with Catabolite repression) was prepared by disolving of 
NaCl (0.5 g/ L), tryptone (20 g/L) and yeast extract (5 g/L) in water. The medium was 
autoclaved and then 20 mM of sterile filtrated glucose was added.  
2.4.5 RDX dispersion agar plates 
The RDX dispersion agar plates were made by dissolving 15 g of agarose in 1 L 
minimal medium (section 2.4.1) containing 2 mM RDX as a sole source of nitrogen. 
The plates have an opaque appearance due to insoluble crystals of RDX (the solubility 
limit of RDX is < 180 µM at 30 ºC [116]). Bacteria able to degrade RDX create a zone 
of clearance which is produced by the removal of precipitated RDX.  
2.4.6 Gordonia terrae strain NBRC 100016 growth medium 
Both broth and agar plates for culturing G. terrae strain NBRC 100016 were prepared 
according to the supplier’s protocol as follows: Broth (pH 7.0) was prepared by 
dissolving of peptone (5 g/L), yeast extract (3 g/L), and MgSO4.7H2O (1 g/L) in 
distilled water. Yeast-Krainsky's Agar (pH 7.3) used for plating bacteria was made by 
dissolving glucose (10 g/L), L-asparagine (1 g/L), K2HPO4 (0.5 g/L), yeast extract (2 
g/L) and agar (17 g/L) in water. 
2.4.7 Gordonia polyisoprenivorans NBRC 16320 growth medium 
The broth medium (pH 7.0) was made of polypeptone (10 g/L), yeast extract (2 g/L) and 
MgSO4.7H2O (1 g/L) in distilled water. Plates were made by adding 15 g/L of agar to 
the broth medium.   
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2.4.8 Y medium 
The Y medium (pH 7.6) was made up of yeast extract (5 g/L), tryptone (20 g/L) and 
MgSO4.7H2O (5 g/L) in distilled water. The pH was adjusted to 8 with 20 mM Tris-
HCl.  
2.5 Microbiological techniques 
2.5.1 Bacterial growth on RDX medium  
Growth and RDX removal of RDX-degrading bacteria were compared by inoculating 
50 µl of 0.1 g/ml bacterial cells  into 50 ml minimal medium in 250 ml flasks containing 
100 µM RDX as the sole source of nitrogen, at 30 ºC with shaking at 180 rpm. The 
growth of the bacteria was monitored by measuring the OD600 using a UV-160A 
recording spectrophotometer (Shimadzu Corp., Kyoto, Japan). The RDX depletion was 
measured by taking 200 µl samples from the culture, centrifuging at 13,000 rpm for 10 
minutes and analysing the supernatant by HPLC (Section 2.8.1).   
2.5.2 Resting cell experiments 
The RDX-degrading bacteria (50 µl) from 0.1 g /L cells in 50 mM potassium phosphate 
buffer pH 7.2 were inoculated into 50 ml minimal medium in 250 ml flask containing 
100 µM of RDX. Bacteria were grown at 30 ºC with shaking (180 rpm) to  OD600 ~0.4-
0.6. Cells were harvested by centrifuging the culture in 50 ml Falcon tubes at 4,500 rpm 
for 10 minutes. The cells were washed twice with 50 mM potassium phosphate buffer 
(pH 7.2) to remove any RDX absorbed to the cells. Cell suspensions (100 µl), made 
from 0.1 g wet cell biomass in 1 ml of potassium phosphate buffer pH 7.2, was added to 
900 µl of potassium phosphate buffer (pH 7.2) containing 100 µM of RDX as a final 
concentration. Resting cell assays were carried out at room temperature with shaking at 
3,000 rpm. RDX removal by the bacteria was monitored by taking 100 µl aliquots at 
different time points followed by a quick stop of the reaction with 10 µl of 10 % TCA. 
The RDX concentration was measured by injecting 50 µl of the reaction into the HPLC 
(Section 2.8.1).    
Chapter 2 
58 
 
2.5.3 Effect of TNT on RDX degradation by bacteria  
The inhibitory effect of TNT on RDX degradation by bacteria was investigated by 
comparing the RDX removal capacity of the bacteria in the presence and absence of 2 
µM TNT. Cell suspensions (100 µl), made up of 0.1 g/ml of cells, were used to 
inoculate 50 ml of minimal medium in 250 ml flasks containing 100 µM RDX, with or 
without 2 µM TNT. Cultures were grown with shaking (180 rpm) at 30 ºC degree. RDX 
removal from both cultures were compared by taking an aliquot (200 µl) from the 
cultures after 9 hours incubation.   
2.6 Molecular biology techniques 
2.6.1 Bacterial total genome extraction 
Bacterial total genomic DNA was extracted by lysing the bacterial cells using TE buffer 
containing 10 mg/ml lysosyme, 10 % SDS and 20 mg/ml proteinase K. Cell debris was 
pelleted by centrifugation at 8000 rpm and proteins were removed using phenol-
chloroform. Nucleic acids were precipitated using 3M sodium acetate and isopropanol, 
washed in 70 % ethanol and resuspended in nuclease free water.  
2.6.2 Total genome sequencing  
The total bacterial genome was extracted (section 2.6.1) and sequenced on the Next 
Generation Sequencing platform Ion Torrent (Life Technologies) at the Biorenewables 
Development Centre (University of York). The Ion Torrent sequencing platform was 
used because it was readily available at the University of York. Additionally, Ion 
Torrent is currently a fast, relatively cheap technique, which produces longer sequence 
reads than the other major sequencing platform available (Illumina). However, Ion 
Torrent has a lower read accuracy than Illumina (Miseq, GAIIx, HiSeq) [117]. The raw 
sequence reads were assembled using the software package Newbler (version 2.7).  
2.6.3 Polymerase chain reaction  
Polymerase chain reactions were performed in a PCR thermocycler (ThermoElectron 
Corp). GoTaq DNA polymerase (promega) was used for routine screening purposes and 
Phusion DNA polymerase (New England Biolabs) for 16S rRNA amplification, cloning 
and site directed mutagenesis.  
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Gotaq DNA polymerase reactions (50 µl) contained 1.2 U GoTaq DNA polymerase, 2.5 
mM MgCl2 solution, 1x Green GoTaq
 
Flexi buffer, 0.2 mM dNTPs, 0.5 µM of primer, 
and 10-200 ng of DNA template. Thermocycler conditions consisted of one cycle of 95 
°C for 2 minutes, and then 35 cycles of denaturation at 95 °C for 30 seconds, annealing 
at an optimised temperature for 30 seconds, and then extension at 72 °C for 1 minute/ 1 
kbp amplicon. This was followed by a final extension phase at 72 ºC for 10 minutes. 
Annealing temperatures varied according to each primer pair. In general, the annealing 
temperature of the reaction was the melting temperature of the primers minus 5 °C. 
Phusion polymerase reactions (50 µl) were made of 1.0 U Phusion DNA polymerase, 1x 
Phusion HF buffer, 3 % DMSO, 10 pmoles of dNTPs, 0.5 µM of each primer, and (50-
250 ng) of DNA template. The following thermocycler conditions were used unless 
otherwise stated; one cycle of DNA denaturation at 98 °C for 30 seconds, followed by 
25 cycles of denaturation at 98 °C for 10 seconds, annealing at 50-70 °C for 30 seconds 
and extension temperature at 72 °C (30 seconds/1 kbp of amplicon). This was followed 
by a final extension phase at 72 °C for 10 minutes.   
2.6.4 Agarose gel electrophoresis 
The DNA fragments and plasmids were separated using a 1 % (w/v) agarose gel made 
up from 1 gram of agarose dissolved in 100 ml of Tris-acetate-EDTA (TAE) buffer 
(4.84 g/L of Tris-HCl, 1 mmol of EDTA and 1.142 ml glacial acidic acid). Ethidium 
bromide (100 µm) was added to the agarose before pouring the gel into the tray. The 
DNA samples (5- 10 µl) were mixed with loading dye, consisted of 0.25 % (w/v) 
bromophenol blue, 0.25 % (v/v) xylene cyanol, and 30 % (v/v) glycerol, before loading 
into agarose gel wells. The DNA was visualized under UV light at 312 nm. The size of 
the DNA product was determined based on 1 kb DNA ladder (NEB). 
2.6.5 Purification of DNA fragments for sequencing  
The DNA fragments from PCR reactions or digested plasmids were cleaned up using 
Wizard
®
 SV Gel and PCR Clean-Up System (Promega) according to the manufacturer’s 
protocol.  The DNA concentration was determined using a nanodrop spectrophotometer 
(Thermo Scientific). 
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2.6.6 Short fragment of DNA sequencing and analysis  
The sequencing of short fragment DNA (PCR products or plasmids) was carried out at 
the Genomics Laboratory, Technology Facility (University of York) or at GATC-
BIOTECH (UK). The ABI Sequence Scanner Software v1.0 (Applied Biosystems) was 
used to check the profile of the sequence.  
2.2.7 Phylogenetic analysis 
Taxonomic characterization of the isolates was performed by amplifying the 16S rRNA 
sequence using the 16S rRNA primers (Table 2.1) and Phusion High-Fidelity DNA 
Polymerase (NEB) (Chapter 2.6.3). The PCR products were cleaned-up (Chapter 2.6.5) 
and directly submitted for sequencing (Chapter 2.6.6). The phylogenetic trees were 
generated by first aligning the 16S rRNA sequences using ClustalX2, and then using 
MEGA software (version 6.0) [118], and Neighbour-joining method. The GenBank 
accession number for each sequence was obtained through submitting the sequence to 
the NCBI database from BankIt (http://www.ncbi.nlm.nih.gov/WebSub/? 
tool=genbank).  
2.6.8 Generating competent E. coli cells  
A single colony was used to inoculate 5 ml of pre-warmed Y medium for 2 hours with 
shaking at 37 ºC. This starter culture was used to inoculate 250 ml LB medium in 2 L 
flask. Cells were grown at 18 ºC with shaking to OD600 0.4-0.6. The culture was 
harvested by centrifugation at 4 °C for 15 minutes (13,000 x g). Cell pellets were 
resuspended in 100 ml filter sterilized ice-cold TfbI solution (potassium acetate (3 g/L), 
rubidium chloride (12 g/L), calcium chloride dehydrate (1.5 g/L), manganese (II) 
chloride tetrahydrate (9.9 g/L), glycerol (15%), pH 5.8 by adjusted it with 10% (v/v) 
acetic acid. The culture was incubated on ice for 5 minutes. Cells were harvested again 
at 4 ºC with 3,000 rpm centrifugation for 15 minutes. Cells were resuspended in 10 ml 
filter sterilized TfbII (MOPS (10 mM), calcium chloride dehydrate (75 mm), rubidium 
chloride (10 mm) and glycerol (15%), pH 6.5 by adjusted it with KOH) and incubated 
on ice for 5 minutes. Aliquots (100 µl) of the cell solution were transferred to 
Eppendorf tubes, snap frozen in liquid nitrogen and stored in -80 ºC freezer. 
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2.6.9 Plasmid transformation by heat shock method 
The E. coli competent cells were transformed by adding 50-100 ng of the plasmid to the 
cells and incubating on ice for 30 minutes (1:50 of 10 fold diluted β-mercaptoethanol in 
water was added to ArcticExpress cells prior of transformation by 10 minutes). The heat 
shock was performed at 42 °C for 90 seconds (or 20 seconds for ArcticExpress). Cells 
were then incubated on ice for 10 minutes. SOC or LB medium (500 µl) was added into 
the competent cells for incubation with shaking at 37 °C for 1 hour. An aliquot of the 
cells (50-150 µl) was then spread on LB plates containing (50-100 µg/ml) of plasmid 
selective antibiotic. In the case of E. coli Rossetta 2 (DE3) cells, additional 34 µg/ml of 
chloramphenicol was added to the plate. 
2.6.10 Plasmid extraction 
Plasmid extraction was performed for cloning and sequencing purposes. The extraction 
was carried out using the QIAprep Spin Miniprep Kit (Qiagen) following 
manufacturer’s protocol.  
2.6.11 Restriction endonuclease digestion of DNA 
Restriction endonuclease digestion of plasmids was carried out at 37 °C using the ratio 
of 10 U of enzyme to 1 µg of plasmid DNA.  The compatible buffer for restriction 
endonuclease digestion was chosen based on manufacturers recommendations.  
2.6.12 DNA Cloning 
All the cloning mentioned in this study was performed using the In-Fusion® HD 
cloning system (Clontech Laboratories). The method is fast and simple, allowing 
precise cloning of the DNA fragment into the linearized vector by adding 15 bp 
extensions (5′) sequence at the ends of the primer, which are complementary to the 
linearized vector at the restriction site. The method allows cloning of any insert, into 
any location, within any vector. Furthermore, it does not require phosphatase treatment, 
or enzymatic ligation.  
For the In-Fusion® HD cloning, primers for the gene of interest were designed based on 
the cloning vector and cloning site using the on-line software provided by manufacture 
(section 2.1). The gene of interest was amplified using PCR with high fidelity Phusion 
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DNA polymerase enzyme (New England Biolabs) (Section 2.6.3). The plasmid was 
linearized at the desired restriction sites using specific restriction enzymes (Section 
2.6.11). Both linearized plasmid and the PCR products were cleaned up using Wizard
®
 
SV Gel and PCR Clean-Up System (Promega) (Section 2.6.5). Concentration of insert 
and plasmid were measured using a nanodrop spectrophotometer (Thermo Scientific). 
The cloning reaction (10 µl) was prepared by mixing 10-200 ng of PCR product 
(depending on the size of the gene of interest) with 50-200 ng of linearized vector, and 2 
µl of 5x In-Fusion HD Enzyme Premix. The mixture was incubated at 50 °C for 15 
minutes. An aliquot of the reaction (2 µl) was used to transform E. coli Dh5α competent 
cells (section 2.6.9). The successful clone was identified by colony PCR (Section 
2.2.14). The correct sequence of the insert was confirmed by sequencing the plasmid 
using plasmid specific primers (Section 2.6.6).     
2.6.13 Site directed mutagenesis 
Site directed mutagenesis was carried out according to the QuickChangeII Site-Directed 
Mutagenesis protocol (http://www.chem.agilent.com/library/usermanuals/Public/20052 
3.pdf). The mutant plasmid was created by PCR (Section 2.6.3). 
PCR reaction (50 µl) was made with 1x Phusion HF buffer, primers (500 nM), plasmid 
(30-50 ng), dNTPs (200 µM), 1 U of Phusion DNA polymerase. The PCR programme 
was as follows; 98 ºC for 5 minutes, 16 cycles of 98 ºC for seconds and 72 ºC for 6:30 
minutes.  Negative controls were prepared in which polymerase was not added. 
Successful mutations were primarily checked by running an aliquot of the reaction on 
agarose gel. The parental stand (methylated) was digested with DpnI (NEB) (20 U) at 
37 ºC for 1 hour. An aliquot (2 µl) of the reaction was transformed into E. coli DH5α 
competent cells. Plasmids of a few colonies were extracted (Section 2.6.10), and 
successful mutants were confirmed by sequencing the insert (Section 2.6.6).  
2.6.14 Colony PCR 
Colony PCR was performed for rountine screening purposes. Single colonies were 
selected from the plate using a sterile pipette tip and stirred in a PCR tubes containing 
25 µl of GoTaq polymerase reaction (Section 2.6.3). The reaction was perfomed in PCR 
thermocycler (Section 2.6.3).  
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2.7 Protein Techniques 
2.7.1 Protein quantification 
Protein concentrations were determined according to the Coomassie (Bradford) Protein 
Assay Reagent Kit (Pierce) (Figure 2.4). A standard curve was created by serial dilution 
of the provided albumin standard (BSA). Sample (10 µl) was mixed with 300 μl of the 
reagent. Reaction was carried out in 96 well plates. The absorbance of the samples was 
read at 595 nm. Protein concentration (µg/ml) is calculated from the absorbance using 
the following equation: C = A/0.009 
Where 
C: is a protein concentration by (µg/ml) 
A: is the absorbance at 595 nm  
 
Figure 2.17: Standard curve of the protein concentration versus absorbance at 595 nm. 
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2.7.2 Cell lysis by sonication  
Cell pellets were resuspended in appropriate buffer (His-binding buffer was used for 
His-tagged proteins and PBS (phosphate-buffered saline) buffer for GST-tagged 
proteins) containing 0.1 M phenylmethane sulfonylfluoride (PMSF) (protease inhibitor). 
Sonication was carried out using a Misonix S-4000 sonicator at 70 kHz for 4 minutes, 
as 3 seconds off followed by 7 seconds on. Samples were kept on ice during the process 
of sonication.   
2.7.3 Expression and purification of XplA and XplB from R. 
rhodochrous 11Y 
The XplA protein was produced as an N-terminally His-tagged protein from a 
previously prepared pET-16b-xplA construct [98]. The expression and purification of 
the protein was performed as described by Rylott et al. (2006) [98]. The XplB protein 
was expressed from a previously generated xplB-pGEX2T construct and purified as 
described by Jackson et al. (2007) [95].   
2.7.4 Sodium Dodecyl Sulphate – PolyAcrylamide Gel Electrophoresis 
(SDS-PAGE) with the Bio-Rad system 
SDS-PAGE was made following the standard procedure [119] and described as follows: 
Gels were polymerised with 12 % (w/v) acrylamide in the separating gel and 4 % (w/v) 
acrylamide in the stacking gel. The protein loading dye (2X) was made up as 2 ml of 
625 mM Tris-HCL pH 6.8, 4 ml of 10 % (w/v) SDS, 2 ml of glycerol, 1 ml of β- 
mercaptoethanol, 30 mg of bromphenol blue and 1 ml of H2O. Samples were prepared 
for SDS-PAGE by mixing with loading dye to 1x concentration and heating at 100 °C 
for 5 minutes. Samples were centrifuged briefly before loading them in the gel. Gels 
were run at 200 V until the dye front ran off of the end of the gel. The gels were either 
stained with InstantBlue, a coomassie-based staining solution (Expedeon, UK), or 
transferred to nitrocellulosefor western blot analysis.  
2.7.5 Protein identification by MALDI-MS analysis  
The desired protein band was cut from the SDS-PAGE gel and protein identification 
was carried out at the proteomics laboratory, Technology Facility (University of York) 
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using Bruker autoflex III MALDI-TOF/TOF. Data was analysed by Mascot (Matrix 
Science) 
2.7.6 Western blot analysis  
Following the SDS-PAGE, the non-stained separating layer of the gel was used for 
western blot analysis. Gel was equilibrated in pre-chilled Towbin buffer (25 mM Tris, 
192 mM glycine, 20 % v/v methanol, pH 8.3) for 5 minutes. A gel-membrane sandwich 
complex was then made by placing the gel onto the nitrocellulose membrane, with three 
layers of pre-soaked filter paper in Towbin buffer on the top of the gel and bottom of 
membrane. Protein was transferred onto the membrane by applying 25 Voltage on 
Trans-Blot SD Semi-Dry Transfer Cell (Bio-Rad) for 20 minutes. Ponceau S stain (0.1 
% w/v Ponceau S, 5 % v/v acetic acid) was used to ensure the successful transfer of the 
protein onto the membrane by immersing the membrane into Ponceau S solution for 5 
minutes. Transferred protein was visualised by partially destaining the membrane with 
water. The blot was completely destained by washing with PBS buffer (NaCl (7.2 g/L), 
Na2HPO4 (1.48 g/L), NaH2PO2 (0.45 g/L), pH 7.2) before the blocking step. 
2.7.6.1 His-tagged protein detection  
Membrane was blocked with PBS buffer containing 3 % (w/v) non-fat milk powder at 4 
ºC with shaking overnight, followed by washing three times with washing buffer (PBS 
buffer containing 0.05 % Tween 20) with 5 minute incubations. The blot was incubated 
with PBS buffer containing 3 % (w/v) BSA (Bovine serum albumin) and Monoclonal 
Anti-polyHistidine Peroxidase Conjugate (Sigma-Aldrich) for 2 hours, and followed by 
another three washing steps with PBS containing 0.05 % Tween 20. The devolvement 
step was done by incubating the membrane in a solution consisting of 2 ml of 4-chloro-
1-naphtol (Sigma-Aldrich, made by dissolving one tablet in 10 ml methanol), 10 ml of 
triethanolamine buffer saline (137 mM NaCl, 27 mM KCl, 12 mM triethanolamine, pH 
7.5),  and 5 μl of freshly added H2O2. The reaction was stopped by washing the 
membrane in water. 
2.7.6.2 XplB detection  
The membrane was blocked in 25 ml PBS buffer containing 3 % (w/v) non-fat milk 
powder (Sigma-Aldrich) at 4 ºC room overnight with gentle shaking. The blot was 
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incubated with XplB polyclonal antibody diluted by (1/5000-1/20000) in 20 ml (PBS 
buffer with 3 % (w/v) of BSA) for 1 hour. Washing of the membrane was carried out as 
follow, twice with PBS containing 0.1 % Tween 20 for 5 minutes; twice with PBS 
containing 0.5 % Tween 20 and 1M NaCl for 5 minutes; and then a brief rinse of the 
membrane in PBS and PBS containing 3 % (w/v) of BSA. The membrane was then 
incubated with secondary goat anti-rabbit conjugated to alkaline phosphatase antibody, 
diluted by 1/20000 in 20 ml of PBS buffer containing 3 % (w/v) BSA, for 1 hour at 
room temperature. The membrane was washed again as follows, twice with PBS 
containing 0.1% Tween 20 for 5 minutes, twice with PBS containing 0.5 % Tween 20 
and 1M NaCl for 5 minutes, and then with brief rinse in 10 mM Tris pH 9.6. The signal 
was developed using Sigma tablets containing of active compound of nitroblue 
tetrazolium (NBT) and 5-bromo-4-chloro-3-indolyl phosphate dipotassium (BCIP). The 
tablet was dissolved in 10 ml of water and the membrane was immersed until the signal 
appeared.  The reaction was stopped by washing the membrane with PBS 0.1 % Tween 
20, then PBS and water. 
2.7.7 Homology modelling 
The model structure of the protein of interest was created by searching for the template 
in http://swissmodel.expasy.org/. A superimposed model structure on the template was 
generated and visualised using Chimera UCSF software [120]. Structure alignment was 
evaluated through Root Mean Square Deviations (RMSDs) value using Reply log 
command.   
2.8 Analytical Techniques 
2.8.1 High-performance liquid chromatography (HPLC) 
The HPLC analytical system (Waters) (Milford, USA) used in this study contained a 
510 pump, a Waters Alliance 2695 separation module and a Waters 2996 Photodiode 
Array. For RDX and TNT detection, sample (50 µl) was injected at a flow of 1 
ml/minute into the system. The HPLC isocratic condition was used, in which mobile 
solvent consisted of either 60:40 or 50:50 methanol: water.  
For the FAD (Flavin Adenine Dinucleotide) detection (Chapter 5), the sample was 
injected at a flow rate of 0.75 ml/minute. Five mM ammonium acetate buffer, pH=6.5 
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(solvent A) and methanol (solvent B) was used at 30 ºC. The HPLC gradient condition 
consisted of: 5 minutes solvent A 85 %: solvent B 15 %; 20 minutes solvent A 25 %: 
solvent B 75 %; 5 minute solvent A 0 %: solvent B 100 %; 5 minutes solvent A 85 %: 
solvent B 15 %. A Sunfire C18 5 µM column (Waters, Wexford, Ireland) was used to 
separate the compound. 
The absorbance peak of each compound was identified by comparing the retention time 
and the spectra generated from the Waters photodiode array detector with the retention 
times and spectra of standard. Chromatograms were generated using Empower-Pro 
Analysis Software at the absorbance at 230 nm for RDX and TNT or at 265 nm for the 
FAD detection. Concentration of the compound was measured by comparing the 
retention area of the sample with the retention area of the known concentration of the 
standard.  
2.8.2 Griess (nitrite) assay 
The Griess assay was  used to determine the amount of nitrite (NO2
-
) in samples.  The 
method relies on the colour (pink) produced as the reasult of the reaction of nitrite with 
the Griess reagent, which is measured at  A540 nm (Figure 2.5).  
Sample (200 µl) was mixed with 50 µL of sulfanilamide and incubated for 5 minutes 
(10 mg/mL sulfanilamide in 0.68 M hydrochloric acid).  Then 20 µL of N-(1-naphthyl)-
ethylenediamine dihydrochloride (NED) (10 mg/mL NED in water) was mixed into the 
reaction. Absorbance at 540 nm (blanked against Griess reagent) was measured. The 
concentration of nitrite is calculated as N= (A+ 0.001)/0.0229 (Figure 2.6). 
N= Nitrite concentration in (µM), A= Absorbance at 540 nm. 
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Figure 2.18: Principle of the Griess assay. Reproduced from Griess Reagent system 
handbook by Promega (https://www.promega.co.uk/~/media/files/resources/ protocols 
/technical%20bulletins/0/griess%20reagent%20system%20protocol.pdf). 
 
Figure 2.19: Griess assay standard curve to determine the concentration of nitrite using 
the absorbance 540 nm. 
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3.1 Introduction  
RDX is a toxic potential carcinogenic compound [121]; pollution with RDX is of 
concern and it is classified by the U.S. Environmental Protection Agency (EPA) as a 
priority pollutant [66]. Although the XplA/XplB system has been shown to actively 
degrade RDX at the lab scale, RDX persists at contaminated sites. One possible 
explanation for the continued pollution is the inhibitory effect of the co-contaminant 
explosive TNT toward XplA activity [95]. The nitroaromatic compound TNT has been 
shown to inhibit RDX degradation by indigenous microorganisms in explosive-
contaminated soil under anaerobic conditions [122]; and by Rhodococcus sp. YH1 
under aerobic condition [106]. Additionally, TNT strongly inhibits XplA activity in 
vitro [95]. Therefore, identification of an RDX-degrading enzyme unaffected by TNT 
would be advantageous for the decontamination of RDX polluted sites. Moreover, 
despite the fact that TNT strongly inhibits XplA activity, all RDX-degrading bacteria 
that have been reported so far have been isolated from soil contaminated not just with 
RDX but TNT also. It is therefore possible that these organisms have also evolved a 
mechanism to detoxify TNT alongside metabolism of RDX. Nejidat et al (2008)[106] 
reported that when Rhodococcus sp. YH1 had been previously grown in minimal 
medium containing ammonium as a sole source of nitrogen source, it is subsequently 
able to transform TNT to 2-amino-2,6-dinitrotoluene (2-ADNT) and 4-amino-2,6-
dinitrotoluene (4-ADNT) before finally degrading RDX. However, the bacterium did 
not transform TNT if it had been previously grown on RDX medium [106].  
This chapter focuses on the isolation of new RDX-degrading bacteria in different 
geographical locations, with the aim of discovering new enzymes and increasing 
understanding about the diversity of the xplA gene. Furthermore, the physiological 
mechanism by which xplA-harbouring microorganisms are able to thrive in sites 
contaminated by both TNT and RDX is also investigated.  
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3. 2 Materials and Methods 
3.2.1 Sample collections  
In order to isolate new RDX-degrading bacteria, explosive-contaminated soil samples 
were collected from six different geographical locations: Belgium, Germany, Ukraine, 
Moldova, the Czech Republic, and the UK. The Belgium soil samples were collected by 
Dr. Astrid Lorenz from an old TNT munition manufacturing site, whereas samples from 
Germany were sent us from a training range at Senne. Furthermore, soil samples were 
also collected from the explosive contaminated sites of Ukraine, Moldova and the 
Czech Republic. In the UK, samples were collected by Professor Neil Bruce and Dr. 
Elizabeth Rylott from the BAE Systems Glascoed site, located in the south east of 
Wales, near Newport, Gwent. The UK site was particularly interesting in terms of 
history of contamination with explosives; it was first opened in 1940 and still 
manufactures munitions. The duration of explosives contamination at the remaining 
sites is not known.  
3.2.2 RDX and TNT extraction from the soil 
The levels of RDX and TNT were determined in soil samples based on EPA (Method 
8330 (http://www.epa.gov/epawaste/hazard/testmethods/sw846/pdfs/8330a.pdf).  Two 
grams of soil were dried at room temperature and ground using 10 mm diameter steel 
balls in a “tumbler” rotator overnight. Acetonitrile (or methanol) (10 ml) was added, 
sample shaken for 1 hour and pelleted by centrifugation. Five ml of the supernatant was 
mixed with 5 ml CaCl2 (5 g/L) and shaken again for 1 hour in the tumbler rotator. The 
samples were filtered through acetonitrile-resistant filters (0.2 uM) and 50 µl of it was 
injected on HPLC to determine the amount of RDX and TNT (Chapter 2.8.1). The total 
amounts of RDX and TNT were calculated from the HPLC results. Spiked control 
samples indicated that the recovery rates for RDX and TNT were 53 % ± 8, and 77% 
±7, respectively. 
3.2.3 Enrichment cultures 
Selective enrichments were carried out to isolate RDX-degrading bacteria by 
inoculating soil samples into 50 ml minimal medium (Chapter 2.4.1) containing RDX as 
the sole source of nitrogen. A 50-fold dilution of the medium was sub-cultured into 
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fresh medium weekly. Unless specified otherwise, all cultures were grown at 30 °C, in 
an incubator with shaking at 180 rpm. In all enrichments, RDX-degrading bacteria were 
first identified by spreading aliquots from the enrichment medium on to RDX-
dispersion plates and checking for a zone of clearance around the colony (Chapter 
2.4.5). Single colonies were isolated by streaking bacteria from colonies on dispersion 
plates onto LB plates. The purity of single colonies was confirmed by analysing the 16S 
rRNA sequence of each isolate. To increase the chances of isolating RDX-degrading 
bacteria some alterations were made as explained below: 
Enrichment Method 1 
Approximately one gram of soil sample was diluted into minimal medium containing 1 
mM RDX. Cultures were grown for one week and then sub-cultured by inoculating 
fresh minimal medium with 1 mM RDX. Sub-culturing was performed three times in 
total and different dilutions of culture were spread on agar dispersion plates (Chapter 
2.4.5).  
Enrichment Method 2 
MacConkey broth was used as a selective medium for gram negative bacteria. The 
medium was chosen because all xplA carrying bacteria reported to date are Gram 
positive, and a Gram negative species might have evolved a different mechanism for 
RDX-metabolism.  In this method, 5 ml of soil slurry, made up by resuspending 1 g of 
soil in 5 ml potassium phosphate pH 7.2, was used to inoculate 45 ml of MacConkey 
broth, which was then grown at 30 C overnight. An aliquot (1 ml) was then used to 
inoculate 50 ml minimal medium containing 1 mM RDX as the sole source of nitrogen. 
Cultures were grown for one week, followed by sub-culturing of 50-fold dilutions into 
fresh minimal medium with RDX for one month in total.  
Enrichment Method 3 
Different carbon sources enrich for different bacterial communities, and using leucine as 
a carbon source has been shown to select the most diverse bacterial community [123]. 
The soil sample enrichment was performed as described in method 1, except 2 mM and 
6 mM leucine was used as a carbon source. 
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Enrichment Method 4 
TNT is known to strongly inhibit XplA activity [95], so in order to increase the chances 
of discovering a new non-XplA-like enzyme, that is able to metabolise RDX in the 
presence of TNT, the isolation for RDX-degrading bacteria was performed by doing the 
enrichment studies in the present of TNT. Prior to performing the enrichment, the 
optimal TNT concentration was determined. A TNT concentration which inhibits the 
RDX-degrading activity by XplA-carrying bacteria but is not lethal to bacteria was 
determined as follows: Fifty microliters of (0.1 g/ml) R. rhodochrous 11Y cells were 
inoculated into 50 ml of minimal medium (Chapter 2.4.1) containing 150 µM RDX and 
450 µM of KNO3 in 250 ml flasks. Alongside, 250 ml flasks containing 50 ml of 
minimal medium, 150 µM RDX, 450 µM of KNO3, and a range of TNT concentrations 
(5, 10, 15, 20, 25, 30, 40, 45, 50 µM) were also inoculated with R. rhodochrous 11Y 
cells. Bacterial growth was monitored by measuring the turbidity at OD600 at day 7, and 
the RDX remaining in the medium was measured by HPLC (Chapter 2.8.1). 
Enrichment Method 5 
This was carried out as enrichment method 1, except 100 µM of KNO3 and NH4Cl was 
added as additional nitrogen sources. The RDX content in the medium was checked a 
week after incubation by HPLC (Chapter 2.8.1).  
Enrichment Method 6 
Five grams of soil was used to inoculate 50 ml minimal medium containing 100 µM of 
RDX as the sole source of nitrogen. An aliquot (200 µl) was taken from the culture at 
different time points to measure RDX content in the medium by using HPLC (Chapter 
2.8.1). RDX-degrading bacteria were isolated as described in the enrichment method 
3.2.3. 
3.2.4 Identification and characterisation of RDX-degrading bacteria 
Identification of the isolates was carried out by amplification then sequencing of the 
16S rRNA gene and phylogenetic analysis (Chapter 2.6.3). RDX degradation by the 
isolates was compared by performing resting cell assays (Chapter 2.5.2). The effect of 
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TNT on RDX degradation capacity by the isolates was further investigated by 
comparing the RDX-removal rate with and without 2 µM of TNT (Chapter 2.5.3).   
3.2.5 Effect of TNT on the growth of R. rhodochrous 11Y  
To investigate the long term effect of TNT on the ability of R. rhodochrous 11Y to 
degrade RDX, a cell suspension (100 µl), made up of 0.1 g/ml of wet weight cells, was 
used to inoculated 50 ml of minimal medium in 250 flasks containing 100 µM RDX, or 
300 µM KNO2, with 0, 1, 5, 10 and 50 µM of TNT. The growth of the bacteria was 
monitored by measuring the OD600. 
3.2.6 Effect of dinitrotoluenes on the activity of purified XplA  
A stock solution containing 250 µM NADPH, 100 µM RDX and XplB (830 µg/ml) was 
prepared in a total volume of 9 ml 50 mM potassium phosphate buffer pH 7.2. Aliquots 
(180 µl) were transferred into Eppendorf tubes, TNT (2,4,6-trinitrotoluene), 2,4-DNT 
(2,4-dinitrotoluene), and 2,6-DNT (2,6-dinitrotoluene) were added to give 2 and 10 µM 
of each compound in 200 µl mixture. The reaction volume was made up to 200 µl and 
the reaction was started upon the addition of purified XplA (4 µg/ml) and stopped after 
30 minutes by the addition of 10 % of 1.5 M of trichloroacetic acid. The RDX 
remaining in each reaction was measured by HPLC.      
The effect of 2-ADNT (2-amino-4,6-dinitrotoluene) and 4-ADNT (4-amino-2,6-
dinitrotoluene) on RDX-denitration activity by purified XplA was also assessed by 
measuring nitrite release from RDX-denitration activity of XplA by the Griess assay. To 
do this, a stock solution was prepared as described above. Aliquots were transferred into 
96 well plates, and 2-ADNT or 4-ADNT was added to give a final concentration of 2.5 
µM and 10 µM in 200 µl reaction. The reaction was started upon the addition of XplA 
and the reaction measured by nitrite release using the Griess assay (Chapter 2.8.2). 
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3.3 Results  
3.3.1 RDX and TNT extraction from soil samples 
Extraction of RDX and TNT was carried out on the soil samples from Belgium, Ukraine 
and Moldavia. TNT was detected in the Belgium soil samples by our collaborators 
using colormeteric assay to detect TNT. The photo presented in Figure 3.1 was taken by 
Dr. Astrid Lorenz showing appearance of the pink colouration indicative of TNT 
present in the samples that were collected. However, neither TNT nor RDX was found 
in these samples by HPLC or mass spectrometry, carried out by Miss Valeria Gazda in 
Centre for Novel Agricultural Products - University of York. 
   
 
Figure 3.20:  Colorimetric assay to detect TNT in soil samples from Belgium. The 
darker red indicates a higher concentration of TNT. 
 
In the Ukraine soil sample, approximately 36 mg/kg of TNT was found, with no RDX 
(Figure 3.2), whereas no TNT or RDX was detected in the Moldova (Figure 3.2) or 
Czech Republic soil samples (Figure 3.3).   
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Figure 3.21: Overlay HPLC chromatograms from the RDX and TNT extraction of 
Ukraine and Moldova soil samples. HPLC mobile phase Methanol 50:50 H2O. 
 
 
Figure 3.22: Overlay chromatograms from RDX and TNT extraction of Czech 
Republic soil samples. HPLC mobile phase Methanol 50:50 H2O. 
 
As neither RDX or TNT were detected in the soil samples from Czech Republic, it was 
assumed that the chances of RDX-degrading bacteria being present in the samples was 
reduced compared to the samples containing explosives; therefore,  enrichment studies 
were not carried out with these samples. Selective enrichment methods 1, 2 and 3 were 
carried out for the Belgium samples, bacteria able to grow using RDX as a sole source 
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of nitrogen were only isolated using enrichment method 1.  
Selective enrichment was also carried out on the German, Ukraine, and Moldovian soil 
samples, using methods 5 to investigate if RDX removal activity could be detected in 
the minimal medium with 100 µM RDX when the samples use as inoculum after 7 days 
of incubation. All RDX was removed from the medium when the soil sample from 
Ukraine was used as inoculum (Figure 3.4) but no RDX removal was detected when the 
soil sample from Germany were used as inoculum. No further sub-culturing was carried 
out on the German soil samples. Only a few isolates were found in the Ukrainian soil 
samples, which were further characterised as described in the next section.  
   
 
Figure 3.23: Overlay HPLC chromatograms of the selective enrichment for the 
Ukraine soil sample inoculated in the minimal medium after 7 days incubation. Mobile 
phase Methanol 60:40 H2O. 
 
Selective enrichment methods 4 and 6 were performed for the United Kingdom soil 
samples collected from 15 distinct locations on the BAE Systems Glascoed site. The 
results using enrichment method 6, which monitored the decrease in RDX over time are 
presented in Figure 3.5. In the samples from stations 8, 10 and 12, clear RDX removal 
from the medium was observed. The aberrant result from station 15 shows an apparent 
increase in RDX concentration over time, and may be due to the RDX concentration in 
the soil sample exceeding the solubility limit, or another, unidentified technical error; it 
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was recorded that this sample was collected from heavily explosives-contaminated site.  
Further sub-culturing of the enrichment medium resulted in the isolation of a number of 
RDX degrading bacteria. 
 
Figure 3.24: Percentage of RDX-removal from the enrichment culture using different 
soil inocula from the UK soil sample (BAE Systems). The RDX remaining in the 
medium was measured by HPLC (Mobile phase, Methanol 60: 40 Water). 
 
Prior to performing enrichment method 4 for the UK soil samples, whereby RDX-
degrading species would be isolated in the presence of TNT to favour the isolation of 
non-xplA carrying bacteria, the concentration of TNT was optimised. The optimisation 
was performed to find a concentration of TNT which strongly inhibited XplA yet had 
the least toxicity towards the bacterial cells. To do this, R. rhodochrous 11Y was grown 
in minimal medium containing either 150 µM RDX or 450 µM KNO3, and with 
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different concentrations of TNT (5, 10, 15, 20, 25, 30, 40, 45, 50 µM). Bacterial growth 
was measured after 7 days and compared to the growth in the absence of TNT (Figure 
3.6). 
 
Figure 3.25: Growth of R. rhodochrous 11Y after 7 days in medium containing 450 µM 
KNO3 (blue bar) or 150 µM RDX (red bar) in the absence or presence of TNT. Data are 
the average of three biological replicates ± SD.   
 
As shown in Figure 3.6, in the absence of TNT R. rhodochrous 11Y grew equally well 
using either KNO3 or RDX as sole nitrogen source. Additionally, at the lowest 
concentrations of TNT (5, 10 and 15 µM), growth using RDX as sole nitrogen source 
was not affected after 7 days; the higher growth in RDX medium after 7 days may be 
due to TNT transformation capability of the bacterium at low concentration and less to 
the inhibitory effect of TNT transformation products on the activity of XplA. However, 
when the TNT concentration was increased above 15 µM, the inhibitory effect of TNT 
on RDX-metabolising XplA activity, and subsequent growth was observed. Where 
KNO3 was supplied as the nitrogen source, the inhibitory effect of TNT was less 
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marked in concentrations lower than 30 µM. The strong effect of TNT on the growth of 
the bacterium in the KNO3 versus RDX medium was observed with TNT concentrations 
from 25 µM, where the growth was suppressed by approximately 2-fold more in the 
presence of RDX compared to KNO3. 
Analysis of the RDX content in the media after 7 days showed that with increasing TNT 
concentration, more RDX remained in the medium, indicating that TNT was inhibiting 
the activity of XplA (Table 3.1). 
Table 3.3: RDXremaining (µM) in the medium after growth of R. rhodochrous 11Y in 
the presence of 25- 50 µM of TNT. 
 
 
 
 
Following this optimisation procedure, a concentration of 25 µM of TNT was added for 
the enrichment cultures on the UK soil samples; however, no RDX-degrading bacteria 
were subsequently isolated.  
3.3.2 Identification and characterisation of the RDX-degrading 
bacteria 
Following selective enrichment procedures, many morphologically distinct, RDX-
degrading bacteria were isolated from the Belgium, Ukraine and UK soil samples 
(Figure 3.7). 
Concentration of TNT (µM) Remaining RDX (µM) 
25 86 
30 114 
35 119 
40 137 
45 138 
50 133 
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Figure 3.26: An RDX dispersion plate inoculated with single colonies isolated from soil 
samples. A zone of clearance is apparent around the colonies which are able to degrade 
RDX.     
 
Characterisation of the isolates were performed on the basis of colony morphology on 
LB plates and 16s RNA sequencing. Isolates differing by one or more nucleotide in the 
16S rRNA were considered as separate isolates. Overall, 13 colonies were isolated, with 
16s rRNA sequencing showing they were all Rhodococcus spp. The given names for the 
isolates are shown in Table 3.2. 
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Table 3.4: List of RDX-degrading bacteria isolated from different geographical 
locations 
Name of isolate Country of origin 
Rhodococcus sp. DS1 Belgium 
Rhodococcus sp. DS2 United Kingdom 
Rhodococcus sp. DS3 United Kingdom 
Rhodococcus sp. DS4 United Kingdom 
Rhodococcus sp. DS5 United Kingdom 
Rhodococcus sp. DS6 United Kingdom 
Rhodococcus sp. DS7 United Kingdom 
Rhodococcus sp. DS8 United Kingdom 
Rhodococcus sp. DS9 United Kingdom 
Rhodococcus sp. DS10 United Kingdom 
Rhodococcus sp. DS11 United Kingdom 
Rhodococcus sp. DS12 United Kingdom 
Rhodococcus sp. 5U Ukraine 
 
The phylogenetic tree of the isolates is shown in Figure 3.8, Rhodococcus sp. DS2 -12 
and Rhodococccus sp. 5U were most closely related to the RDX-degrading bacterium 
Rhodococcus sp. DN22 isolated from Australia [112] and the non-RDX degrading 
bacterium R. qingshengii strain BGQ-1 (GenBank accession number: KF704112.1) 
isolated from the Qinghai-Tibet Plateau for crude oil degrading bacteria by Wang,Y 
(unpublished data). Rhodococcus sp. DS1 was more distantly related to the other 
isolates, and more closely related to a dibenzo-p-dioxin-degrading bacterium R. opacus 
SAO101 (GenBank accession number:  AB032565) isolated from a Japanese soil 
sample [124] and a nitrophenolic-compound-degrading bacterium R. wratislaviensis 
strain J7 (GenBank accession number: AY940038).   
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Figure 3.27: Unrooted phylogenetic tree for the 16S ribosomal RNA gene sequence of 
the RDX-degrading bacteria isolated in this study (shown in bold) and closely related 
bacteria in the databases. Previously reported RDX-degrading bacteria have a red 
square next to the branch.   
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In order to characterise the isolates further, resting cell assays were carried out (Figure 
3.9). The rates at which RDX was removed from the media by the isolates appeared to 
split into two groups: Rhodococcus sp. DS1, DS4, 5U and DS9 all removed RDX more 
slowly than R. rhodochrous 11Y and the other isolates. The second group Rhodococcus 
sp. DS8, Rhodococcus sp. DS2, Rhodococcus sp. DS3 and Rhodococcus sp. DS11 all 
removed RDX at faster rates than R. rhodochrous 11Y.  
 
 
Figure 3.28: RDX uptake by isolated bacteria during the resting cell assay. Data is the 
average of two or three biological replicates ± SD.   
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In order to identify if the enzyme conferring the ability to grow on RDX as a sole 
nitrogen source is xplA, PCR analysis was conducted. The xplA gene was amplified in 
all the isolates regardless of the geographical locations from which they had been 
isolated (Figure 3.10).  
 
Figure 3.29:  PCR products from amplification of the xplA region in newly isolated 
RDX-degrading bacteria. A shows the 520 bp region of the xplA-heme domain in the UK 
isolates, +ve is the positive control using the same primers with R. rhodochrous 11Y 
genome, -ve is the PCR product of the same reaction using nuclease-free distilled water 
instead of genomic DNA. B and C show the amplification of the 1,073 bp of xplA in the 
Belgian and Ukrainian isolates, respectively. 
 
In order to compare RDX uptake by the isolates in the presence of TNT, RDX removal 
was measured in the presence and absence of 2 µM of TNT (Chapter 2.5.3). As shown 
in Figure 3.11, as little as 2 µM TNT inhibits RDX removal. RDX uptake by R. 
rhodochrous 11Y and Rhododoccus sp. DS1 was most affected by the presence of TNT, 
whereas Rhodococcus sp. DS7 was least affected (Figure 3.11). 
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Figure 3.30: Percentage of RDX removal by RDX-degrading isolates in the presence of 
2 µM of TNT over 9 h. Data is the average of two or three biological replicates ± SD.   
 
The result from Figure 3.11 support the inhibitory effect of TNT on RDX removal 
activity reported for Rhodococcus sp. YH1 [106] and poses the question: How do XplA-
expressing bacteria degrade RDX in a military site co-contaminated with TNT? To tease 
apart the effects of TNT on XplA activity from the more general cellular toxicity of 
TNT, R. rhodochrous 11Y was grown in flasks where RDX was the sole nitrogen 
source (Figure 3.12A) and separately, where KNO2 was the sole nitrogen source (Figure 
3.12B). As shown in Figure 12A, as little as 1 µM of TNT has a significant inhibitory 
effect at the 1 day incubation on the bacterial growth, whereas the growth of R. 
rhodochrous 11Y with KNO2 was unaffected by the same concentration of TNT. 
Although TNT concentration was not measured over time, several bacteria, including 
many Rhodococcus spp, are known for having nitroreductase enzymes which can 
convert TNT to 4-ADNT 2-ADNT. Transformation of TNT to ADNT was reported for 
the Rhodococcus sp. YH1 [106], therefore, recovery of growth by the bacteria over the 
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time course was thought to be most likely due to less or non-inhibitory effect of the 
TNT transformation products toward XplA. 
 
Figure 3.31: Effect of increasing concentrations of TNT on growth of R. rhodochrous 
11Y in minimal medium containing RDX (A) or KNO2 (B) as the sole source of 
nitrogen. Results are the mean of three biological replicates ± SD. 
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To test the hypothesis if the gradual decreasing effect of TNT on the growth of 11Y is 
due to less or non-inhibitory effect of the TNT derivatives on XplA activity, the effect 
of 2 and 4-ADNT on XplA activity was tested by measuring the nitrite release from 
RDX-denitration by XplA using the Greiss assay. As shown in Figure 3.13, at 
concentrations at which TNT is inhibitory to XplA, neither 2or 4-ADNT had any 
significant effect on XplA-dependent nitrite release. 
 
Figure 3.32: Nitrite release from RDX-denitritation by XplA in the presence of 2-
ADNT and 4-ADNT. Data is the average of four biological replicates ± SD.   
 
These data suggest that reducing one of the three nitro groups of TNT to an amino 
group is enough to prevent inhibition of XplA, at least in the concentrations tested. To 
confirm this observation, it was decided to investigate the effect of 2,4-DNT and 2,6-
DNT on RDX degradation. As shown in Figure 3.14, no significant difference in the 
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rate of RDX-denitration was observed in the present of 2 or 10 µM of 2,4-DNT or 2,6-
DNT, whereas, 2 µM and 4 µM of TNT reduced XplA activity by 64% and 87%, 
respectively.     
 
Figure 3.33: RDX-removal activity of the XplA with and without 2,4- and 2,6-DNT in 
comparison with TNT. Data is the average of five biological replicates ± SE.   
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3.4 Discussion 
In this study, soil samples from different geographical locations that were military sites 
or industrial sites where munitions are processed were used to isolate RDX-degrading 
bacteria. The locations were all historically contaminated with explosives; however, 
following collection, analysis to detect RDX and TNT in the Belgium, Ukraine and 
Maldovian soil samples, showed that TNT was only found in the soil samples from 
Ukraine. The inability to detect RDX in the Ukrainian soil could be due to the different 
adsorption properties of the two compounds; TNT is known to bind strongly to the soil, 
whereas RDX is highly mobile in soil [65].  
Selective enrichment from these soil samples resulted in the isolation of in total, thirteen 
RDX-degrading bacterial species from the soil samples from Belgium, Ukraine and the 
United Kingdom. Based on 16S rRNA sequences, the isolates were found to belong to 
the genus Rhodococcus. In addition to Rhodococcus spp., Gram positive 
Microbacterium sp. MA1 [103], Gordonia sp. KTR9, Williamsia sp. KTR4 [114] 
Williamsia sp. EG1 [113] and Gram negative Stenotrophomonas maltophilia PB1 [125], 
Pseudomonas sp. HK-6 [126], Pseudomonas putida II-B and Pseudomonas fluorescens 
I-C [94] have all been reported to have the ability to degrade RDX. However, the 
evidence, based on the Biolog analysis system and the fatty acid profile [126], is 
insufficient to conclude that HK-6 is in the Pseudomonas genus.   
To maximise the chances of isolating new RDX-degrading species, some alterations 
were made to the enrichment methods; the additional nitrogen sources KNO3 and 
NH4Cl were added during the enrichment because it has been reported that adding 
ammonium to RDX-containing medium enhanced RDX-degradation by Gram negative 
Pseudomonas putida II-B, and Pseudomonas fluorescens I-C [94]. Leucine was used as 
a carbon source because it was reported to support the most diverse bacterial 
communities [127].  MacConkey broth was used in the first step of the soil enrichment 
as Gram positive bacteria are reported to predominate in the explosive contaminated 
sites [96, 100, 101, 103, 106, 112-114, 128], and MacConkey broth is known to inhibit 
the growth of Gram positive bacteria [129]. Additionally TNT is known to inhibit RDX 
denitration by XplA [95], TNT was used to increase the chance of discovering new 
isolates with novel, non-XplA-based mechanisms for RDX metabolism. However, 
despite these modifications, no novel RDX-degrading spp. were identified.  
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Rhodococcus spp. is the most frequently reported genus with the ability to degrade 
RDX in aerobic conditions; RDX-degrading species include  R. rhodochrous 11Y and 
19 other Rhodococcus spp. from the UK [100], Rhodococcus sp YH1[111], 
Rhodococcus sp. T7 and Rhodococcus sp. T9N from Israel [101], Rhodococcus sp. 
DN22 from Australia [112], Rhodococcus spp from Belgium (unpublished data as cited 
in [128]) and Rhodococcus sp. EG2A and EG2B from the United states  [113]. 
Additionally, from a taxonomical viewpoint, both Williamsia and Gordonia are closely 
related to Rhodococcus spp. This is suggestive that Rhodococcus spp is the most 
abundant RDX degrading genus on explosive contaminated sites. In support of this 
observation, Rhodococcus spp. was found to be the predominant genus in a study by 
Andeer  et al. (2013) [113], where fully labelled 
15
N-RDX was used to analyse bacterial 
communities able to degrade RDX [113]. The dominance of Rhodococcus spp. at 
explosive-contaminated sites is probably due to the genome flexibility and adaptive 
capacity of these bacteria to metabolise xenobiotic compounds. Rhodococcus species 
are generally known for having a versatile metabolic activity, and several Rhodococcus 
spp. have been isolated and characterised for their ability to degrade many other 
anthropogenic compounds for example Rhodococcus erythropolis strain PR4 [130] and 
Rhodococcus opacus R7 [131] were isolated for their abilities to degrade several 
different chain lengths of alkanes as a carbon or energy source, and Rhodococcus 
globerulus P6 [132] and  Rhodococcus corallinus B-276 [133] were isolated for their 
ability to degrade polychlorobiphenyl and trichloroethene, respectively.   
The RDX-degrading capacity of the isolates was found to be mediated XplA. Although, 
XenA, XenB [94] and Type I oxygen insensitive nitroreductases [90] have been 
reported to have the ability to degrade RDX this is not their primary role in metabolism. 
XplA has been found in all RDX-degrading Gram positive bacteria tested to date [96, 
100-103, 128], with sole exception of Rhodococcus sp. HS4 [100]. Although the 
enzyme responsible for RDX-degradation in Rhodococcus sp. HS4 was not identified, it 
is considered that the RDX-degrading capacity of the bacterium is due to a xplA-related 
cytochrome P450 enzyme, as the activity is inhibited by  the P450 inhibitor metyrapone 
[100]. The conservation, and dominance, of xplA across a diverse geographical range of 
RDX-contaminated sites [100-103, 128] is intriguing considering the relatively recent 
introduction of the novel compound RDX in the environment. In a metagenomic study, 
xplA was even identified in the extreme anaerobic condition of the ovine rumen, in 
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which RDX was efficiently degraded [134].  The wide dispersion of the highly 
conserved xplA gene in nature has led to questioning of the mechanism by which the 
gene has dispersed around the world, and the evolutionary origin of xplA is investigated 
further in Chapters 4 and 6.  
The comparison of RDX-degradation in the presence and absence of TNT suggests that 
TNT affects RDX-degradation in all of the isolates. It has been reported that TNT 
strongly inhibits RDX-degradation by Rhodococcus sp. YH1 [106] and by indigenous 
microbial soil in anaerobic conditions [122]. Growth of R. rhodochrous 11Y in RDX 
versus KNO2-supplemented media with TNT suggests that TNT is affecting the growth 
of RDX-degrading bacteria is two ways; first by inhibiting XplA, and second through 
the toxicity of TNT and possibly its transformation products towards the bacteria. The 
detoxification pathway of TNT in bacteria that are resistant to TNT, such as 
Enterobacter cloacae, has been well-characterised [77]. As described in Chapter 1, 
many bacteria have the capability of transforming TNT to HADNTs predominantly 2,4-
HADNT in the case of E. cloacae, by a nitroreductase nfsI. The HADNT products are 
further reduced to ADNTs. Subsequent transformation events can follow, and 
triaminotoluene (TAT) has been identified in some bacteria under anaerobic conditions 
[135]. An alternative pathway catalysed by members of the Old Yellow Enzyme family 
of flavoproteins transforms TNT via hydride and dihydride Meissenheimer complexes 
[75, 81, 83].   
The inhibitory effect of TNT on XplA activity in R. rhodococcus 11Y in liquid cultures 
decreases over time, suggesting that these bacteria have some, albeit limited, ability to 
detoxify TNT. In agreement with this, the transformation of TNT to ADNTs has been 
reported in Rhodococcus sp. YH1 [106]. Moreover, a gene encoding for a nitroreductase 
was found from the total genome sequence of R. rhodchrous 11Y (Contig00054) which 
has 100 % sequence identity to the nitroreductase family protein in Rhodococcus sp. 
EsD8 (Accession number: WP_006940961) and Rhodococcus rhodochrous ATCC 
21198 (Accession number: CCW13257) (Methodology and study on the R. rhodochrous 
11Y genome is in Chapter 4). Interestingly, 2-ADNT, 4-ADNT, 2,4-DANT and 2,6-
DANT were not found to significantly inhibit the activity of XplA. The results 
presented here show that TNT  inhibits RDX-degradation by xplA expressing bacteria, 
supporting the inhibitory effect reported in Rhodococcus sp. YH1 by Neijidat et al. 
(2008) [106], and inhibitory effect of TNT on XplA protein reported by Jackson et al. 
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(2007) [95]. Considering the fact that many bacteria and fungi are able to detoxify TNT 
under aerobic conditions [76, 77, 136-141], survival of the xplA-carrying bacteria at the 
explosive-contaminated sites could be hypothesised through detoxification of TNT by 
TNT-transforming organisms. Gram positive bacteria are generally found to be more 
sensitive to TNT, and TNT products, than Gram negative bacteria [141]. This study has 
indicated that both TNT and reduction products slow the growth of RDX-degrading 
Rhodococcus spp., highlighting the presence of recalcitrant TNT as a hindrance to 
RDX-degradation in the environment. 
 
 
 
 
 
 Chapter 4: Characterisation of the 
RDX-degrading Genomic Island 
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4.1 Introduction  
Microorganisms are known for their ability to quickly adapt to environmental changes, 
including exposure to xenobiotics [10]. There are many xenobiotic degrading bacteria 
that have been reported, and characterised, for their potential application in 
biotechnology [1].  
Microorganisms have also evolved to degrade the explosive RDX, a toxic synthetic  
compound which has been in the environment for less than a century [128]. The 
biodegradation of RDX was initially reported only under anaerobic conditions [86, 92, 
142, 143]; however, in the late 1990s, three aerobic RDX-degrading Rhodococcus spp, 
with the ability to utilise RDX as a sole source of nitrogen, were isolated from Israel, 
Australia and the United Kingdom [96, 111, 112]. 
The enzymes involved in the aerobic biodegradation of RDX were first isolated from R. 
rhodochrous 11Y and identified as an unusual cytochrome P450, XplA, and 
accompanying flavodoxin reductase partner, XplB [96]. Subsequently, a number of 
aerobic RDX-degrading bacteria have been reported, from different geographical 
locations [100, 101, 103, 113, 114, 128], but all belonging to the Actinomycetales and  
xplA with  > 99 % identity has been identified in those tested [100-103, 128]. The 
highly conserved nature of xplA suggests its rapid distribution by horizontal gene 
transfer [100, 103, 128].  
Genes involved in xenobiotic catabolism are often located in a mobile genetic element, 
accompanied by insertion elements and are integrated into the bacterial chromosomal or 
plasmid [10]. Both xplA and xplB are plasmid encoded in Microbacterium sp. MA1, R. 
rhodochrous 11Y [103] and Gordonia sp. KTR9 [105]. Partial sequence analysis of the 
plasmid carrying the xplA and xplB genes in Microbacterium sp. MA1 revealed that the 
genes are also associated with transposable elements in this bacterium [103]. 
Furthermore, a 6.7 kbp region flanking xplA and xplB is nearly identical (> 99 %) 
between Microbacterium sp. MA1 and R. rhodochrous 11Y (Figure 4.1) [103]. 
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Figure 4.34: Sequence comparison of the 7.5 kbp region flanking xplA and xplB in R. 
rhodochrous 11Y (top) with the partial sequence of the pMA1 plasmid from 
Microbacterium sp. MA1. Reproduced from Andeer et al. (2009) [103]. 
                 pHSX1 and PCR amplified R. rhodochrous 11Y sequence with > 99 % nucleotide 
identity to ORF30 to ORF 34 in Microbacterium sp. MA1 fosmid library; pHSX1 is the 
7,567 bp sequence of the xplA/xplB region in R. rhodochrous 11Y [96].  
            pHSX1 sequence with no similarity to Microbacterium sp. MA1 fosmid sequences. 
 
In Gordonia sp. KTR9, an RDX-degrading bacterium isolated from North America 
[114], xplA is located on a 182 Kbp plasmid (pGKT2) (GenBank accession number: 
CP002112) [105]. The xplA gene in Gordonia sp KTR9 has high sequence identity to 
other known RDX-degrading bacteria (> 99 %), while the 5′ end of xplB is fused with a 
glutamine synthetase-encoding gene, glnA [105]. Upstream of xplB-glnA, are cyp15C 
and xplR, which encode cytochrome P450 and transcriptional regulatory protein, while 
downstream of xplA are four genes encoding for hypothetical proteins (Figure 4.2). 
 
 
Figure 4.35: The regions flanking xplA in Gordonia sp. KTR9. The gene locus 
KTR9_4921, KTR9_4922, KTR9_4923 and KTR9_4924 are encoded for transcriptional 
regulators, cytochrome P450, XplB-GS and XplA proteins, respectively. The gene loci 
KTR9_4925 to KTR9_4928 are encoding hypothetical proteins. 
 
In this chapter, the mobile element carrying xplA and xplB will be characterised by 
comparing the sequence in the vicinity of xplA between several RDX-degrading bacteria 
isolated from distinct geographical locations. In addition, the xplA/xplB was compared 
between these isolates to construct the evolutionary origin of xplA gene.  
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4.2 Materials and Methods 
The xplA and xplB containing region was studied in eleven RDX-degrading bacterial 
species (Table 2.2, Chapter 2). The species originated from different geographical 
locations and belong to four genera of aerobic RDX-degrading bacteria. 
The isolates were characterised based on phylogenetic trees using 16S rRNA sequences 
as described in Chapter 2.2.7. Further characterisation of the isolates was carried out by 
investigating the growth and RDX-removal rates of the isolates in minimal medium 
containing 100 µM RDX as a sole source of nitrogen (Chapter 2.5.1). 
Initially, the RDX-genomic islands were studied by identifying the boundary of the 
sequence similarity in the xplA region between R. rhodochrous 11Y and 
Microbacterium sp. MA1. A cosmid library, which had been previously prepared from 
R. rhodochrous 11Y genomic DNA by Dr. Cyril Bontemps, was used, in combination 
with sequence data from pHSX.1, a plasmid library containing 7,567 bp sequence of the 
xplA and xplB region from R. rhodochrous 11Y [96]. A cosmid library was sequenced 
using primer walking to obtain more sequence in the region of xplA and then compared 
with online data of a 52.2 kbp sequence from Microbacterium sp. MA1 (GenBank 
accession number: FJ577793). 
Subsequently, PCR analysis, using overlap primers designed from R. rhodochrous 11Y 
sequence, was used to amplify the same region in the other Rhodococcus spp. and 
Williamsia sp. EG1. A list of the primers used to amplify the xplA and xplB region can 
be found in Table 2.1, Chapter 2. The location of each primer binding site in the gene 
cluster is shown in Figure 4.3. The diversity of the xplA and xplB genes was 
investigated by studying single nucleotide polymorphisms (SNP) in the xplA/B region 
between the isolates. The xplA and xplB genes were sequenced from the PCR products 
as shown in Figure 4.3. 
Lastly, the full genomes of R. rhodochrous 11Y and Williamsia sp. EG1 were 
sequenced to identify the genes in common on the xplA-carrying plasmids between 
those bacteria. The genome sequencing methodology is described in Materials and 
Methods, Chapter 2.6.2.  
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Figure 4.36: Schematic representation of the primer pair locations used to amplify the 
xplA flanking regions in Rhodococcus spp. and Williamsia sp. EG1. The sequence of each 
primer can be found in Table 2.1, Chapter 2.  
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4.3 Results  
4.3.1 Characterisation of RDX-degrading isolates  
Further characterisation of the RDX-degrading bacteria was performed by generating a 
phylogenetic tree, using 16S rRNA sequences, and monitoring the growth and RDX 
removal capacity of the bacteria in minimal medium containing 100 µM RDX as a sole 
source of nitrogen. 
The RDX-degrading bacteria belong to Actinomycetales, and a phylogenetic tree of the 
isolates is shown in Figure 4.4. Rhodococcus sp. EG2 (U.S.A.), Rhodococcus sp. 5U 
(Ukraine), Rhodococcus sp. 9UK (United Kingdom), Rhodococcus sp. BL-1 (Belgium), 
and Rhodococcus sp, DN22 (Australia), were found to be closely related to each other 
and more distantly related to R. rhodochrous 11Y (United Kingdom) and Rhodococcus 
sp. YH1 (Israel).  
Microbacterium sp. MA1 appears distantly related to all Rhodococcus spp., whereas 
Williamsia sp. EG1 and Gordonia sp. KTR9 are more closely related to the 
Rhodococcus spp (Figure 4.4).  
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Figure 4.37: Rooted phylogenetic tree analysis of the RDX-degrading isolates. The 16S 
rRNA sequences were analysed using the neighbour joining method and bootstrapped with 
1000 replicate runs using the MEGA 6 tree building program.  The RDX-degrading species 
used in this study are shown in bold. The scale bar indicates substitutions per nucleotide, and 
the tree was rooted using 16S rRNA sequence of Bifidobacterium pseudocatenulatum. 
 
To compare the ability of all the RDX-degrading species listed in Table 2.2 (Chapter 2) 
to grow and take up RDX in liquid culture, they were grown in minimal medium with 
100 µM RDX as the sole source of nitrogen. All the cultures of Rhodococcus spp. 
removed RDX at faster rates than Microbacterium sp. MA1, Gordonia sp. KTR9 and 
Williamsia sp. EG1. The amount of RDX removed by the Rhodococcus spp. after 16 
hours was 100 %, 79 %, 98 %, 93, 64 %, 65 % and 100 % by R. rhodochrous 11Y, 
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Rhodococcus sp. YH1, Rhodococcus sp. 9UK, Rhodococcus sp. DN22, Rhodococcus 
sp. 5U, Rhodococcus sp. BL-1 and Rhodococcus sp. DS1, respectively (Figure 4.5A). 
Amongst the four different genera, Williamsia sp. EG1 had the lowest rate of RDX 
removal from the medium with just 4 % removed after 16 hours, whereas Gordonia sp. 
KTR9 and Microbacterium sp. MA1 had removed 20 and 25 % of the RDX, 
respectively (Figure 4.6A).  
In terms of growth, Rhodococcus spp were shown to grow at faster rates than those in 
other genera. Amongst the Rhodococcus spp., Rhodochrous sp. DS1 was the slowest 
growing bacterium, achieving an OD600 of 0.43 after 44 hours of incubation (Figure 
4.5B). Gordonia sp. KTR9 was the slowest growing of the non Rhodoccus spp., with an 
OD600 of just 0.22 after 44 hours (Figure 4.6B); half the growth of the slowest 
Rhodococcus spp. 
Chapter 4 
102 
 
 
Figure 4.38: RDX removal (A) and growth (B) of eight Rhodococcus spp. Data shown 
are mean of three biological replicates ± SD. Reproduced from Chong et al. (2014) 
[144]. 
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Figure 4.39: RDX removal (A) and growth (B) of R. rhodochrous 11Y, Williamsia sp. 
EG1, Microbacterium sp. MA1, and Gordonia sp. KTR9. Data shown are mean of three 
biological replicates ± SD. Reproduced from Chong et al. (2014) [144]. 
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4.3.2 Analysis of the sequence flanking xplA in the RDX-degraders 
Approximately 15 kbp of the region flanking xplA was sequenced in R. rhodochrous 
11Y using the primer walking method. The sequence from each primer walk (~1 kbp) 
was verified by designing complementary primers and using PCR to analyse the region.    
A sequence comparison showed that there is a 13.8 kbp region of the R. rhodochrous 
11Y sequence, encoding twelve ORFs, that shares > 99 % sequence identity to the 14.3 
kbp region in Microbacterium sp. MA1. There were only three differences in the whole 
region between these two phylogenetically-distant related species: Firstly, the gene 
encoded for the transposable element (pMA1.028) and 148 nucleotide sequences 
downstream of the gene is present in Microbacterium sp. MA1, but missing in R. 
rhodochrous 11Y. Secondly, the gene encoding a transcriptional regulatory protein 
containing a GAF-domain (pMA1.022) is truncated in Microbacterium sp. MA1, while 
the full length gene is present in R. rhodochrous 11Y. Lastly, there are six SNPs within 
the whole 14.3 kbp region, with one of the SNP located upstream of the xplB gene 
(pMA1.030), four are located in the xplB/xplA region, and the last one is located in the 
gene downstream of xplA (pMA1.033) (Figure 4.7).   
 
Figure 4.40: Comparison of the genes flanking xplA between R. rhodochrous 11Y and 
Microbacterium sp. MA1. The 14.3 kbp region (ORF 22 to ORF 34) in Microbacterium sp. 
MA1 is highly conserved in R. rhodochrous 11Y. The ORF 28, which encoded for the 
transposable element, is the only gene which is missing in R. rhodochrous 11Y. The colour 
code for each gene is described in the figure.  
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Sequence comparison of the 13.8 kbp region spanning ORFs 22-34 from R. 
rhodochrous 11Y with the, xplA carrying plasmid (pGKT2) from Gordonia sp. KTR9 
showed that there is only a 3,099 bp region that is nearly identical (> 99 %) between 
these two bacteria. The 3,099 bp region starts at the 4
th
 nucleotide from the ATG start 
site of the xplB gene and extends to the 103 nucleotides downstream of xplA. 
Additionally, there were just three SNPs within that region, one located in xlpA and the 
other two in the xlpB region.   
Further analysis using PCR (Chapter 2.6.3) with the primers listed in Table 2.1 
confirmed that the 13.8 kbp region in R. rhodochrous 11Y could be amplified in the 
other seven Rhodococcus spp. using the overlapping primer pairs (Data not shown).  
In Williamsia sp. EG1, the gene cluster appeared to be different from the other three 
genera of RDX-degrading bacteria: while the xplA and xplB region was amplified, the 
region between marR and xplB could not be amplified in the bacterium using the F, G, 
H and I primer pairs at either 50 or 55 ºC annealing temperature  (Figure 4.8) . 
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Figure 4.41: PCR products from amplifying the regions between marR to the end of 
xplA within the genome of Williamsia sp. EG1. The PCR was carried out using two 
different annealing temperatures (50 ºC and 55 ºC). R. rhodochrous 11Y genome was used 
as a positive control. The product sizes are: 1,351 bp, 1,038 bp, 1,078 bp, 1,049 bp, 900 bp, 
1,065 bp, 1,073 bp from F to L region, respectively.  
 
Further attempts to amplify the marR to xplB region in Williamsia sp. EG1 were made 
using PCR and a wider range of annealing temperatures (45 ºC, 50 ºC and 55 ºC). 
Simultaneously, PCR was also carried out to amplify the two genes downstream of xplA 
in Williamsia sp. EG1 using three primer pairs (M, N and O) (Figure 4.9). The expected 
PCR products were found for the two genes downstream of xplA, while again, the 
expected bands were not found for the region between marR and xplB in the Williamsia 
sp. EG1 genome (Figure 4.9).  
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Figure 4.42: PCR products from amplifying upstream of xplB and downstream of xplA 
in Williamsia sp. EG1. The annealing temperatures of the reaction were 45 ºC, 50 ºC, 55 ºC. 
The expected size of the products of F, G, H, I, M, N, and O are 1,351 bp, 1,038 bp, 1,078, 
1,049 bp, 977, 1,143, 981, respectively. Genomic DNA from R. rhodochrous 11Y was used 
as a positive control. 
 
In order to investigate whether Williamsia sp. EG1 has a full length xplB or if xplB is 
fused to glnA in a similar manner to that seen in Gordonia sp. KTR9, a forward primer 
was designed to anneal to the first nucleotide of xplB (5′-ATGGACATCATGAGT 
GAAGTGG-3′) and was used with the reverse internal xplB primer (I-R) as well as an 
internal reverse primer of xplA (J-R) (Figure 4.10).  Additionally, primers designed to 
amplify the full length of xplB-glnA were also used. The results revealed that Williamsia 
sp. EG1 has a full-length xplB gene which is not fused to glnA. 
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Figure 4.43: PCR products from the amplification of the xplB region in Williamsia sp. 
EG1.  P refers to the PCR products using the primers designed to amplify xplB from the start 
codon with an internal xplB reverse primer; the expected band is 797 bp. Q refers to the 
product of the same forward primer with the internal reverse primer from xplA gene (J-R); 
the expected product size is 1,532 bp. R refers to the PCR product of the primers which 
amplify full length glnA-xplB; expected product size is 2,445 bp. The annealing temperature 
of each product is written above each band. Positive controls for both P and Q were made by 
using the same primers but with R. rhodochrous 11Y DNA. The same primers were used for 
the positive control (+) of R, but with the Gordonia sp. KTR9 DNA. K is the PCR product 
from the xplA region in Williamsia sp. EG1 genome, expected size = 1,065 bp. 
 
Although the region from marR to xplB could not be amplified from Williamsia sp. EG1 
by PCR, the upstream region of marR was amplified by PCR as shown in Figure 4.11. 
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Figure 4.44: PCR products of the five primer pairs which were designed to amplify the 
genes upstream of marR in Williamsia sp. EG1 genome. The E, D, C, B and A letters 
represent the PCR products for the region of the upstream of the marR gene; L is the PCR 
product for xplA region.  The annealing temperature for each reaction is written above the 
bands. R. rhodochrous 11Y was used as a positive control.  The product size for E, D, C and 
B are 1,246, 886, 958, 1,130 and 1,274 respectively. The PCR product for L is 1,073 bp.   
 
The data presented in  Figure 4.11 demonstrate that Williamsia sp. EG1 has all five 
ORFs (ORF27 to ORF 22), in the same order as in Microbacterium sp. MA1 and R. 
rhodochrous 11Y, but unlike Microbacterium sp. MA1, the Williamsia sp. EG1 has a 
full length gaf gene. The gaf to marR region was also confirmed by sequencing the PCR 
products A to E. 
To investigate the proximity of marR to xplB and sequence upstream region of xplB, an 
attempted was made to amplify the region using primers designed to anneal to 
nucleotide number 97 upstream of the marR region (5′- ACGTCGAGTGTCGGGCGG 
ACC-3′) with the reverse primer annealing to base number 86 downstream of xplB (5′-
AGTTGCTGTGCGGTGAAAC-3′). No PCR product was detected in the Williamsia sp. 
EG1 genome using a gradient of annealing temperatures (56-70 ºC), while the expected 
PCR product was found in the positive control (Figure 4.12). 
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Figure 4.45: PCR products amplifying the region between marR and xplB gene in 
Williamsia sp. EG1. The PCR was carried out using a gradient annealing temperature from 
56 ºC to 70 ºC with the primers anneal to upstream of marR and downstream of xplB. 
Positive control is the PCR products of the same primers using R. rhodochrous 11Y genome. 
Expected product size is 3,388 bp.  
 
Recently, three short contigs in the xplA-region were published from the fosmid library 
sequence of the Williamsia sp. EG1 [113]. The first contig, which has the GenBank 
accession number KF571922, is 2,141 bp and is identical to xplA starting at the 
nucleotide position number 60 to the nucleotide number 393 of the 450 bp long gene 
encoding succinate-semialdehyde dehydrogenase (termed A in Figure 4.13). 
The second contig, (GenBank accession number: KF571923), is 952 bp and is identical 
to the minus strand of the 1,071 bp length gene encoding a dihydrodipicolinate 
reductase from the nucleotide position number 1,007 to 56 (terms as B in Figure 4.13). 
The third contig of Williamsia sp. EG1 (GenBank accession number: KF571924), is 909 
bp and is identical to the sequence encoding the transposable element (ORF28) at the 
position 895 to the nucleotide number 321 of the 1,395 bp length gene encoding for the 
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permease (ORF 29) (terms as C in Figure 4.13). A summary of the published sequence 
data for Williamsia sp. EG1 can be seen in Figure 4.13.  
 
Figure 4.46: Comparison of the published contigs of Williamsia sp. EG1 to partial 
sequence of Microbacterium sp. MA1. A, B and C represent the region from contig 
sequence which has accession number KF571922, KF571923, and KF571924, respectively. 
Dotted line is unconfirmed sequence area between genes. Straight line is continuous region.  
 
Overall, a 5,645 bp region, starting from nucleotide 32 of xplB to the gene encoding the 
AMP-binding enzyme (pMA1.034), was sequenced in Williamsia sp. EG1. The region 
between the gaf to marR was also confirmed by PCR and sequencing. The region 
upstream of xplB could not be amplified by PCR using the primers designed from R. 
rhodochrous 11Y genes, nor by using primers designed for xplB-glnA from Gordonia 
sp. KTR9. The results presented here suggest that the region upstream of xplB is 
different from other known RDX-degrading bacteria. A summary of the xplA–flanking 
regions in Williamsia sp. EG1, R. rhodochrous and Microbacterium sp. MA1 is shown 
in Figure 4.14.   
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Figure 4.47: Comparison of the xplA flanking region in three different genera of 
aerobic RDX-degrading bacteria, Microbacterium sp. MA1, R. rhodochrous 11Y and 
Williamsia sp. EG1. The dotted line represents unconfirmed gene sequence. Straight line is 
continuous genes. 
 
Despite the fact that several of the genes flanking xplA and xplB are highly conserved in 
all the RDX-degrading bacteria studied here, only xplA and xplB appear to be directly 
involved in RDX degradation [95, 96, 144]. To understand the evolutionary relationship 
between these isolates, a SNPs study was carried. Sequence analysis revealed that the 
bacteria all contained nearly identical copies of the xplA and xplB genes, as shown in 
Figure 4.15. There are only six SNPs ,Three of the SNPs are located in the heme-
domain of the xplA gene, occurring at positions 757, 877 and 1621, which affect 
residues 253, 293 and 541, respectively.  
 
Figure 4.48: Comparison of the nucleotide sequence of the xplA and xplB genes 
amongst the RDX degrading bacteria. Only the SNP variation is shown in all the isolates.  
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4.3.3 Total genome sequencing 
To identify the sequence upstream of xplB in Williamsia sp. EG1 and sequence the 
plasmid carrying the xplA and xplB genes in R. rhodochrous 11Y, both bacteria were 
submitted for total genome sequencing. The methodology for total genome sequencing 
is described in Chapter 2.6.2. Prior to sequencing, the 16S rRNA regions were 
sequenced to ensure that the DNA samples were from the correct species (data not 
shown). Additionally, the xplA gene was amplified from the DNA samples to make sure 
that the plasmids had not been cured from the bacterial genomes during the extraction 
process. The quality and quantity of the genomic DNA samples was analysed using an 
Agilent TapeStation 2200, and the results are shown in Figure 4.16. 
 
Figure 4.49: Genome analysis of R. rhodochrous 11Y and Williamsia sp. EG1 using an 
Agilent TapeStation 2200. A1 is a ladder (93.8 ng/µl). B1 is the 5-fold dilution of R. 
rhodochrous 11Y genome (concentration= 12.9 ng/ µl). C1 is the 5-fold dilution of 
Williamsia sp. EG1 genome. D1 is the blank.  
 
The genome sequencing was performed by Dr. Deborah Rathbone in the Biorenewables 
Development Centre at the University of York using Ion Torrent (Life Technologies) 
next generation sequencing. 
The raw data from the genome sequencing was assembled by Dr. Yi Li in the Centre for 
Novel Agricultural Products at the University of York using Newbler (version 2.7), the 
results of the sequence assembly are shown in Table 4.1.  
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Table 1: Sequence assembly results of the total genome sequence of R. rhodochrous 11Y 
and Williamsia sp. EG1 
 R. rhodochrous 11Y Williamsia sp. EG1 
Peak depth 
87.0 212.0 
Number of all contigs 
2,362 155 
Number of bases 
8,794,871 4,428,181 
Average of contig size 
4,514 37,150 
N50 of contig size 
8,725 66,310 
Largest contig size 
153,643 252,087 
Estimated genome size 
8.9 MB 4.4 MB 
 
4.3.3.1 Analysis of the total genome sequence of R. rhodochrous 11Y 
Scanning for xplA in the contigs of the R. rhodochrous 11Y genome sequencing, 
revealed that the gene appeared in the 50,923 bp contig00008 in R. rhodochrous 11Y. 
The contig could not assembled to any other contig using Newbler software, nor by 
PHRAP (http://www.phrap.org/) software having the total genome sequence of R. 
erythropolis PR4 (= NBRC 100887), plasmid (pGKT2) of Gordonia sp. KTR9 or 
Gordonia bronchialis DSM 43247 as a reference sequence.  
Manual sequence analysis showed that the 5′ end of the contig0008 overlays with the 
reverse complementary sequence of the 2,578 bp length contig000853 as both contigs 
contained a portion of the sequence encoding a helicase-associated protein (gene locus: 
KTR9_4946) within plasmid (pGKT2) in Gordonia sp. KTR9. Subsequent PCR 
confirmed that the contigs 0008 and 000853 can be assembled together (Data not 
shown). As no other contigs aligned in this region, further contig assembly was not 
possible. 
Sequence annotation of the 53,711 bp region spanned by contigs 0008 and 000853 was 
carried out using a Bacterial Annotation System (BASys) [145] and NCBI Prokaryotic 
Genome Annotation Pipeline (PGAP), then further checked manually using the BLAST 
search engine in NCBI. The annotation revealed that the region encodes 58 ORFs, 21 of 
which are hypothetical proteins, and three genes encode for transposable elements 
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(Gene loci: 11Y.043, 11Y.044 and 11Y.057), which are located downstream of xplA 
(Figure 4.17). The first two transposable elements encoded by (Gene loci: 11Y.043 and 
11Y.044) belong to the Class II transposable elements, and are identical to a 
multispecies transposase in Corynebacterineae (GenBank accession number: 
WP_011331220). The third transposable element (Gene locus: 11Y.058) is identical to a 
putative site-specific recombinase (gene locus: RER_pREC1-00620) of the linear 
plasmid 1 pREC1 in Rhodococcus erythropolis PR4. 
The 15 kbp region downstream of the gene loci: 11Y.043, encodes for first transposable 
element to the end of the sequence was found to be nearly identical (15913/15915; 99 
%) to the linear plasmid1 (pREL1, length= 271,577 bp) of the alkane-degrading 
bacterium R. erythropolis PR4 [130] at the region (Gene loci: RER_pREC1-00610 to 
RER_pREC1-00750). 
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Figure 4.50: Schematic representation of the partial 53,711 bp plasmid sequence 
flanking xplA and xplB in R. rhodochrous 11Y. The colour code for each gene is explained 
in the figure.  
 
Interestingly, there was an 11.8 kbp region found to be nearly identical (> 99 %) 
between the partial plasmid sequence of the R. rhodochrous 11Y and the plasmid 
carrying xplA (pGEKT2) from Gordonia sp. KTR9. The region starts at the nucleotide 
position number 364 upstream of Gene locus 11Y.02 to the end of the gene locus 
11Y.017 in R. rhodochrous 11Y, which is identical to the sequence region from gene 
loci KTR9_4945 to KTR9_4801 in Gordonia sp. KTR9. There were three differences in 
the 11.8 kbp region between these two bacteria:  First, the transposable element encoded 
by gene locus KTR9_4947 is missing in the partial sequence of R. rhodochrous 11Y. 
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Second, the gene encodes for replicative DNA helicase in Gordonia sp. KTR9 (Gene 
locus: KTR9_4801) which is truncated and fused with truncated 23s rRNA sequence in 
R. rhodochrous 11Y (Gene locus: 11Y.017). Lastly, there were six nucleotides 
(CCGAGC) in a noncoding region between the gene loci 11Y.010 and 11Y.011, which 
are missing in the corresponding region in Gordonia sp. KTR9.  
4.3.3.2 Analysis of the total genome sequence of Williamsia sp. EG1 
The whole genome sequence of Williamsia sp. EG1 was first scanned for xplA and xplB. 
Surprisingly, the sequences for xplA nor xplB could not be found in the assembled 
contigs. Further sequence analysing was carried out by comparing all the contigs to a 
partial 53 kbp region from R. rhodochrous 11Y and full plasmid (pGKT2) sequence, 
carry xplA/xplB, from Gordonia sp. KTR9. Again there was no significant sequence 
similarity between the Williamsia sp. EG1 contigs and either the R. rhodochrous 11Y 
gene cluster or plasmid (pGKT2) of Gordonia sp. KTR9. 
To investigate the possibility of whether the wrong sample had been sequenced, 16S 
rRNA of Williamsia sp. EG1 (GenBank accession number: KF571870.1) was aligned 
against the assembled contigs, and the entire length of the sequence found to align to 
contig00109 with 99 % sequence identity (1359/1366). Further analysis of the raw 
sequence data identified a single fragment (~ 300 bp) with > 99 % sequence identity to 
the xplA of R. rhodochrous 11Y. As there were no contigs containing the xplA region 
from the whole genome sequencing of Williamsia sp. EG1, no further analysis on the 
xplA region using these data could be done.  
Overall, a 13.8 kbp gene cluster (termed the A region in Figure 4.18) flanking xplA and 
xplB which is conserved amongst Rhodococcus spp. regardless of the geographical 
location from where each species had been isolated. The A region is also conserved in 
Microbacterium sp. MA1, with the exception of a transposable element (Gene locus: 
pMA1.028), which is missing in the Rhodococcus spp gene cluster, and a gaf gene 
(Gene locus: pMA1.022), which is truncated in Microbacterium sp. MA1. Several genes 
within the A region of Williamsia sp. EG1 were also amplified by PCR and sequenced. 
Williamsia differs from Rhodococcus spp. by having a gene encoding a transposable 
element next to the aroP gene, whereas Williamsia sp. EG1 is different from 
Microbacterium sp, MA1 by having a full length of the gaf gene. There is only 3.1 kbp 
of the A region in Gordonia sp. KTR9, which encodes to xplA and xplB genes. The xplB 
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gene in Gordonia sp. KTR9 is fused at the 5’ end to glnA; different from all the other 
bacteria studied here.    
Partial sequencing of the 53 kbp region flanking xplA in R. rhodochrous 11Y revealed a 
11.8 kbp sequence (termed the B region in Figure 4.18) upstream of the A region and a 
570 bp sequence upstream of a transposable element (gene loci=11Y.043) (termed the C 
region in Figure 4.18) sharing sequence homology (> 99 %) with a 13.6 kbp region and 
932 bp region of the plasmid (pGKT2) in Gordonia sp. KTR9. There are two main 
differences in the B region between Gordonia sp. KTR9 and R. rhodochrous 11Y. In 
Gordonia sp. KTR9 there is a transposable element (Gene locus: KTR9-4947) in the B 
region which is missing from the corresponding region in R. rhodochrous 11Y. 
Furthermore the gene locus: KTR9-4801, which encodes a replicative DNA helicase, is 
truncated and fused with truncated 23s rRNA in in R. rhodochrous 11Y (Gene locus: 
11Y.017). In the C region of Gordonia sp. KTR9, the Gene locus KTR9_4944 encoding 
for the hypothetical protein, is truncated in R. rhodochrous 11Y (Gene locus: 11.042).  
In addition to the sequence homology between R. rhodochrous 11Y and Gordonia sp. 
KTR9, there are two regions (termed the D1 and D2 regions in Figure 4.18) which are 
nearly identical between the 52 kbp sequence of Microbacterium sp. MA1 and the 
plasmid (pGKT2) of Gordonia sp. KTR9. The D1 region is 2185 bp upstream of a 
transposable element (Gene locus: pMA1.015) in Microbacterium sp. MA1 which is 
identical to the 2188 kb region (Gene loci: KTR9_4933 to KTR9_4937) located at 5.2 
kbp downstream of the xplA in Gordonia sp. KTR9.  The D2 region is 1260 bp located 
downstream of the same transposable element (Gene locus: pMA1.015) in 
Microbacterium sp. MA1, and it is identical to the 1273 kb region (Gene loci: 
KTR9_4802 to KTR9_4806) located nearly 150 kb upstream region of the xplA/xplB in 
Gordonia sp. KTR9. A summary of the sequence analysis can be seen in Figure 4.18. 
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Figure 4.51: Schematic representation of the RDX-degrading genomic island in four genera of aerobic RDX-degrading bacteria. A is region 
containing xplA and is 13,865 bp in R. rhodochrous 11Y, 14,312 bp in Microbacterium sp. MA1 and 3,099 bp in Gordonia sp. KTR9. In this region 
Microbacterium sp. MA1, contains a transposable element which is absent in both R. rhodochrous 11Y and Gordonia sp. KTR9. Additionally, in Gordonia 
sp. KTR9 the xplB gene is fused with glnA. B refers to a 11.846 bp region in R. rhodochrous 11Y, which shares sequence homology with a 13,687 region in 
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Gordonia sp. KTR9. In this region, the transposable element tnpA of Gordonia sp. KTR9 (Gene locus: KTR9_4947) is missing in R. rhodochrous 11Y. C is 
the 570 bp region located next to two transposable elements in R. rhodochrous 11Y (Gene loci: 11Y.041 and 11Y.042), and it shares sequence similarity to the 
932 bp sequence in Gordonia sp. KTR9. The D1,2 region in Microbacterium sp. MA1 is composed of 4,873 bp, and is similar to the 3,461 bp region 
in Gordonia sp. KTR9 in two separate regions D1 and D2. D1 which is 2,188 bp and D2 is 1,270 bp; the transposable element tnpA is located in the D1,2 
region in Microbacterium sp. MA1 (Gene locus: pMA.015) is missing in Gordonia sp.KTR9. White coloured regions have no sequence homology in 
corresponding bacteria. Dotted line is unconfirmed sequence region. The gene encoded for transposable elements are shown in yellow colour.       
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4.4 Discussion 
Comparison of the RDX removal rates between RDX-degrading isolates showed that all 
Rhodococcus spp. had faster RDX removal rates than Microbacterium sp. MA1, 
Gordonia sp. KTR9 and Williamsia sp. EG1. 
Considering that XplA alone is enough to denitrate the RDX structure in the organism 
[98, 105] and XplB enhances this activity [95, 144], the differences in the RDX-
removal rate is either due to the impairment of XplA/XplB proteins, or differences in 
the physiology between the strains and species. The sequence analysis presented in this 
chapter showed that both xplA and xplB are highly conserved between the RDX-
degrading bacteria with only six SNPs in the entire length of the two genes. 
The xplA gene in Williamsia sp. EG1, the species with the slowest rate of RDX-
removal, is 100 % identical to the xplA gene of R. rhodochrous 11Y, the fastest RDX-
removal bacterium. Thus, differences in RDX-removal rates are not due to the 
impairment in the XplA functionality, and are more likely due to differences in the 
physiology between the strains and species presented here. 
Studies whereby the xplA and xplB-carrying plasmid (pGKT2) from Gordonia sp. 
KTR9 was transferred into Gordonia polyisoprenivorans, Rhodococcus jostii RHA1 
and Nocardia sp. TW2 via transconjugation, demonstrated that pGKT2 conferred  the 
ability to grow using RDX as sole nitrogen source, with the faster rate of RDX-removal 
by Rhodococcus jostii RHA1 [104]. Additionally, R. jostii RHA1 transformed with xplA 
from Gordonia sp. KTR9 through pTip type II shuttle vector resulted in a 14 times 
faster rate of RDX-removal by the transformed R. jostii [105]. 
It is known that there are differences between the rates of xenobiotic catabolism by the 
same enzyme within different species. For example, Ancylobacter aquaticus AD20, 
Ancylobacter aquaticus AD25 and Xanthobacter autotrophicus GJ10 all carry identical 
copies of the dhlA gene for haloalkane dehalogenase and they degrade 1,2-
dichloroethane (DCE), and other halogenated aliphatic compounds, at significantly 
different rates on the genus level but are less different at the strain level [146].  Thus, it 
is not surprising that R. rhodochrous CW25 transformed with the 7.5 kbp region 
(pHSX1) from R. rhodochrous 11Y, which encodes both XplA, XplB, showed slower 
RDX removal rate compared to the R. rhodochrous 11Y [96]. 
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Another factor that could influence differences in the RDX-degradation rates between 
the species is XplB activity. The xplB knock-out in R. rhodochrous 11Y decreased the 
RDX-degradation rate by 70 %  [144] and transgenic plant lines expressing both xplA 
and xplB removed RDX faster than plants expressing xplA alone [95]. Both of these 
observations demonstrate that XplB is important for RDX degradation. Gordonia sp. 
KTR9 has the second slowest RDX-removal rate of all the bacteria tested here and is 
likely to be the result of a single mutation (3
rd
 substitution) in XplB which encodes 
serine-385 in the place of a highly conserved aromatic tryptophan residue. Moreover, 
the fusion of xplB to glnA is likely to further inhibit the reductase activity of XplB. The 
XplB-GS fusion is studied and discussed in more detail in Chapter 5.  
XplB in Microbacterium sp. MA1 has isoleucine-172 in the place of conserved 
phenylalanine-172 in the XplB of RDX-degrading bacteria. Although, the homology 
modelling of the XplB protein was revealed that the Phe residue is not located in the 
FAD moiety of the XplB protein (data not shown), replacing an aromatic residue 
(phenylalanine) by isoleucine might affect the activity of the protein, similar to XplB in 
Gordonia sp. KTR9.  
Williamsia sp. EG1 exhibited the slowest rate of RDX removal of all the isolates, 
slower even than Gordonia sp. KTR9 which contains a XplB-GS fusion with reduced 
XplB activity. While the partial xplB sequence from Williamsia sp. EG1 was identical to 
xplB from R. rhodochrous 11Y, sequence directly upstream of xplB in Williamsia sp. 
EG1could not be obtained.  It is possible that xplB in the Williamsia sp. EG1 is fused to 
an unknown protein, resulting in decreased reductase activity, in a manner similar to the 
XplB-GS fusion in Gordonia sp. KTR9 or the levels of xplB expression are impaired. 
A particularly curious observation during the analysis of the xplA/B-containing region in 
Williamsia sp. EG1 was the inability to obtain DNA sequence, either by PCR or total 
genome sequencing techniques, directly upstream from xplB. This could be due to a 
high GC content of the region or repetitive DNA sequences. Such a case is not without 
precedence: sequence assembly of the contig carrying a gene for chlorate reduction was 
also reported to fail due to the presence of several repeat sequences in the region  [147]. 
[105]. Additionally, although a portion of the xplA gene was found in the raw sequence 
data of Williamsia sp. EG1, the xplA/xplB genes could not be located in the genome 
sequence of this bacterium. Loss of the plasmid by the majority of the bacterial cells 
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after growth in non-selective LB medium prior to DNA extraction could be one possible 
explanation for the absence of xplA/xplB in the genome sequence of the bacterium.  
With few plasmids present, coverage may have been too low in the xplA region for the 
sequence to be adequately assembled. If the xplA/xplB-containing plasmid has been lost 
during growth in LB, this perhaps suggests the plasmid is not stable, and can be cured 
when the selective pressure is not present. A previous attempt to create independent 
xplA and xplR knock-out strains of Gordonia sp. KTR9 resulted in the strains being 
cured of the plasmid [105]. Moreover, a study to identify the gene responsible for RDX-
degradation in Rhodococcus sp. HS4 suggested that long term storage in non-selective 
medium in freezing conditions might have caused a loss of the RDX-degradation 
capacity in the bacterium [57]. 
The xplA and xplB genes are highly conserved amongst different genera of aerobic 
RDX-degrading bacteria isolated from distinct geographical location, which further 
supports the theory of the recent evolution of these genes, and dissemination around the 
world though the horizontal gene transfer [100, 103, 104]. In a similar manner, 
naphthalene degrading genes (nahAc) [148], N-heterocycle morpholine degrading genes 
(morABC) [149], atrazine degrading genes (atzABC) [150] and haloalkane dehalogenase 
(dhaA) [151], (chloro)biphenyl-degrading (bph)genes [152], as well as dhlA, the gene 
involved in 1,2-dichloroethane in Xanthobacter and Ancylobacter aquaticus, [146, 153] 
were all found to be highly conserved to the level of identical copies of the same gene 
found amongst different bacteria isolated from diverse geographical locations. 
In addition to xplA and xplB, there are several neighbouring genes which are nearly 
identical between bacteria from four different genera. This fact is surprising, 
considering that xplA alone is sufficient for the catabolism of RDX [98, 105].   
Considering that xplA is located on a plasmid, rather than within the chromosomal 
genome in both R. rhodochrous 11Y,  Microbacterium sp. MA1 [103] and Gordonia sp. 
KTR9 [105],  that there are transposable elements in neighhbouring regions (Figure 
4.18), it is possible that the xplA and xplB genes are part of a larger mobile element such 
as an Integrative and Conjugative Element (ICE) or genomic island in the conjugative 
plasmid. Similarly, the genes for the degradation of xenobiotics such as chlorobenezene 
by Pseudomonas sp. strain B13 [35, 36] and biphenyl degradation by Ralstonia 
eutropha A5 are also found part of the on the larger mobile element [152]. ICEs are 
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known to excise and integrate into the genome through conjugation [1, 31], and 
sequence analysis of the R. rhodochrous 11Y genome has shown that there is a gene 
encoding an phage related intergrase (Gene locus: 11Y.057) belonging to the tyrosine 
recombinase family, which shares 100 % sequence identity with a site-specific 
recombinase in R. erythropolis PR4. Moreover, the RDX-degradation capacity of 
Gordonia sp. KTR9 was successfully transferred into Gordonia polyisoprenivorans, 
Rhodococcus jostii RHA1 and Nocardia sp. TW2 through conjugation[104], 
demonstrating that this is a possible transfer mechanism. 
The genomic island in R. rhodochrous 11Y is 36,032 bp in length and encodes 42 
ORFs, starting from 11Y.002 to 11Y.043 (Figure 4.18). The first transposable element 
(gene locus= 11Y.043) is likely to be the end of the genomic island as the 15 kb 
downstream of this gene is nearly identical (> 99 %) to the plasmid1 (pREL1) from the 
alkane-degrading R. erythropolis PR4. Interestingly, pREL1has been shown to share 
sequence homology with the downstream region of the pathogenicity island in the 
plasmid pRFWT701 of R. equi [130]. 
In Gordonia sp. KTR9, several genes within RDX-degrading genomic islands are 
missing or rearranged on the plasmid carrying xplA and xplB, which suggest that the 
genes have been acquired by horizontal gene transfer through recombination events. 
Interestingly, the sequence analysis of plasmid (pGKT2) in Gordonia sp. KTR9 
suggests that xplA and xplB are integrated into an operon involved in the degradation of 
N-heterocyclic alkaline, as the genes upstream of xplB/xplA (xplR,cyp151C and glnA) 
share high sequence similarity and arrangement to the mor and pipe gene clusters 
involved in the degradation of morpholine, piperidine and related compounds in 
mycobacterium and rhodococci [105]. The lack of several genes within the xplA and 
xplB containing genomic island in Gordonia sp. KTR9 that are present in R. 
rhodochrous 11Y and Microbacterium sp. MA1, indicates that the encoded gene 
products are not required for RDX degradation. This is referred to as the common 
evolutionary prospect “use it or lose it”, in which microorganisms lose the gene(s) 
which are not essential for catabolic activity [21]. The deletion of aroP and marR, the 
two genes upstream of the xplA and xplB gene in R. rhodochrous 11Y, previously 
thought to be involved in RDX degradation [144], did not affect RDX degradation in 
the bacterium. The large reduction of the plasmid from the pathogenic Shigella spp. and 
enteroinvasive Escherichia coli, which was acquired from the ancestral commensal E. 
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coli, was reported to enhance virulence in both bacteria [22]. However, there is no direct 
evidence of the advantage of the genome reduction of Gordonia sp. KTR9.   
 
 
  
  
Chapter 5: Expression, Purification 
and Characterisation of the XplB-
Glutamine Synthetase Fusion Protein 
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5.1 Introduction  
The partnering reductase XplB is an NADPH-dependent flavodoxin protein which 
contains one mole of FAD as a cofactor and shares sequence homology with the bovine 
adrenodoxin reductase partner to the mitochondrial P450 (GenBank: P08165.3)[96].  
XplB is involved in the activation of the catalytic centre of XplA via the transfer of an 
electron from NADPH to a flavodoxin domain fused to the N-terminal of the P450 
domain of XplA [95]. 
The role of XplB in RDX degradation has been shown in both R. rhodochrous 11Y and 
a transgenic plant line expressing the xplA/B genes. Knock-out experiments on the xplA, 
xplB, aroP and marR genes in R. rhodochrous 11Y revealed that xplB is directly 
involved in the RDX-degradation and knock-out of the gene in R. rhodochrous 11Y 
reduced the RDX-degradation capacity by ~70 % compare to wild-type [144] (Figure 
5.1).  
 
Figure 5.52: RDX removal by R. rhodochrous 11Y wild type and knock-out strains 
during the resting cell assays. (A) The 13.8 kbp region in the vicinity of xplA in the 
bacterium. (B) The RDX-removal capacity by each xplA, xplB, aroP and marR knock-out 
strains in R. rhodochrous 11Y in comparison to the wild-type. Reproduced from Chong et al. 
(2014) [144].   
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Similarly, plants expressing xplA and xplB genes removed RDX significantly faster than 
transgenic plants expressing xplA alone [95].  
In Gordonia sp. KTR9, the gene encoding XplB is naturally fused with a glutamine 
synthetase encoded by the  glnA [105], an arrangement which has not yet been found in 
other RDX degrading bacteria (Chapter 4).  A transcriptomic study of Gordonia sp. 
KTR9 revealed that the xplB-glnA fusion is part of an operon along with two 
surrounding genes: xplA downstream and cyp151C upstream. Furthermore, the 
transcription site for these three genes is located 12 nucleotides upstream from the 
cyp151C gene (Figure 5.2) [29]. 
 
Figure 5.53: The xplA gene cluster arrangement in Gordonia sp. KTR9. The arrow 
represents the transcription start site, which is located 12 nucleotides upstream of cyp151C. 
Reproduced from Chen et al. (2012) [154].    
 
Glutamine synthetase (GS; EC 6.3.1.2) is an essential enzyme in nitrogen metabolism, 
catalysing the ATP-dependant production of glutamine from glutamate and ammonia.  
There are three different classes of GSs: GSI, GSII and GSIII [155-157]. The GSIs are 
dodecamer enzymes, made up of 12 identical subunits, and are mainly found in bacteria 
and archaea. The GSIIs are decamer enzymes, comprising of two pentamer subunits and 
are located in eukaryotic and soil-borne bacteria. The GSIIIs, like the GSI class, are also 
dodecamer enzymes and are found in a few anaerobic and cyanobacteria [155, 156].  
The GSI enzymes are further subdivided into two subclasses, GSI-α and GSI-β. In the 
GSI-α class, the activity of the enzymes is regulated by glutamine feedback inhibition, 
while GSI-β activity is regulated by adenylation of a tyrosine residue located in the 
active site of the protein. The GSI-β enzymes also differ from GSI-α enzymes by having 
a short insertion of an amino acid sequence which is not found in GSI-α [155-158].   
In addition to glutamine production, the GSI-α enzyme in Bacillus subtilis is known for 
its important role in regulating nitrogen metabolism in the cell by controlling the 
expression of GlnR and TnrA [158, 159]. Mutation of the B. subtilis GSI-α enzyme 
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resulted in constitutive expression of both nitrogen regulatory genes glnR and tnrA 
[160] 
This chapter will focus on characterisation of the naturally fused XplB-GS protein in 
Gordonia sp. KTR9. The functionality of the XplB part of XplB-GS was compared with 
XplB from R. rhodochrous 11Y. Additionally, the GS component part of XplB-GS was 
characterised, and the potential role of the protein within the cell was investigated. 
5. 2 Materials and Methods 
5.2.1 Cloning xplB-glnA  
The xplB-glnA gene was cloned into the pET-28(a)+ vector at the EcoRI and XhoI 
restriction sites to allow for expression of a N-terminally His-tagged protein. As 
expression was low and there was not enough soluble protein, the gene was 
subsequently cloned into pGEX2T, at the BamHI and EcoRI sites, in order to express 
the gene as an N-terminally GST-tagged protein.  
The primers used to amplify the full-length gene, with complementary overhang 
sequences to each plasmid, were designed based on In-Fusion HD cloning software 
(Clontech Laboratories) (Chapter 2, Table 2.1). The xplB-glnA gene was amplified from 
the Gordonia sp. KTR9 genome using PCR (Chapter 2.6.3).   
Cloning was performed as described in Chapter 2.6.12 using 20 ng of PCR product with 
100 ng of linearized vector. An aliquot of the reaction (2 µl) was used to transform E. 
coli DH5α competent cells (Chapter 2.2.9). Transformed cells were then plated on LA 
plates containing 100 µg/ml of kanamycin and 100 µg/ml carbenicillin for pET-28(+)a 
and pGEX2T vectors, respectively. 
The successful cloning was confirmed by performing colony PCR (Chapter 2.6.3) using 
plasmid specific primers and GoTaq polymerase (Chapter 2, Table 1). Plasmids from a 
few positive colonies were extracted and sent for sequencing (Chapter 2.6.6). 
5.2.2 Expression of xplB-glnA  
The xplB-glnA gene was initially expressed as an N-terminally His-tagged protein by 
using pET-28(a)+.  The expression trials were performed using E. coli BL-21 (DE3) and 
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E.coli Rossetta 2 (DE3) cells. The cells were grown to OD600 ~0.6-0.8 at 37 ºC and then 
the gene expression was induced with 1 mM IPTG at 20 ºC with shaking. An aliquot 
(50 ml) was collected from the culture in a 50 ml falcon tube before induction as well as 
1, 3 and 18 hours after induction. The aliquots were spun down, pellets were snap 
frozen and kept at -80 ºC for subsequent analysis on SDS-PAGE.  
The xplB-glnA gene was also expressed as N-terminally GST-tagged protein using 
pGEX2T vector. The expression of pGEX2T-xplB-glnA was carried out in E.coli BL-
21(DE3) and E. coli ArticExpress cells. The cells were grown at 37 ºC to OD600 ~0.6 
and then the xplB-glnA expression was induced using varying concentrations of IPTG 
(0.1, 0.25 and 1 mM IPTG). The cells were kept shaking at 15 ºC for 14 hours. Cultures 
were harvested prior to and 14 hours post-induction. Expression levels were compared 
on SDS-PAGE with an empty vector, pGEX2T, as a control.  
After several trials, maximal expression of glnA-xplB was achieved by expressing the 
gene in E. coli BL-21(DE3),  induction was most efficient with 0.5 mM IPTG 
supplemented with 50 µg/ml riboflavin at 20 ºC for 14 hours.     
5.2.3 Reductase assay for XplB and XplB-GS 
Purified XplB-GS was tested for reductase activity with purified XplA protein. 
Commercial spinach ferredoxin reductase (0.1 Unit) (Sigma-Aldrich), which has been 
reported to work as a reductase partner to XplA [95], was used as a positive control. The 
reaction mixture was in 1 ml of 50 mM potassium phosphate buffer (pH 6.8), contained 
300 µM NADPH, purified XplA and XplB or spinach feredoxin reductase. The reaction 
was initiated by the addition of 100 µM of RDX at room temperature and stopped 
intermittently with 10 % TCA. RDX removal was monitored by HPLC and nitrite 
release, from degraded RDX by XplA, was measured by Griess assay (Chapter 2.8.2). 
The amount of reductase and XplA used in each experiment is mentioned in each 
corresponding results section.  
5.2.4 Determination of the amount of FAD in XplB  
The amount of FAD cofactor bound to XplB and XplB-GS proteins was measured 
following the method described by Aliverti et al. (1999) [161]. The protein was boiled 
at 100 ºC, in the dark, for 20 minutes and the precipitated protein removed by 
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centrifugation at 13,000 rpm for 10 minutes. FAD in the supernatant was analysed by 
spectrophotometry and HPLC, using commercially available FAD as a reference. For 
the spectrophotometric analysis, the UV-visible spectrum of the protein was recorded 
(200 to 600 nm) in 1 ml UV cuvettes. 
5.2.5 Activity assay for glutamine synthetase  
The activity of XplB-GS was measured based on the protocol described by Kingdon HS 
et al. [162] as cited by Sigma-Aldrich.  
A 3 ml reaction mixture contained the following components: 34.1 mM imidazole, 8.5 
mM ATP, 1.1 mM phosphoenolpyruvate, 60 mM MgCl2, 18.9 mM KCl, 45 mM NH4Cl, 
0.25 mM NADH, 28 units pyruvate kinase, and 40 units L-lactic dehydrogenase and 0.6 
unit of E. coli glutamine synthetase K12 (as a positive control), or 1 ml of purified 
XplB-GS. The components were mixed by inversion of the cuvette and the A340 was 
monitored until constant at 37 ºC. The reaction was initiated upon the addition of the 
substrate sodium glutamate (102 mM). The activity of glutamine synthetase was 
calculated based on the oxidation rate of β-NADH to β-NAD on the spectrometer at 
A340 during the conversion of L-glutamate to L-glutamine. The principle of the assay is 
shown below (Reproduced from Sigma-Aldrich Company https:// 
www.sigmaaldrich.com/content/dam/sigma-aldrich/docs/Sigma/Enzyme_Assay/ 
glutaminesynthetase.pdf).  
 
 
 
 
 
Glutamate + NH4
+ 
+ ATP                                       L-glutamine + ADP + Pi  
 
ADP + Phospho(enol)pyruvate                              ATP + Pyruvate  
Pyruvate + β-NADH                                         L-lactate + β-NAD 
+NH4++ATP                             L-glutamine+ ADP+ Pi  
 
Glutamine synthetase 
Pyruvate kinase 
L-Lactic dehydrogenase 
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5.3 Results  
5.3.1 Cloning and expression of xplB-glnA  
xplB-glnA was initially cloned, using an In-Fusion® HD cloning system, into pET-
28(a)+ to be expressed as a N-terminal His-tagged protein  (Figure 5.3).  
 
Figure 5.54: Cloning of xplB-glnA into pET-28(a)+ vector. (A) pET-28(a)+ digestion: 1 
and 2 are undigested plasmid; 3 and 4 are single digested plasmid with EcoRI and XhoI, 
respectively; 5 is the double digested plasmid with both restriction enzymes. (B) 
Amplification of the xplB-glnA gene by PCR, product size = ~2.5 kbp. (C) Colony PCR of 
the different transformed colonies.  
 
During preliminary expression trials using E. coli BL-21 and E. coli Rossetta 2 (DE3), 
soluble XplB-GS was not detected and even as early as three hours after induction, 
significant amounts of the protein were detected in the insoluble fraction (Figure 5.4).  
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Figure 5.55: Expression trials of xplB-glnA as N-terminally His-tagged protein. (A) and 
(B) are 12 % (w/v) SDS-PAGE gels of E. coli BL-21 (DE3) and E. coli Rossetta 2 (DE3) 
expressing XplB-GS, respectively. In both A and B panels, the gels show from left to right; 
molecular markers (1); lysate from cells containing the empty vector (2), E. coli cell lysate 
before induction (3), and the E. coli cells inducted after one hour (4), three hours (5) and 18 
hours (6).  The letter (a) refers to the soluble fraction of the cell lysate, (b) to the insoluble 
fraction. Expected protein size ~92 kDa. 
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From the results of the SDS-PAGE presented in Figure 5.5, it appeared that only low 
levels of soluble XplB-GS were achieved with pET-28a-xplB-glnA in E. coli BL-21 
(DE3)  using 0.1 mM IPTG  at 20 ºC shaking for 18 hour. However, soluble protein was 
just detectable by western blot analysis using anti-XplB polyclonal antibody. 
 
 
Figure 5.56: SDS-PAGE (A) and western blot (B) analysis for the expression trials of 
xplB-glnA as N-terminally His-tagged protein in E. coli BL-21 (DE3). In both A and B, 
(1) is protein markers; (2), (3), (4) and (5) refer to the E. coli cell lysate expressing pET-28a-
xplB-glnA, pET-28a, pGEX2T-xplB, and pGEX2T, respectively.  Molecular weight of XpB-
GS is 92 kDa and XplB is 72 kDa.     
 
XplB from R. rhodochrous 11Y was also reported to be insoluble and the 
characterisation of the protein was carried out by recombinantly expressing the protein 
fused with a 26 kDa GST-tag using pGEX2T vector [95]. As the pET-28a system failed 
to yield soluble protein, it was decided to clone the xplB-glnA sequence into pGEX2T 
(Figure 5.6). 
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Figure 5.57: Cloning of xplB-glnA into pGEX2T vector. (A) The pGEX2T digestion 
vector at BamHI and EcoRI restriction sites; (1) is the double digested plasmid with both 
restriction enzymes; (2) and (3) are single digestion of the plasmid with BamHI and EcoRI, 
respectively; (4) is the undigested plasmid control. (B) 1 % (w/v) agarose gel of the PCR 
product of the insert (xplB-glnA) gene (four replicates), product size= ~2.5 kb.  (C) 1 % 
(w/v) agarose gel of the colony PCR for several transformed E. coli cells. 
 
The expression trials of the pGEX2T-xplB-glnA construct were conducted using E. coli 
ArticExpress and BL-21 expression strains. The expression of xplB-glnA was induced 
with 0.1, 0.25 and 0.25 mM of IPTG, at 15 ºC for 14 hours. The amount of the soluble 
protein achieved with the N-terminally GST-tagged protein was significantly higher 
when compared to the N-terminally His-tagged XplB-GS (Figure 5.7).  
 
Figure 5.58: SDS-PAGE analysis for the expression trials of GST-tagged xplB-glnA in 
E.coli ArticExpress (A) and E. coli BL-21(DE3) (B). In (A) and (B), the gels show from 
left to right, molecular markers (1), lysate of the E. coli strain expressing an empty vector 
(2), lysate of the E. coli strain expressing xplB-glnA before induction (3), and the cells lysate 
induced with 0.1 mM IPTG (4), 0.25 mM IPTG (5) and 0.5 mM IPTG (6) after 14 hours, and 
purified XplB (7); expected protein size ~114 kDa.  
 
The production of over-expressed XplB-GS in E. coli BL-21 was subsequently scaled 
up into 6 x 500 ml culture in 2L flasks and purified using glutathione sepharose 4B 
batch purification as described Jackson et al. (2007) (Figure 5.8) [95].  
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Figure 5.59: SDS-PAGE analysis for the purification of GST-tagged XplB-GS using 
glutathione sepharose 4B batch purification. From left to right; molecular markers (1), 
lysate of the E coli expressing an empty vector (2), lysate of the E. coli expressing xplB-glnA 
gene (3), flow-through (4), washed proteins (5), and eluted protein ( 6-10). Size of the 
protein is ~114 kDa. 
 
The identity of purified XplB-GS was confirmed by western analysis using XplB 
polyclonal antibody (Figure 5.9) and MALDI-MS analysis.  
 
Figure 5.60: SDS-PAGE (A) and western analysis (B) of purified GST-tagged XplB-GS. 
In both (A) and (B), (1) refers to the protein marker, (2) is the E. coli lysate expressing xplB-
glnA, and (3) is the purified XplB-GS. Expected size of the protein ~114 kDa.  
Chapter 5 
137 
 
It was noticed when performing SDS-PAGE and western blots analysis (Figure 5.9), 
that there was a band below that of purified XplB-GS suggesting that some protein was 
degraded after purification.  
5.3.2 Characterisation of XplB-GS  
Prior to testing the reductase activity of XplB-GS, XplB and XplA from R. rhodochrous 
11Y were purified as described in Chapter 2.7.3 (Figure 5.10).   
 
Figure 5.61: SDS-PAGE analysis of XplA (A) and XplB (B) from R. rhodochrous 11Y. 
(A) SDS-PAGE analysis for E. coli Rossetta 2 (DE3) expression of xplA as N-terminally 
His-tagged protein in pET-16b, the gel shows from left to right, protein markers (1), lysate 
(2), flow-through (3), washed proteins (4), purified XplA (5); expected XplA size= 66 kDa. 
(B) SDS-PAGE analysis for the E. coli Bl-21 (DE3) expression of xplB as N-terminally  
GST-tagged protein in pGEX2T, the gel shows from left to right, protein markers (1), E. coli 
lysate (2), purified XplB (3); expected XplB size= 72 kDa. 
 
The activity of the purified proteins was assessed before conducting the reductase assay 
for XplB-GS. XplA (0.08 mg) was assayed for RDX degrading activity using 
commercial spinach ferredoxin reductase (Sigma-Aldrich). The XplA was found active, 
as reported by Rylott et al. (2006) [98], and nitrite released from the RDX degradation 
was detected and measured by Griess assay (Chapter 2.8.2). No RDX was observed in 
the absence of XplA or reductase (Data not shown).  
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Purified XplB (0.22 mg) was also assayed for reductase activity with XplA. XplB from 
R. rhodococcus 11Y was also found to be active as described by Jackson et al. (2007) 
[95]. 
When XplB was replaced with XplB-GS in the reaction mixture, there was no nitrite 
released after 3 hours incubation. Further analysis, using HPLC confirmed that RDX 
had not been depleted (Data not shown). 
During purification of recombinant XplB-GS from E. coli, it was noticed that the total 
lysate was colourless, while the lysate of E. coli expressing xplB was yellow (Figure 
5.11A). This was also observed for the purified proteins; XplB was a yellow colour, 
whereas XplB-GS colourless.  
It has been reported that FAD is only loosely bound in XplB [95], as XplB-GS was 
colourless, it appeared likely that no FAD was bound to the purified protein. The 
amount of FAD in 3.5 µM of XplB and XplB fused GS was measured using both HPLC 
and spectrophotometric methods. No FAD was not detected in XplB-GS, while nearly 
25 % FAD was found in XplB (Figure 5.11B). 
 
Figure 5.62: (A) E. coli BL21 (DE3) lysate expressing XplB-GS (right) and XplB (left). 
(B) Overlaid chromatograms of FAD peaks from purified XplB and XplB-GS by HPLC 
with commercial FAD as a reference.  
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In order to investigate whether the encoded XplB portion of the XplB-GS fusion was 
inactive or had lost activity during protein purification, the lysate from cultures of E. 
coli BL-21 cells expressing pGEX2T-xplB-glnA were tested with XplA for RDX-
degrading activity.  
Equal amounts of cell lysate (3.7 mg) expressing pGEX2T, pGEX2T-xplB-glnA and 
pGEX2T-xplB were used instead of purified protein as a reductase in assays containing 
purified 1.25 mg of XplA. The reaction was initiated by the addition of 100 µM RDX, 
and stopped after 10, 60 and 120 minutes. The expression of the glnA-xplB and xplB in 
the lysates was also confirmed by SDS-PAGE (Figure 5.12).  
Figure 5.14 shows that when lysate from cells expressing pGEX2T-xplB was used as 
the reductase, all the RDX was removed within 10 minutes. However, when the lysate 
from cells expressing pGEX2T-xplB-glnA was used, although reductase activity was 
detected, this was much lower than activity in lysate from cells expressing just the 
empty vector (pGEX2T) (Figure 5.13). Thus, this data is confirming that XplB fused 
with GS is inactive as a reductase partner to XplA. 
 
Figure 5.63: SDS-PAGE for the E. coli BL-21(DE3) cell lysate expressing pGEX2T, 
pGEX2T-xplB-glnA and pGEX2T-xplB. The gel shows from left to right, protein markers 
(1), the lysate of the cells expressing an empty vector (2-4), XplB-GS (5-7), and XplB (8-
10).    
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Figure 5.64: RDX removal by XplA with XplB and XplB-GS. The assays all contained 
50 mM potassium phosphate buffer, pH 6.8, 300 µM NADPH. Data shown are mean of 
three biological replicates ±SD.   
 
The sequence alignments of the XplB portion of the XplB-GS were shown > 99% 
sequence identity with full length XplB from R. rhodochrous 11Y (Figure 5.14). There 
are just two amino acids differences: first is the Met-1 which is missing in XplB-GS as 
a result of the fusion to GS. Second is Ser-385 in the XplB of Gordonia sp. KTR9 
which is Trp-386 in XplB from R. rhodochrous 11Y. The Ser/Trp-386 was found to be 
the result of a single base difference, TCG encoding tryptophan and TGG encoding 
serine. 
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Figure 5.65: Sequence alignment of the XplB region of the XplB-GS fusion protein 
from Gordonia sp. KTR9 (XplB-KTR9) and XplB from R. rhodochrous 11Y 
(XplB_11Y). The residue Ser-385 and Trp-386 are highlighted with yellow and are red in 
colour.   
 
Trp-386 was thought to be important for the functionality of XplB protein as the 
multiple sequence alignment was revealed that the residue is highly conserved amongst 
several FAD-containing proteins in database which share as low as 26 % sequence 
identity to XplB. The sequence alignment of the proteins, their sequence identity to 
XplB-GS and the accession number of each protein is shown in Table 5.1. Additionally, 
the phylogenetic trees of the FAD-containing proteins, which were used in the Table 
5.1, are shown in Figure 5.15.   
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Table 5.5: Shows the conserved tryptophan residue, corresponding to ser-385 in XplB-
GS, amongst several FAD containing proteins in database using ClustalW2 website at 
the EMBL European Bioinformatics Institute (http://www.ebi.ac.uk/). Name of the 
organisms are written in the left hand side, ID is the sequence identity of the protein to 
XplB-GS. UniProt AC is the accession number of the protein in UniProt database. The 
conserved Trp residues are highlighted in yellow; Ser-385 in Gordonia sp. KTR9 is also red 
in colour. 
 
 
 
Figure 5.66: Unrooted phylogentic tree between several FAD-containing proteins which 
has conserved Trp with XplB portion of XplB-GS using MEGA 6 tree building 
program and neighbour joining method, bootstrapped with 1000 replicates.  The 
accession number of XplB-GS from Gordonia sp. KTR9 is red and bold.  The organisms 
which have the FAD-protein were identified are in Table 5.1 above.     
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5.3.2.1 An investigation into the role of Trp-386 in the catalytic activity of XplB  
To investigate whether Ser-385 is the reason for the lack of activity and reduced flavin 
binding in XplB-GS, the equivalent residue in XplB (Trp-386) was mutated to serine. 
The XplB (W386S) mutant was created through a single mutation (C instead of G) as 
described in (Chapter 2.6.13), by using primers shown in (Chapter 2, Table 2.1).  
The xplB and xplB(w386s) were expressed as described Jackson et al. (2007) (Chapter 
2.7.3) [95]. On purification, it was observed that the lysate of the XplB(W386S) mutant 
was much paler in colour, whereas the wild type XplB expressing culture was yellowish 
(Figure 5.16A). Both proteins were purified and the level of FAD measured by HPLC 
analysis. FAD was found in XplB but not in the XplB(W386S) mutant(Figure 5.16B). 
Furthermore, when XplB and XplB(W386) were used as reductases for XplA, activity 
was only observed when XplB protein was supplied as the reductase; no RDX was 
removed in assays using XplB-W386 as reductase (Data not shown). 
 
Figure 5.67: (A) Total lysate of E. coli BL-21 expressing XplB and XplB(W386S). (B) 
Overlaid chromatograms of FAD peaks from purified XplB and XplB(W386S) by 
HPLC. 
 
As Trp-386 appears to play a crucial role in retaining FAD in XplB, homology 
modelling was used to predict the location of this residue in the structure of the protein.  
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Using automated homology modelling software (http://swissmodel.expasy.org/), the 
structure of XplB was created based on the template structure of NADPH: adrenodoxin 
oxidoreductase (AR) from the steroid hydroxylating system of adrenal cortex 
mitochondria of bovine (Bos taurus) (PDB: 1E6E subunit A) (Access date: 15/9/2014)  
[163]. This adrenodoxin oxidoreductase is the closest structure solved for protein that 
shares sequence identity (29.73 %) with XplB. The structure of XplB was superimposed 
onto the template structure (RMSD value: 0.767 Aº) and visualized using the Chimera 
UCSF software [120]. Surprisingly, the Trp-385 was found not located on the FAD 
moiety of the protein, but instead on the last α-helix towards the C-terminus of XplB 
(Figure 5.17). 
 
Figure 5.68: A model of the structure of XplB (green) superimposed on chain C of 
adrenodoxin oxidoreductase (pink). FAD is yellow. Predicted position of Trp386 is 
labelled in the XplB structure. Root mean square deviation (RMSD 0.767 ºA). 
 
To investigate the influence, and more specifically the FAD retaining capacity, Ser-385 
in XplB-GS was mutated to Trp-385. XplB(S385W)-GS was expressed in E.coli Bl-21. 
During the purification step, it was noticed that the cell lysate from the XplB(S385W)-
GS mutant was yellow. However, following purification, as shown in Figure 5.18, the 
XplB(S385W)-GS mutant protein was colourless.  
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Figure 5.69: SDS-PAGE gel from purification of XplB (S385W)-GS. From left to right, 
protein markers (1), cell lysate (2) and purified protein (3).  
 
Using HPLC analysis, purified XplB(S385W)-GS was found to lack any detectable 
FAD. Further studies using XplB(S385W) (0.9 mg) as a reductase partner to purified 
XplA in Greiss assays confirmed that XplB(S385W)-GS was inactive.  
E. coli lysate expressing empty vector, xplB-glnA and xplB(S385W)-glnA were assayed 
for the RDX-removal activity on HPLC using equal amount of purified XplA. The 
results showed that XplB(S385W) is active as there was a faster rate of RDX removal 
by XplA (42 ±11 %) when the lysate expressing XplB(S385W)-GS used as a reductase, 
whereas just 16 ±0.5 % of RDX was removed by XplA when an empty vector was as a 
reductase.  
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5.3.3 Characterization of GS portion of XplB-GS  
In Gordonia sp. KTR9, XplB is fused with a key enzyme in nitrogen metabolism, GS 
[105].  Whether this fusion affects GS activity and subsequent nitrogen metabolism is 
not known. Here, the GS portion of the fusion is investigated by both sequence analysis 
and the activity assay for GS. 
5.3.2.1 Sequence analysis of the GS protein fused to XplB  
The class of GS from XplB-GS was identified using multiple sequence alignments 
(MSA) with several characterised GSI protein sequences [155-157]. The MSAs 
revealed that the GS in XplB-GS belongs to GSI-α, lacking the insertion signature 
sequence found in class GSI-β [155] (Table 5.2). 
Table 5.6: Classification of the GS fused with XplB in Gordonia sp. KTR9 based on 
multiple sequence alignment. GS proteins from Streptomyces coelicolor, Synechococcus 
sp., Anabaena sp., Salmonella typhimurium, Pyrococcus furiosus, Haloferax volcanii, and 
Methanococcus voltae are classified by Brown et al. (1994) [155]. The GS proteins from 
Mycobacterium tuberculosis, and Bacillus subtilis are characterised by Hayward et al. (2009) 
[157] and Murray et al. (2013) [156], respectively. Name of the organism, GS class, UniProt 
accession number, and a portion of the sequence alignment in the insertion region is shown 
below. The insertion sequence is yellow highlighted in the alignment.   
 
 
The MSA of GS from Gordonia sp. KTR9 with the three closest homologues from the 
ExPASy database (http://www.expasy.org/), shares >78 % sequence identity with the 
protein, reveals that the GS in XplB-GS is truncated. The missing region consists of 71 
amino acids at the C-terminal, comprising 15 % of the total protein size (Figure 5.19). 
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Figure 5.70: Part of the multiple sequence alignment of three GS proteins close 
homologues to GS-XplB. The name of the organism and the UniProt accession number of 
each protein is written next to its corresponding sequence. The yellow highlighted sequence 
is the region which is missing in the GS of Gordonia sp. KTR9.   
 
It is known that most of the active site residues in the glutamine synthetase are located 
in the C-terminal of the protein [156]. To investigate whether the missing residues form 
part of the active site, the model structure of the GS was created based on the closest 
homologue in the protein database bank for which structural data is available: GS from 
Bacillus subtilis (pdb: 4lnn.1.I) (Access date: 18/09/2014). 
GS from B. subtilis shares 29.06 % sequence identity with GS from XplB-GS.  
Superimposing the model structure of the GS from XplB-GS on the GS from B. subtilis 
(RMSD: 1.141 ºA) revealed the structure and position of the missing active sites and 
amino acids (Figure 5.20).  
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Figure 5.71: Superimposed model structure of the GS from XplB-GS of Gordonia sp. 
KTR9 (blue colour) on the GS structure of B. subtilis (golden colour). The location of each 
active site loop is labelled. The red coloured region is the sequence which is found in the GS 
structure of the template and is missing in the GS from Gordonia sp. KTR9.  Root mean square 
deviation (RMSD 1.14 ºA).  
 
Based on the homology modelling shown in Figure 5.20 and knowledge from the 
structure of the GSI-α of B. subtilis [156], it was found that the missing residues in the 
GS fusion include two residues which are involved in the formation of the active site 
Tyr loop. The other residues located on the other loops, mediating the catalysis activity 
of the enzyme, present in GS from B. subtilis are also found in GS from Gordonia sp. 
KTR9. This is including Asn loop which found remarkably similar between GS of GS-
XplB and GS from B. subtilis, while the Asp
50
′ (Latch loop) is found to be extended in 
the fused GS compared to the GS from B. subtilis. The position and the sequence of the 
residues located on each loop are shown in Table 5.3. 
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Table 5.7: Sequence and the position of the residues located in active site loops of the 
model structure GS fused with XplB.  
Site Position Sequence 
Asp
50
′ (latch loop) 65-89 QHRTAMANLQAGRDGVLMAGGVGAS 
Tyr
179  
loop 172-181 TFRPDSSPAYH 
Asn loop 253-264 FMPKPGVGGYMGN 
Glu flap 324-330 DAGQFAP 
Tyr loop 384-390 PGAPTVG 
 
5.3.2.2 Measuring glutamine synthetase activity in the GS-XplB fusion 
Purified XplB-GS (0.283 mg/ml) was assayed for the glutamine synthetase activity. As 
the GS from Gordonia sp. KTR9 is a fusion protein, XplB from R. rhodochrous 11Y 
was tested to see if it interfered with the assay. The result shows that GS fused to XplB 
is active and able to convert 55.9 ±3.7 µmol. min of L-glutamate to L-glutamine at pH 
7.1 at 37 °C (Figure 5.21). 
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Figure 5.72: Glutamine synthetase activity assay of purified GS-XplB. The activity of the 
GS-XplB/GST tagged was examined spectrophotometrically based on the oxidation rate of the 
β-NADH at A340. The commercial GS of E. coli K12 (Sigma-Aldrich) was used as a positive 
control. Background interference of the XplB-GST, fused with GS enzyme in KTR9, was 
studied by using the purified XplB-GS from R. rhodochrous 11Y. 
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5.4 Discussion 
In summary, the analysis of the XplB-GS fusion from Gordonia sp. KTR9 presented 
here demonstrates that XplB is inactive, but even though the GS portion of the protein is 
truncated it still demonstrates glutamine synthetase activity. The XplB is inactive 
mainly as a result of having Ser-385 in place of highly conserved Trp that is present in 
the FAD containing proteins.  
5.4.1 The XplB portion of the XplB-GS fusion 
The level of soluble XplB-GS was very low when it was expressed as a N-terminally 
His-tagged protein, however an advantage of the pET-28(+)a system, if it had worked, 
would have been that the His-tag is a relatively small percentage of the overall protein 
when compared to the GST-tag encoded by the pGEX2T vector. This poor solubility of 
the protein is in agreement with the protein previously reported [95, 164]. The 
expression of soluble XplB-GS was greatly enhanced when it was expressed as a GST-
tagged protein, as seen with XplB from R. rhodochrous 11Y [95], and several other low 
soluble proteins [165]. 
Sequence comparison of the xplB part of xplB-glnA with xplB from R. rhodochrous 11Y 
revealed two nucleotides substitution in xplB-glnA: first mutation is neutral and results 
in the formation of a silent mutation; however the second substitution is appeared to 
have a deleterious effect on the reductase activity of the XplB protein through the 
formation of Ser-385 in the place of Trp386 in XplB. It has been proposed that most 
gene mutations are having neutral or deleterious effect on the growth of microorganism 
[6, 14]. As shown in Figure 5.14, the XplB of XplB-GS is inactive as a reductase part 
for XplA. Less RDX removal by purified XplA in the cell lysate expressing XplB-GS in 
comparison to the empty vector could be due to less availability of the endogenous 
reductase in the E. coli cell as the result of over expressed XplB-GS. Previously it was 
shown that plant or bacterial endogenous reductase can supply electrons to XplA [96, 
98, 105, 144]. The deleterious effect of the second mutation and the importance of the 
Trp residue for the functionality of the XplB was shown by creating a XplB(W386S) 
mutant, which resulted in the loss of reductase activity. Additionally, the FAD was not 
detected in the purified XplB(W386S) mutant, whereas purified XplB contained 25 % 
of its potential FAD.  Previous reports have also indicated that FAD binds weakly to 
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XplB; Jackson et al. (2007) reported that only 50 % of FAD was found  bound in 
purified XplB [95], while a recent study of XplB from R. rhodochrous 11Y yielded no 
detectable FAD [164]. The corresponding tryptophan residue to Trp-386 in XplB could 
be important for the functionality of other FAD containing proteins as it is found to be 
conserved in all the FAD-containing proteins examined, but no other protein was tested 
here.  
Although Trp has a dramatic influence on the FAD binding and functionality of the 
XplB protein, homology modelling of the XplB protein showed that this residue is not 
located in the FAD-binding site. Multiple sequence alignments of XplB with other 
reductases revealed that the Trp-386 is ubiquitous in all reductases, with the sole 
exception of XplB-GS. The importance of Trp-386 in FAD binding was further 
demonstrated by the observation that lysate expressing the XplB (S385W)-GS mutant 
had increased activity when compared to the endogenous reductase activity of E. coli 
expressing empty vector. The purified XplB(S385W)-GS, which has identical sequence 
like XplB from R. rhodochrous 11Y, was inactive which suggest in addition of the 
effect of Ser in the place of Trp, the reductase activity of the XplB(S385W)-GS was 
strongly, but not totally, inhibited by the GS protein fused to it. Considering that 
Gordonia sp. KTR9 was isolated from the soil without any detectable amount of 
explosive [114], then perhaps the lack of selective pressure is the reason for losing 
reductase activity of XplB-GS or the recombination and reduction of the genomic island 
which resulted in the fusion of the XplB to GS. As there was low reductase activity 
detected for the XplB(S386W)-GS in comparison to the empty vector in the whole cell 
assay, thus recombination in the genomic island, which resulted of the fusing XplB to 
GS, could be the reason for the deleterious mutation in XplB from Gordonia sp., KTR9. 
It has already been proposed that a useless gene can be deactivated through sequence 
mutation [21].  
5.4.2 The GS portion of the XplB-GS fusion 
Despite the fact that the GS component of the XplB-GS fusion is truncated, it was found 
to be active, demonstrating that the purified protein is correctly folded and the missing 
residues are not essential for the functionality of the GS protein.  
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Due to very low yields of proteins, enzyme kinetics of the XplB-GS fusion was not 
carried, and thus the activity of the enzyme could not be compared with other GS from 
the same class.  
Finding GS fused with XplB to be active is in agreement with the homology model 
where the module shows all the residues located on the active sites of the protein are 
conserved, apart from an incomplete Tyr loop. Importantly, activity assays demonstrate 
that the incomplete Tyr loop, including missing catalytic tyrosine residue, does not 
affect the functionality GS fused to XplB. The Tyr loop is involved in the regulation of 
the GSI-β by adenylation of the catalytic Tyr in the active site, however GS from XplB-
GS is belong to GSI-α.  
The GS from the GS-XplB fusion belongs to GSI-α and is in the same operon with 
xplB/A this may suggests a potential involvement of GS in RDX degradation, possibly 
regulation of nitrite levels in the cell through regulating the expression of the GlnR. It is 
already known that GSI-α from B. subtilis plays an important role in regulating nitrogen 
levels by controlling the expression of GlnR and TnrA in the cell through feedback-
inhibition of glutamine mechanism [156, 158, 166], in which Glu flap [166] and Arg62 
in GSI-α are shown to be involved [156]. Mutation in GS of B. subtilis resulted in the 
constitutive expression of both proteins [166].  
In the Gordonia sp. KTR9, glnR is shown to be important in the assimilation of the 
nitrite in the cell. A knock-out mutant of glnR in Gordonia sp. KTR9 resulted in the 
accumulating of nitrite [167] and down-regulation of the nitrite reductase gene locus  
KTR9_1306 and KTR9_1307 [168]. Additionally, the glnA mutant from KTR9 lost the 
ability to utilise RDX, nitrite and nitrate as a sole source of nitrogen, but not ammonium 
or glutamine.  Similarly,  deleting of the tnrA gene, which has a similar C-terminal to 
GlnR [169], in the nrgAB operon of the B. subtilis impaired the ability of the bacterium 
to use allantoin, γ-aminobutyrate, isoleucine, nitrate, urea and valine as  nitrogen 
sources [160].   
 
 
 
  
Chapter 6: Expression, Purification 
and Characterisation of XplA-
homologues from non-RDX 
degrading bacteria 
 
 
  
Chapter 6 
155 
 
6.1 Introduction  
The cytochrome P450 XplA (CYP1771A1) is an unusual P450 that consists of a heme 
domain C-terminally fused to a native flavodox domain. This enzyme, with its reductase 
partner XplB, catalyses the reductive denitration of the recalcitrant pollutant RDX 
(Chapter 1) [1, 2]. 
Unusually for a P450, the biodegradation of RDX by XplA is not an oxygen dependent 
reaction and can occur both aerobically and anaerobically; however, while oxygen is not 
required for activity it influences the level of denitration of RDX. In both conditions, 
the ring structure of RDX is cleaved to produce nitrite and formaldehyde with either 4-
nitro-2,4-diazabutanal (NDAB) under aerobic conditions, or  methylene dinitramine 
(MEDINA) under anaerobic conditions (Figure 6.1). 
 
 
Figure 6.73: Biodegradation pathway of RDX catalysed by XplA from R. rhodochrous 
11Y.  (A) is the anaerobic pathway, in which the RDX structure is cleaved after denitration 
and hydration to produce one mole of nitrite, two moles of formaldehyde, and methylene 
dinitramine (MEDINA). (B) is the aerobic biodegradation pathway of RDX; the RDX is 
double denitrated, then hydradated to form two moles of nitrite, formaldehyde and 4-nitro-
2,4-diazabutanal (NDAB). Reproduced from Jackson et al. (2007) [95]. 
 
The crystal structure of the XplA-heme domain has been solved and shown to share the 
same overall structure with other P450 enzymes, but with three differences: The first 
Chapter 6 
156 
 
and most significantly, is that the I-helix in the XplA-heme domain is broken above the 
iron heme in the region which is usually occupied by the highly conserved Glu/Asp-
Thr/Ser residues. These acidic residues, that are essential for oxidation activities in other 
P450s, have been replaced by Met-394 and Ala-395 in XplA. The second difference is 
that the D-helix is distorted in the middle of the helix between Asp-262 and Arg-266. 
Third and lastly, is the addition of a short helix near the N-terminal of the protein 
(Figure 6.2). 
 
Figure 6.74: Topology of the XplA-heme (pdb: 2wiy). Overall structure of the XplA-heme 
domain has a canonical structure, like other P450s. The α-helix and β-sheet components of 
the protein are shown in red cylinders and yellow arrows, respectively. Heme cofactor is 
shown in silver and buried at the center of the protein. N-term refers to the N-terminal; C-
term refers to C-terminal part in the protein structure. Reproduced from Sabbadin et al. 
(2009) [99].   
 
The XplA-heme has a hydrophobic active site, characterised by having three clustered 
methionine residues (Met-318, Met-322, Met-394) above the heme iron ring. 
Additionally, Trp-230, Trp-224, Phe-540, Leu-238, Val-387, Val-391, Ala-395, Gln-
438, Cys-503 and Pro-437 are also found in the active site of the protein (Figure 6.3). 
 
Chapter 6 
157 
 
 
 
Figure 6.75: The XplA-heme active site. The residues located in the heme binding site are 
shown, including characteristic three methionines (Met-394, Met-322 and Met-318) above 
the heme iron ring. The ligand imidazole (labelled as Imid) is bound to the active site. 
Reproduced from Sabbadin et al. (2009) [99].  
 
Two putative channels have been identified on the surface of the XplA-heme protein, 
which were proposed to be involved in ligand transport into the XplA active site. The 
largest channel is bound by the side chains of Phe-319, Leu-323, Ala-541, Gln-438, and 
Met-322. The small channel is bound by the two positively charged side chain residues 
of Arg-288 and Arg-545, and could be responsible for capturing RDX.  These channels 
together make a path to the methionine cluster in the heme active site at the centre of 
XplA-heme (Figure 6.4) [1]. 
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Figure 6. 76: The putative ligand transport channels in the XplA-heme protein. (A) is 
the electrostatic surface of the XplA heme. The residues Arg-538, Phe-319 contribute to the 
formation of the large channel, whilst Arg-545 and Arg-288 are located around the small 
channel. (B) is a magnification of the partially transparent electrostatic surface of the ligand 
transport channel in XplA. The Arg-543, Arg-288, Arg-545, Gln-538, and Phe-319 residues 
are making a path for the ligand from the surface to the active site of the protein in the 
location above methionine cluster. The imidazole ligand (labelled as Imd) can also be seen 
through the pore from the surface of the XplA-heme. Reproduced from Sabbadin et al. 
(2009) [99]. 
 
As described in Chapter 1, the XplA/XplB system has now been characterised in detail 
and the the application of XplA to clean-up RDX contaminated soil is in progress. 
However, one aspect that remains unclear is the evo1utionary origin of xplA. Uniquely, 
XplA is the only cytochrome P450 that has so far been identified that is N-terminally 
fused to a flavodoxin domain. Nearly identical versions of xplA have been identified in 
all RDX-degrading Actinomycetales that have been tested, despite the fact that they 
have been isolated from distinct geographical locations (Chapter 4) [100, 102, 103]. The 
gene has not, however, been found in non-RDX degrading bacteria, nor in 
environmental DNA sequencing projects [98]. The closest homologue of XplA in 
databases is Erwinia carotovora subsp. atroseptica. (Uniprot ID Q6D569), a plant 
pathogen, with  41 % sequence identity [99].  
In this chapter, the evolutionary origin of the XplA enzyme was investigated by 
characterising three, published, putative cytochromes P450 that share sequence 
homology with XplA. Two of the P450s are from the auto-annotated, whole genome 
shotgun sequence of Gordonia polyisoprenivorans NBRC16320 (Sequence release date: 
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02/12/2011) and the third one is from the genome shotgun sequencing of Gordonia 
terrae strain NBRC100016 (Sequence released date: 16/02/2012). There is no data 
currently available regarding the RDX-degrading capability of these two species or 
whether they had been exposed to explosives. G. terrae NBRC100016 was isolated 
from a soil samples in Japan by Tsukamura (1971) and, interestingly, the bacterium was 
characterised for the ability to use a wide range of substrates as nitrogen sources 
including pyrazinamide, serine, methionine, acetamide, nitrate, nitrite, nicotinamide, 
isonicotinamide, benzamidec [170]. Whereas, G. polyisoprenivorans NBRC 16320, 
which is also called G. polyisoprenivorans kd2T DSM=44302T, was isolated for its 
ability to degrade rubber from fouling water fauna inside a deteriorated automobile tyre 
in Germany [171]. 
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6.2 Materials and Methods 
6.2.1 Cloning of the cytochrome P450 genes 
The putative cytochromes P450 used in this study have not previously been 
characterised.  Here the P450 from G. terrae strain NBRC 100016 (CYP177B1) 
(GenBank accession number: GAB46351) is referred to as "GT-XplA", and the two 
cytochromes P450 of G. polyisoprenivorans NBRC 16320, which have accession 
numbers GAB24219 and GAB24226, as “CYPA” and “CYPB”, respectively. CYPA 
and CYPB have been also officially named as CYP177C1 and CYP1051A1, 
respectively.  
All sequence analyses of the genes encoding the three cytochrome P450s were carried 
out using the NCBI database (http://www.ncbi.nlm.nih.gov/). 
The G. terrae strain NBRC 100016 and G. polyisoprenivorans NBRC 16320 were 
provided by The Biological Resource Centre (NBRC), the National Institute of 
Technology and Evaluation (NITE) in Japan. 
The gt-xplA was amplified from the total genome of G. terrae and cloned into a pET-
28(a)+ at the restriction sites EcoRI and XhoI to be expressed as an N-terminally His-
tagged protein (Chapter 2.6.12).  
The genes encoding CYPA, engineered to contain an ATG as a start codon instead of 
GTG which express in E.coli as valine and CYPB were amplified from the total DNA 
genome of G. polyisoprenivorans. The genes were cloned into NdeI and BamHI 
restriction sites of a pET-16b vector, allowing the protein to express as an N-terminally 
His-tagged protein (Chapter 2.6.12).  
Expression of soluble CYPA in pET-16b was problematic. To overcome this, cypA was 
re-cloned into pET-28(+)a, and then later into pET-16b as truncated CYPA as follows: 
Cloning of cypA into pET-28(+)a was carried out by amplifying the gene from the 
cypA-pET-16b construct, then cloning into pET-28(+)a at the NcoI and SalI restriction 
sites of the vector to achieve a C-terminally His-tagged protein. A truncated version of 
the cypA gene was constructed by cloning the cypA gene, missing the 60 bp at the 5′ 
region, into pET-16b at the NdeI and BamHI restriction site. 
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6.2.2 Expression of the cytochromes P450 
The putative P450s were expressed in an E. coli expression strain. For protein 
expression trials, freshly transformed E. coli cells were used to inoculate 125 ml LB 
medium in 500 ml flasks while for protein purification purpose cells were used to 
inoculate larger cultures of 500 mL LB medium in 2 L flasks. The LB medium 
contained 100 µg/ml of the plasmid specific antibiotic and 34 µg/ml of chloramphenicol 
was added when E. coli Rossetta 2 (DE3) cells were used (strain specific antibiotic 
resistance). Culture were grown with shaking at 37 ºC to OD600 ~0.6-08, cooled to 20 
°C and gene expression was induced by addition of IPTG. At the same time, ALA (δ-
aminolevulinic acid, 0.5 mM), FeCl3 (0.5 mM), and riboflavin (50 μg/L) were also 
added. The expression level of the proteins was checked by running the soluble and 
insoluble fractions of E. coli cell lysates on SDS-PAGE. The strain of E. coli, 
concentration of IPTG, induction temperature and time are mentioned in the 
corresponding result sections.  
6.2.3 Purification of the cytochromes P450  
The E. coli cells expressing the gene of interest were harvested and resuspended in His-
binding buffer (50 mM sodium phosphate pH 8, 300 mM NaCl). Cells were lysed by 
sonication (Chapter 2.7.2). Cell debris and other insoluble components were separated 
from soluble protein by centrifugation of the total cell lysate at 15,000 rpm for 15 
minutes using a Sorval Evolution RC high speed centrifuge (Kendro laboratory 
products). 
The expressed proteins were purified using a 5 ml HisTrap FF crude column containing 
prepacked Ni sepharose and AKTA purifier UPC10 system (GE-Healthcare). The lysate 
was loaded into a 50 ml superloop and then injected into the column at a flow rate of 1 
ml/minute. Protein was washed with five column volumes of His-washing buffer (His-
binding buffer containing 5 mM imidazole, pH 8.0). Elution was carried out using a 
gradient increasing of imidazole concentration in the buffer through gradual increasing 
ratio of the His-eluting buffer (His-washing buffed with 300 mM imidazole, pH 8) to 
the ratio of His-washing buffer. The soluble expressed proteins were generally eluted 
with ~150 mM imidazole. The purified fractions of the protein were identified from a 
chromatogram generated by AKTA Unicorn software (version 5.31) and from visual 
inspection for pink to red colour of the P450 proteins. The eluted fractions of the protein 
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were pooled and dialysed twice in 5 L dialysis buffer (50 mM potassium phosphate 
buffer, pH 7.0). The fractions from the protein purification steps were collected and 
analysed by SDS-PAGE.           
6.2.4 Spectra analysis of purified protein 
The absorbance for each of the reduced forms of the cytochromes P450 with CO was 
identified by UV-spectra analysis of the purified protein on a spectrophotometer 
(Shimadzu Corp., Kyoto, Japan). The purified protein was diluted in 50 mM potassium 
phosphate buffer pH 7.0 and the UV-visible spectrum of the oxidised form of the P450 
protein was recorded in the range of 300 to 600 nm in 1 ml UV cuvettes. The reduced 
and CO-bound spectra of the P450 were generated by first reducing the protein with 
sodium dithionite and then bubbling with CO.  
UV-Spectra of the protein were also used to investigate if the purified protein can bind 
to RDX by comparing the UV-spectra of the protein before and after adding of 100 µM 
of RDX.  
6.2.5 Whole cell assays 
E. coli cell cultures expressing the P450s, including the truncated CYPA and mutant 
forms, as well as the mutant from of GT-XplA were tested for RDX degradation 
capability. The mutant forms of the CYPA and GT-XplA were constructed as described 
in Chapter 2.6.13. Freshly transformed E. coli Rossetta 2 (DE3) cells were grown in 100 
ml flasks containing 10 ml of auto-induction medium with 50 µg/ml of the plasmid 
selective antibiotic and 34 µg/ml of chloramphenicol. Cells were grown at 37 ºC to 
OD600 ~0.6-0.8. The cultures were cooled to 20 ºC, then 0.5 mM ALA, 0.5 mM FeCl3, 
50 µg/ml riboflavin, and 100 µM RDX added. An aliquot of the medium (200 µl) was 
taken at different time points and used to detect nitrite released from RDX degradation 
by using the Griess assay (Chapter 2.8.2).  The composition of the auto-induction 
medium is shown in Table 6.1.  
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Table 6.8: The composition of the auto induction medium 
Medium component  Ingredients  Quantity  
ZY solution (in 1 L 
of water) 
Tryptone  10.0 g 
Yeast extract  5.0 g 
50X M solution ( in 1 
L water) 
Na2SO4 36.0 g 
NH4Cl 134.0 g 
KH2PO4 170.0 g 
Na2HPO4 177.0 g 
50X 5052 solution (in 
L in water) 
Glycerol  250.0 g 
Glucose  25.0 g 
α-Lactose  100.0 g 
1000X metals (in 1 L 
of water) 
0.1 M FeCl3.6H2O (in 0.1 M HCL) 500 ml 
1.0 M CaCl2 20 ml 
1.0 M MnCl2.4H2O 10 ml 
1.0 M ZnSO4. 7H2O 10 ml 
0.2 M CoCl2.6H2O 10 ml 
0.1 M CuCl2.2H2O 20 ml 
0.1 M NiCl2. 6H2O 10 ml 
0.1 M Na2MoO4.5H2O 20 ml 
0.1 M Na2SeO3.5H2O 20 ml 
0.1 M H3BO3 20 ml 
 
Component  Volume (ml in 1 L of solution)  
ZY solution  928.0  
MgSO4 (1 M) 1.0 
1000X metals  1.0 
50X 5052 solution 20.0 
50X M Solution 50.0 
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6.3 Results 
6.3.1 Sequence analysis of the XplA homologues  
An NCBI database scan for the XplA homologues revealed three putative cytochrome 
P450s (GT-XplA, CYPA and CYPB) sharing sequence homology to XplA.  
The sequence comparison showed that the cytochrome P450 domain of Gordonia terrae 
(GT-XplA) shares 44 % amino acid sequence identity with the heme domain of XplA. 
Additionally, GT-XplA was found to have a putative flavodoxin fused with the heme 
domain of the protein with 51 % sequence identity to the flavodoxin domain of XplA. 
Moreover, sequence analysis of the contig where gt-xplA is located (contig: 
GOTRE150, GenBank accession number: NZ_BAFD01000115.1) revealed that the 
gene is located in a region sharing sequence similarity to the xplA gene cluster in RDX-
degrading Rhodococcus spp. and Microbacterium sp. MA1. The gene located directly 
upstream of gt-xplA encodes a ferredoxin- NADP reductase with 37 % amino acid 
sequence identity with XplB; xplB is directly upstream of xplA in Rhodococcus spp and 
Microbacterium sp. MA1. The C-terminal of the succinate-semialdehyde 
dehydrogenase encoded by gabD gene, located downstream of gt-xplA, also shares 47 % 
sequence identity with the succinate-semialdehyde dehydrogenase encoded by the gene 
downstream of xplA (Figure 6.5A and B). 
The genes encoding the putative cytochromes P450 (CYPA and CYPB) are located in a 
143,465 bp contig: GOPIP064 (GenBank accession number: BAEI01000064.1) from 
the shotgun genome sequence of G. polyisoprenivorans NBRC 16320. The cypB is 
located in an ~8.0 kbp region upstream of cypA and there is also a similar gene 
arrangement to the xplA gene cluster in RDX-degrading bacteria. The CYPB has only 
37 % amino acid sequence identity with the heme domain of XplA. The gene upstream 
of cypB encodes a putative FMN binding protein, which shares 55 % sequence identity 
to the entire sequence of the flavodoxin domain of XplA. Interestingly, there is also a 
gene encoding an XplB-like reductase upstream of the gene encoding FMN binding 
protein, sharing 40 % identity to > 96 % of the XplB protein (Figure 6.5C). 
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Figure 6.77: (A) The 8.9 kbp region flanking the gt-xplA in G. terrae strain NBRC 100016. The yellow highlighted box is gt-xplA. B- is the graphic 
view for GT-XplA; the residues Met-1 to Trp-140 encompass the flavodoxin domain and Pro-147 to Ser-553 contains the cytochrome P450 domain. 
C-The 8.0 kbp region surrounding cypB in G. polyisoprenivorans NBRC 16320; cypB is highlighted in yellow. In both (A) and (C), the red bar represents 
the genes and black arrows represent the direction of transcription. Name of the proteins encoded by each gene is written above the gene, and each gene locus 
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is written next to the bar.  The graph is a modified version of that downloaded from the graphic view of the contig from NCBI database 
(http://www.ncbi.nlm.nih.gov).   
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CYPA was shown to have the highest overall sequence identity (51 %) with XplA, but 
the genes flanking cypA do not share sequence homology with those flanking xplA in 
RDX-degrading bacteria (Data not shown).  
Homology modelling shows that CYPA has a similar architecture to the XplA-heme 
domain (pdb: 2WIY), and several residues in the putative active of CYPA identical to 
those in XplA-heme structure including three methionine residues (Met-255, 179 and 
183) forming a cluster above the heme, similar to those in XplA-heme domain (Figure 
6.6).  
 
 
Figure 6.78: A model structure comparing the CYPA and XplA-heme active sites (pdb: 
2WIY). The model indicates that most of the residues located in the active site of XplA-
heme domain are also conserved in the active site of CYPA. The Root Mean Square 
Deviation (RMSD) = 0.194 ºA.  
 
The sequence alignments of the GT-XplA, CYPA, and CYPB to XplA revealed that 
most of the residues located in the active site of the XplA-heme are also conserved in 
CYPA, including Met-255 that breaks the I-helix in XplA-heme structure. Interestingly, 
codon sequence analysis of the gene shows that the adjacent residue, that is essential for 
XplA activity[99], (Ala-395), is replaced by Asp-256 as a result of a single nucleotide 
variation (GCC is Ala, GAC is Asp). A comparison of the XplA active sites residues to 
those in GT-XplA, CYPA and CYPB is shown in Table 6.2.  
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Table 6.9: The corresponding residues of XplA-heme active site in CYPA, CYPB and 
GT-XplA. Identical residues are shown in Bold. Information on the effect of mutation in the 
residues were obtained from the study taken by Sabbadin et al. (2009) [99]. 
  
 
 
 
 
 
 
XplA CYPA CYPB GT-XplA Note 
Trp-224 Trp-86 Gly-73 Asn-224 Heme Binding Pocket 
Trp-230 Trp-92 Trp-79 Phe-230 Heme Binding Pocket 
Leu-238 Ile-100 Leu-87 Leu-239 Heme Binding Pocket 
Val-387 Met-248 IIe-237 Leu-239 Heme Binding Pocket 
Val-391 Leu-252 Ser-241 Ser-392 Heme Binding Pocket 
Met-394 Met-255 His-244 Pro-395 Heme Binding Pocket. Met394leu mutant 
decreased kcat/KM by 2 fold. 
Ala-395 Asp-256 Asn-245 Asn-396 Heme Binding Pocket. Ala395Thr has the 
most remarkable effect, decreased the  
kcat/KM of the enzyme approximately 200 
fold. 
Pro-437 Pro-298 Pro-287 Val-438 Heme Binding Pocket 
Gln-438 Glu-299 Glue-288 Glu-439 Heme Binding Pocket and bounded the 
largest channel in XplA.  Gln438Ala mutant 
decreased kcat/KM value 17 times. 
Cys-503 Cys-364 Cys-353 Cys-504 Heme Binding Pocket 
Phe-540 Phe-401 Arg-390 Arg-541 Heme Binding Pocket 
Met-318 Met-179 Thr-167 Leu-319 Met318Leu mutant decreased the kcat/KM of 
the enzyme 20 times. 
Met-322 Met-183 Met-171 Met-323 
 
Met322Leu mutant decreased  kcat/KM value 
just one time. 
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6.3.2 Cloning and expression of putative ancestral XplA cytochromes 
P450 
The gene encoding GT-XplA was cloned into pET-28(+)a to be expressed as N-
terminally his-tagged protein (Figure 6.7). 
 
Figure 6.79: Cloning of the gt-xplA gene into pET-28(a)+ vector. (A) is the pET-28a(+) 
vector digestion; 1 and 2 are undigested plasmid; 3 and 4 are single digested plasmid with 
EcoRI and XhoI, respectively; 5 is the double digested plasmid with both restriction 
enzymes. (B) PCR amplification of the insert (gt-xplA), expected PCR product = ~1.7 kbp. 
(C) Colony PCR of the different transformed colonies using gene specific primers.  
 
The gene gt-xplA was expressed in E. coli Rossetta 2 (DE3), and protein production 
induced with 1 mM IPTG. The cells were harvested 16 hours after induction and GT-
XplA purified using a 5 ml HisTrap FF crude column and AKTA-purifier UPC10 
system.  A band corresponding to the expected protein size was found on SDS-PAGE in 
the eluted fraction (Figure 6.8). This band was cut from the gel and identified as GT-
XplA by MALDI-MS.  
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Figure 6.80: (A) Example of a typical chromatogram of GT-XplA purification on Ni-
affinity column using an AKTA-purifier. The chromatogram was generated using Unicorn 
5.31 software. (B) SDS-PAGE of the purification fractions of the GT-XplA proteins using 
HisTrap purification column. From left to right: molecular marker (1), lysate of E. coli 
expressing an empty vector (2), lysate of the E. coli cells expressing GT-XplA (3), flow-
through (4), washed proteins (5 and 6), purified GT-XplA (7), and XplA-heme domain (8). 
The predicted size of the GT-XplA= 65 kDa. 
 
The genes encoding both CYPA and CYPB were cloned into pET-16b and expressed as 
N-terminally His-tagged proteins (Figure 6.9).   
 
Figure 6.81: Cloning of cypA and cypB genes into pET-16b vector. (A) Digestion of the 
pET16b vector; 1 is uncut plasmid; 2 and 3 are single digested plasmid with NedI and 
BamHI, respectively; 4 is a double digested plasmid with both NdeI and BamHI. (B) PCR 
amplification of the cypA, product size = 1,245 bp. (C) Colony PCR of the different 
transformed colonies with cypA using gene specific primers. (D) PCR amplification of the 
insert cypB, product size = 1,209 bp. (E) Colony PCR of the different transformed colonies 
with cypB using gene specific primers.  
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The cypA and cypB genes were expressed in E. coli Rossetta 2 (DE3) cells, by inducing 
with 1 mM IPTG. The proteins were purified using an AKTA purifier (see section 
6.2.3). The expected band for the CYPA was not visualised by SDS-PAGE in the 
fractions from purification steps, while a single band, matching the expected size of the 
protein, was found for CYPB (Figure 6.10).  
 
Figure 6.82: SDS-PAGE of the fractions from purification steps of the CYPA (A) and 
CYPB (B) using AKTA purifier. In both gels, 1 is the molecular markers, 2 is the lysate 
from empty vector, 3 is the lysate from E. coli expressing the gene; 4 and 5 and from the 
washing steps, 6 is the elution fraction, 7 is purified His-tagged protein as a positive control 
for western blot. 
 
Western blot analysis using anti-His antibody failed to detect soluble His-tagged CYPA 
from cell lysate; however, His-tagged CYPB was detected in both crude cell lysate and 
the eluted fraction after purification (Figure 6.11).  The identity of eluted His-tagged 
CYPB was confirmed by MALDI-MS analysis. 
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Figure 6.83: Western blot analysis of the fractions from purification steps of CYPA (A) 
and CYPB (B) using monoclonal His-antibody. In both membranes, 1 is a molecular 
markers, 2 is the lysate from empty vector, 3 is the lysate from E. coli expressing the cypA 
gene, 4 and 5 are fractions from the washing steps, 6 is the elution fraction, and 7 is purified 
His-tagged protein as a positive control for western blot.  
 
An attempt was made to express CYPA as a soluble protein by decreasing the 
concentration of IPTG to 0.1 mM, using E. coli Rossetta 2 (DE3) cells expressing the 
protein at 20 ºC for 16 hours. No band was detected using SDS-PAGE or western blot 
analysis from the soluble fraction of cell lysate expressing the gene, whereas the band 
matching the expected size of the protein was found in the insoluble fraction (Figure 
6.12). 
 
Figure 6.84: SDS-PAGE (A) and western blot (B) analysis of the expression trials of 
CYPA. In both A and B, 1 refers to protein markers, 2 is the lysate from empty vector, 3 is 
the lysate of the E. coli cells expressing empty vector, 4 is a His-tagged protein as a positive 
control for western blot, and 5 is the insoluble fraction of the total lysate expressing CYPA 
gene. The western blot was developed using monoclonal His-antibody.    
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As the protein appeared to be insoluble when expressed as an N-terminal His-tagged 
protein, an attempt was made to achieve soluble CYPA by cloning the gene into pET-
28(+)a,  between SaII and NcoI restriction sites, to be expressed as a C-terminal His-
tagged protein (Figure 6.13).  
 
Figure 6.85: Cloning of the cypA gene into pET-28(+)a. (A) is the digestion of the pET-
28(a)+ vector; 1 is double digested plasmid with both SalI and NcoI; 2 is the single digested 
plasmid with SalI; 3 is the single digested plasmid with NcoI; 4 is undigested plasmid. (B) 
PCR amplification of the cypA gene; predicted PCR product= 1,245 bp.  (C) Colony PCR of 
the different transformed colonies using universal plasmid primers (T7 F and R). 
 
The cypA-pET-28(a)+ construct was expressed in E. coli Rossetta 2 (DE3) cells and 
induced with 0.1, 0.25 and 0.5 mM IPTG at 20 ºC for 11 hours. Soluble expression of 
the protein was checked by analysing the lysate by SDS-PAGE. The expected protein 
band was not detected in the soluble fraction of the cell lysate (Figure 6.14).  
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Figure 6.86: SDS-PAGE analysis for the expression trials of CYPA as a C-terminally 
His-tagged protein. The gel from left to right, protein marker (1), lysate of E. coli 
expressing empty vector (2), the lysate of E. coli Rossetta 2 (DE3) cells expressing CYPA 
and induced with 0.1 mM (3), 0.25 mM (4) , 0.5 mM IPTG (5), purified His-tagged tagged 
protein (6). (a) and (b) refer to the soluble and insoluble fractions, respectively.  
 
Further attempts to achieve soluble expression of CYPA were made by expressing the 
gene at 15 ºC for 21 hours in the E. coli Rossetta 2 (DE3) and E. coli ArticExpress cells   
induced with 0.1, 0.25 and 0.5 mM IPTG. Again, no band was detected in the soluble 
fraction of the cells in SDS-PAGE corresponding to CYPA (Figure 6.15). 
 
Figure 6.87: SDS-PAGE analysis of expression trials for CYPA in E. coli Rossetta 2 
(DE3) (A) and ArticExpress (B).  In both A and B, 1 refers to protein markers; 2 is the total 
lysate of E. coli expressing empty vector; 3, 4 and 5 are the total lysate of E. coli expressing 
CYPA and induced with 0.1, 0.25 and 0.5 mM IPTG, respectively. Number 6 is the purified 
His-tag protein, 7 is the insoluble fraction of E. coli expressing protein. 
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Furthermore, soluble CYPA was not detected by SDS-PAGE analysis of the soluble cell 
lysate of E. coli Rossetta 2 (DE3) grown in LB and induced by 0.1, 0.25 and 0.5 mM 
IPTG at different growth stage (after 3, 5, 7, and 16 hours from induction) (Data not 
shown). 
A bioinformatics approach was taken to investigate if CYPA has transmembrane 
peptides. Sequence analysis of the protein was carried out using both Dense Alignment 
Surface (DAS)-Transmembrane prediction [172] and the HMMTOP web service [173, 
174]. According to the DAS-Transmembrane prediction web service, residues Ile-261 to 
Gly-264 encode a transmembrane region in CYPA (Figure 6.16), whereas HMMTOP 
predicted the Ala-246 to Leu-265 region to be transmembrane helices.  
 
 
Figure 6.88: Prediction of the transmembrane region in the CYPA protein using DAS-
Transmembrane prediction. Reproduced from the DAS-transmembrane website 
(http://www.sbc.su.se/~miklos/DAS/). 
 
Sequence alignment of the CYPA with the XplA-heme domain showed that both 
predicted transmembrane regions are also conserved in XplA-heme domain (Figure 
6.17), suggesting that this is unlikely to be the cause of the insolubility. However, the 20 
amino acid sequence at the N-terminus of CYPA was not found in the XplA-heme 
domain and was therefore identified as the potential cause of insolubility (Figure 6.17).   
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Figure 6.89: Sequence alignments of the CYPA and XplA heme domain. The yellow 
highlighted region is the transmembrane region according to the HMMTOP service, the 
underlined residues are those predicted to be transmembrance by DAS. Gray highlighted 
residues are those amino acids which are missing in the XplA-heme domain. Sequence 
alignments were performed in (http://www.ebi.ac.uk/Tools/msa/clustalw2/). 
 
To investigate if removing the 20 amino acids from the N-terminus of CYPA would 
enhance the solubility of the protein, a truncated version of cypA was cloned into pET-
16b, at the same previously digested restriction sites, to be expressed as N-terminally 
His-tagged protein (Figure 6.18). 
 
Figure 6.90: Cloning steps of the truncated cypA gene into previously digested pET-
16b. (A) PCR amplification of the insert (truncated cypA); PCR product size= 1,185 bp.  (B) 
Colony PCR of the different transformed colonies using universal plasmid primers. 
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The truncated-CYPA was expressed in E. coli Rossetta 2 (DE3) by inducing with 0.1, 
0.5 mM IPTG at 20 ºC. Soluble expression of the protein was checked 15 hours after 
induction. A band at the expected size of the protein was detected by western blot in the 
soluble lysate using His-antibody (Figure 6.19).  
 
Figure 6.91: Expression of CYPA as a truncated protein in pET-16b. (A) is a SDS-
PAGE gel and (B) is a western blot of the expression trial. 1 is protein molecular markers; 2 
is the cell lysate before induction; 3 and 4 are the soluble cell lysate induced with 0.1 mM 
IPTG after 3 hours and 14 hours. 5 and 6 refer to the cells induced with 0.5 mM IPTG after 3 
and 15 hours, respectively. 7 is the insoluble fraction of the cell expression line.   
 
In order to increase the amount of soluble protein, expression levels of truncated CYPA 
were monitored after 12 hours from induction in the E. coli Rossetta 2 (DE3) cells with 
0.1, 0.5 and 1 mM IPTG at 20 ºC. No significant increase in the expression level of the 
soluble protein was observed in western blot analysis of the cell lysate (Figure 6.20). 
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Figure 6.92: SDS-PAGE (A) and western blot (B) analysis for the expression trial of 
truncated-CYPA in pET-16b. In both (A) and (B), 1 is protein markers; 2 is the lysate from 
empty vector; 3, 4 and 5 are the lysate from the cells inducted with 0.1, 0.5 and 1 mM IPTG, 
correspondingly. 6 refer to a purified His-tagged protein as a positive control for western 
blot. 7 is the insoluble fraction of the cells expressing truncated CYPA. The western blot was 
developed with a His-antibody.    
 
Although the expression level of the protein was very low, an attempt was made to 
purify the protein using 5 ml HisTrap FF crude column on the AKTA-purifier system.  
Two bands were present in the SDS-PAGE analysis of the elution fractions, and just one 
of the bands was detected in western blot analysis using monoclonal His-antibody 
(Figure 6.21).  
 
Figure 6.93: SDS-PAGE (A) and western blot analysis (B) for the purification steps of 
truncated CYPA. In both (A) and (B), 1 is protein markers, 2 is the E. coli cell lysate, 3 is 
flow-through, 4 is unbound proteins, 5, 6 and 7 are purified proteins. The western blot was 
developed with a His-antibody. 
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Both bands were sent for MALDI-MS protein identification (Chapter 2.7.5); the top 
band was identified as CYPA and the lower band as elongation factor Tu from E. coli.    
6.3.2 Spectrophotometric analysis of the putative cytochromes P450 
Spectrophotometric analysis was carried out on the purified GT-XplA, truncated CYPA 
and CYPB.  Absorbance peaks for GT-XplA, truncated-CYPA and CYPB were found 
at 420, 422 and 416 nm, respectively (Figure 6.22). The spectral shift of the cytochrome 
P450 from 420 to ~450 nm upon CO binding of the reduced form was seen for GT-
XplA and CYPB, but not for the truncated-CYPA (Figure 6.22).  
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Figure 6.94: UV-visible spectra of the purified GT-XplA, Truncated-CYPA and CYPB 
proteins in oxidised form (red line), reduced with sodium diothionate (blue line), and 
reduced CO-bounds (black line) forms.  
 
In cytochromes P450, the spectral shift from ~420 (low spin) to 390 nm (high spin) 
indicates the positive binding of the enzyme to the substrate. However, such a spectral 
shift was not seen for GT-XplA, truncated-CYPA and CYPB after the addition of 100 
µM RDX (Figure 6.23).  
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Figure 6.95: UV-visible spectra for RDX-binding of GT-XplA, truncated-CYPA, CYPB and 
purified XplA (positive control). The red line is the peak of the corresponding protein before 
adding of RDX, while, blue is the peak of the protein after the addition of 100 µM RDX. 
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6.3.3 Mutagenesis study and whole cell activity assay  
As spectrophotometric analysis of the purified proteins was suggesting that the putative 
cytochrome P450s do not have activity toward RDX, site directed mutagenesis was 
applied to see if targeting specific residues by site directed mutagenesis could produce 
variants with activity towards RDX. The mutagenesis study was carried out for GT-
XplA and truncated-CYPA by substituting residues in the putative active site of each 
protein with those observed in the active site XplA-heme. The mutant forms of each 
protein were created as described in Chapter 2.6.13 (Figure 6.24). 
 
 
Figure 6.96: Example of an agarose gel from the mutagenesis experiment of the 
cytochromes P450. Number 1 refers to the PCR products of the mutant strands, 2 is the 
negative control of the same mutagenesis experiment. 
 
Overall, two mutations in GT-XplA (single mutant and double mutants), with six 
mutations of truncated-CYPA (single to hextuple mutants) were created by site directed 
mutagenesis (Table 6.3). 
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Table 6.10: Mutant constructs generated from truncated cypA and gt-xplA   
Construct Mutant forms of the construct Location of the mutated residue 
Truncated-
cypA 
CYPA- D256A Heme Binding Pocket 
CYPA- D256A, E299Q Heme Binding Pocket 
CYPA- D256A, E299Q, P184L Bounded the large channel of XplA 
CYPA- D256A, E299Q, P184L, L252V Heme Binding Pocket 
CYPA- D256A, E299Q, P184L, L52V, 
M248V 
Heme Binding Pocket 
CYPA-D254A, E299Q, P184L,  L252V, 
M248V, I100L 
Heme Binding Pocket 
gt-xplA 
GT-XplA(N396A) Heme Binding Pocket 
GT-XplA(N396A, P395M) Heme Binding Pocket 
 
The first two mutants of Truncated-CYPA (CYPA- D256A and CYPA- D256A, 
E299Q) were tested to see if the mutation would enhance the solubility of the protein. 
However, neither of the mutants appeared to more soluble compared to the wild-type of 
truncated-CYPA (Figure 6.25). 
.   
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Figure 6.97: Expression trials for single and double mutants of the truncated-CYPA. 
SDS-PAGE (A) and western blot (B) analysis of the single mutant truncated-CYPA. In both 
A and B, 1 is a molecular markers; 2 is the lysate of the empty vector; 3,4 and 5 are lysate of 
the cell induced with 0.1, 0.5 and 1 mM IPTG, respectively; 6 is the positive control and 7 is 
the insoluble fraction from the lysate expression the mutant. C and D are SDS-PAGE and 
western blot analysis for the double mutant truncated-CYPA. 1 refers to a protein markers, 2 
is the cell lysate expressing the empty vector, 2, 4 and 5 are the cell lysate expressing 
truncated-CYPA induced with 0.1, 0.5 and 1 mM IPTG. Number 7 is insoluble fraction of 
the protein. 8 is a His-tagged purified protein as a positive control for the western blot. 
 
Whole cells of E. coli expressing the cytochromes P450 and mutant form of GT-XplA 
and truncated-CYPA were tested for RDX degradation capacity using the whole cell 
assay. In this assay, E. coli Rossetta 2 (DE3) expressing each construct was tested for 
RDX-degradation capacity using the colormetric Griess assay to monitor the production 
of nitrite from RDX.  Interestingly, the pink colour indicative of nitrite production in the 
Griess assay was detected in the quadruple, pentuple and hextuple mutants of truncated-
CYPA after 24 hours incubation with RDX. After 48 hours, a strong pink colour was 
observed for the double, triple and quadruple mutant of CYPA, with a faint colour from 
a single mutant of Gt-XplA (Table 6.4).  
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Table 6.11: Preliminary results from the whole cell assay of the XplA-homologues and 
mutants toward RDX by Griess assay. The pink colour indicates release of nitrite in the 
culture.  
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6.4 Discussion 
Ancestral XplA cytochromes P450 
In silico sequence analysis revealed that GT-XplA shares 45 % sequence identity with 
XplA isolated from RDX-degrading bacteria. Additionally, GT-XplA has a flaxodoxin 
domain fused N-terminally to the heme domain of the protein, an arrangement that was 
previously unique to all xplA-containing bacteria. Purified GT-XplA did not show the 
expected spectral shift from 420 to 390 nm after addition of 100 µM RDX, and nitrite 
was not detected in the whole cell experiment by Griess assay, suggesting that RDX is 
not a substrate for GT-XplA. This inability to catalyse denitrify RDX is likely to be due 
to the overall differences in the GT-XplA sequence, and particularly within the putative 
heme binding site, when compared to the XplA-heme binding site. A single amino acid 
residue difference in the active site of an enzyme can have marked effect on activity, for 
example, melamine deaminase (TriA) has 98 % amino acid sequence identity with the 
entire sequence of  atrazine chlorohydrolase (AtzA) enzyme although neither enzyme 
has detectable activity with their respective  substrate [16]. Site directed mutagenesis, a 
classical approach to investigate the effect of single mutations on protein function [175], 
was used to substitute two of the different residues in the putative active site of the GT-
XplA to those present in the XplA-heme domain binding pocket. The mutant constructs 
of GT-XplA, along with the other constructs reported in the work, were tested for RDX-
degrading activity using E. coli whole cell assays to detect nitrite release from RDX-
denitration using the colorimetric Griess assay.   
While GT-XplA does not have any RDX-degradation capacity, a pink colour was 
observed in the medium from E. coli cells expressing the single mutant (N396A) of GT-
XplA. This result suggests there is an evolutionary relationship between these two 
proteins, and further supports the importance of A396 (which is equivalent to A395 in 
XplA) in the denitration step in the active site of the protein. A similar mutagenesis 
study on the R. rhodochrous 11Y XplA-heme also showed that A395 to be important 
for the activity of the XplA-heme with a A395T mutant of the XplA-heme decreasing 
the activity of the enzyme ~200 folds [99]. Changing the substrate specificity of an 
enzyme through a single mutation is not unusual, for example, the activity of N-
acetylornithine transcarbamylase (AOTCase) can be converted to N-succinylornithine 
transcarbamylase (SOTCase) activity via a single mutation in the active site of  E92 to 
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P, S, V or A. Mutation of the corresponding residue of E92 in SOTCase, (which is P90), 
to E reversed the activity of the SOTCase to AOTCase [176]. 
The inability to detect nitrite from whole cell assays on the double mutants (N396A, 
P395M) of the GT-XplA, under the preliminary experiments conducted, suggests that 
the second mutation (P to M) impairs the activity of the single GT-XplA (N396A) 
mutant, i.e. proline is a preferential residue in that position for the RDX-dentritration 
activity of GT-XplA (N396A). It would be interesting to investigate if XplA activity 
could be increased in a M394P mutant. In some cases, substituting a residue has 
enhanced the activity of the protein, for example the hydroxylation activity of the 
cytochrome P450 monoxygenase (or vitamine D3 hydroxylase, Vdh) is increased by 
~80 fold through a single mutation (T107A) in the putative Fdx-binding site of the 
protein [177]. Mutation of the corresponding residue of P395 in the R. rhodochrous 11Y 
XplA-heme (M394 to L) slightly affected (only by two fold) the activity of the XplA-
heme enzyme [99], although it did increase the ability to bind to HMX (with KD 4.33 
µM). 
Of all the cytochromes P450 currently described in the databases, CYPA has the highest 
sequence identity (> 50 %) with the heme domain of XplA. Additionally, the putative 
active site of CYPA was shown to have one, which is M255, of the two hydrophobic 
residues (M394, A395) in common with XplA, in the place of the highly conserved 
acidic Glu/Asp residues in other P450s. Furthermore, the tertiary structure of the 
putative heme binding site appears to closely resemble the XplA-heme domain binding 
site. Although cytochromes P450 from prokaryotic organisms are generally considered 
to be cytosolic, and expressed as soluble proteins [178, 179], the soluble CYPA could 
not be produced in E. coli under the T7 promoter. Previously, xplA from R. rhodochrous 
11Y also could not be expressed as a soluble protein under the same promoter using  
pET-11a and pET-16b vectors [180] without supplying the E. coli cells with ALA, 
FeCl3, and riboflavin as a heme precursors [181]. Soluble XplA protein was obtained in 
pET-16b after addition heme precursors [98]. Although all expression trials of the 
CYPA were carried out in the presence of the ALA, riboflavin and FeCl3, no soluble 
protein was detectable by either SDS-PAGE or western blot. One commonly known 
reason for protein insolubility is from over expression of the protein, which can result in 
the formation of incorrectly folded protein and aggregation in inclusion bodies [182]. 
However, decreasing the rate of protein expression by lowering temperature, IPTG 
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concentration and harvesting the cells in the different growth stage were unsuccessful. 
A different approach to expressing CYPA as a soluble protein was taken by changing 
the location of the His-tag attached to the CYPA protein sequence. Studies have shown 
that the location of the His-tag can affect expression [183], as well as the solubility level 
of the protein [183, 184]. Again the protein was found in the insoluble fraction when 
CYPA was expressed as a C-terminally His-tagged protein.  
A putative transmembrane region [172-174] was considered to be artifactual as it was 
also conserved in the XplA heme domain, which has been successfully expressed as a 
soluble protein [98]. Truncating CYPA by deleting the 20 amino acids from the N-
terminus in the region which are not present in XplA-heme, resulted in the production 
of soluble protein, possibly implying that the region is a transmembrane sequence. 
However, the spectral shift from low spin to high spin was still not observed, and nitrite 
was not detected after addition of RDX suggesting that the protein does not have 
activity toward RDX.  
While the quadruple, pentatuple and hextuple mutants of truncated-CYPA all had 
activity towards RDX at 24 hours’ time point, as activity was not observed for the triple 
mutant; adding the fourth mutation (L252 to V) in truncuated-CYPA appears to be the 
key to gaining denitration activity. Although there are no data available on the effect of 
mutating the corresponding residue (V391) on RDX-degradation by XplA-heme, the 
structure of the XplA-heme, with the ligand imidazole, shows H-bonding of the residue 
with A395 to imidazole through a water molecule (Figure 6.26) [99].  
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Figure 6.98: The residues located in the heme binding site of XplA. The ligand 
imidazole (labeled as Imid) is bound to the active site. Reproduced from Sabbadin et al. 
(2009) [99].  
 
The RDX-denitration activity was also detected for the double and triple mutants of 
truncated-CYPA showing that these two mutations are enough to confer RDX-
degrading activity in truncated CYPA. Furthermore, these results show the importance 
of adding the second mutation (E299Q) in the truncated-CYPA (D256A). The E299 
corresponds to Q438 in the XplA-heme, which is located in the heme binding pocket 
and projects towards the centre of the heme within H bonding distance of the imidazole 
ligand [99] (Figure 6.26). The Q438A mutant of XplA-heme decreases the kcat/KM 
value by 17 times in comparison to the wild-type XplA-heme [99]. The decrease in pink 
colouration of the Griess assay on the quadruple, pentatuple and hextuple mutants of 
truncated-CYPA at 48 hour time points may have been due to  the reducing of free 
nitrite in the medium by E. coli through the expression of nitrite reductase genes nrfA 
[185]. 
The CYPB was found to have 36 % identity with XplA-heme domain, but the proteins 
encoded by the genes upstream of cypB also share sequence homology to the flavodoxin 
domain, and XplB from RDX-degrading bacteria. Although the CYPB was successfully 
expressed and purified, spectrophotometric analysis and Greiss assays indicated that it 
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was not active towards RDX. Mutagenic studies were not applied to this protein due to 
the number of differences in the putative active site of the protein in comparison to the 
XplA-heme binding pocket.  
Due to time restrictions, no further experiments or characterisation of the constructs 
were carried out, however the preliminary results of the whole cell assay for the GT-
XplA and truncated CYPA could be further improved by optimising the expression 
conditions, especially in case of CYPA.  Solubility and activity might be increased by 
co-expression with XplB.  
Overall the results presented here, combined with the knowledge that the XplA 
homologues are from bacteria belonging to Actinomycetals order like all the xplA-borne 
RDX-degrading bacteria characterised to date, suggest that these cytochromes P450 
could share a common ancestor with the XplA.  
Origin of the xplA and xplB genes 
The genes surrounding gt-xplA and cypB share both sequence similarity and 
arrangement with those in xplA gene cluster in RDX-degrading bacteria. Genes 
encoding for the XplB like protein and flavodoxin reductase are found in the same 
operon cypB and gt-xplA and the gene products share sequence homology with XplB 
and the flavodoxin domain of RDX-degrading bacteria. Furthermore, the previously 
identify cytochrome P450 from Erwinia carotovora subsp. atroseptica, which has 41 % 
identity to XplA [99], is also in the operon which have 52 % and 35 % sequence identity 
to the flavodoxin domain and XplB in RDX-degrading bacteria. Moreover, all RDX-
degrading bacteria tested for xplB and xplA in the same order (Chapter 4). This 
observation suggests that the genes encoding for the xplB, flavodoxin domain and 
cytochrome P450 domain might have  evolutionary relationship, or they were ‘born 
together’, as the Natal model suggested [186], rather than they became clustered 
together because of a fitness advantage as postulated by the Fisher model [186].
  
Chapter 7: Final Discussion  
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7.1 Final discussion  
Previous studies have been performed over recent years to isolate bacteria that can 
degrade RDX, to elucidate the enzymes involved in RDX degradation, and to explore 
the potential applications of XplA/XplB to clean up RDX contaminated sites [84, 86-89, 
95, 96, 98, 100, 101, 103, 106, 112-114, 128]. This study builds on the knowledge 
gained so far to gain a further understanding of the mechanisms by which bacteria have 
evolved to metabolise this novel compound. Focusing mainly on the evolutionary 
aspects of aerobic RDX degradation by bacteria, the results presented here emphasise 
the fascinating capacity of bacteria to adapt to previously unseen compounds.  
Following the rapid evolution of xplA from an, as yet, unknown gene, xplA and xplB 
have been subsequently distributed around the world within a genomic island through 
horizontal gene transfer.   
Chapter 3 described the selective enrichment procedures that were carried out on 
explosive-contaminated soil. The soil was collected from distinct geographical locations 
with the aim of isolating, and further characterising, new RDX-degrading bacteria. The 
isolates were all identified as Rhodococcus spp. and, despite the fact that the soil used 
was from disparate geographical locations, all contained near identical copies of xplA. 
That only rhodococci were isolated could be either due to the methodology used in the 
study providing a favourable environment for rhodococci to flourish, or that the results 
are a true reflection that rhodococci are the dominant aerobic explosive metabolising 
bacteria in the contaminated soil, and by extrapolation, the military sites. In support of 
the latter theory, in situ studies on microbial communities degrading RDX in 
contaminated sites, using fully labelled 
15
N-RDX, also revealed that rhodococci are the 
most abundant genus in explosive-polluted soils [113]. The results suggest that 
Rhodococcus has a particularly well-developed adaptive capacity. Indeed members of 
this Gram positive group are routinely identified for their ability to metabolise organic, 
xenobiotic compounds [130-133]. In all species tested, the RDX-degrading capacity was 
found to correlate with the presence of xplA; irrespective of the geographical locations 
from which the bacteria were isolated. Furthermore, xplA has been detected in all Gram 
positive aerobic RDX-degrading bacteria that have been tested to date [100-103, 128]. 
In addition to XplA, bacterial nitroreductase I [90], XenA and XenB [94] have (albeit 
slow) activity toward RDX. That new, non-xplA dependent, RDX-degrading isolated 
were not found in this study is perhaps surprising as there are existing nitroreductases 
Chapter 7 
193 
 
with low activity to RDX already present in many soil species that could be expected to 
evolve under the selective pressure of RDX.  
Type-I oxygen-insensitive nitroreductases with the ability to transform RDX under 
anaerobic conditions, have been identified in Morganella morganii strain B2 and 
Enterobacter cloacae strain 96 [90]. Under either aerobic or anaerobic conditions, the 
enzyme is also able to transform TNT [90]. In a similar manner, the XenA (from 
Pseudomonas putida II-B) and XenB (from Pseudomonas fluorescens I-C) enzymes can 
also transform RDX along with a number of other explosive compounds including 
HMX, CL-20 and chemically related compounds [94]. The activity of XenA and XenB 
is greatly inhibited by oxygen, thus RDX transformation only occurred under anaerobic 
conditions and under artificially created “anoxic” conditions that supplied with NH4
+
 to 
grow [94]. In the study by Fuller et al. (2009) [94] several factors indicated that the 
products of RDX transformation have a cytotoxic effect on the cells. Firstly, it was 
observed that while increasing RDX concentrations negatively affected RDX 
transformation, increasing RDX concentration increased the RDX transformation rate of 
purified XenB. Secondly, increasing RDX concentrations did not inhibit the growth 
rates of the XenA/XenB harbouring strain under aerobic conditions, i.e. when RDX 
transformation is not occurring [94]. However, the exact cytotoxic mechanism of the 
RDX-transformation was not described [94]. Cytotoxicity of RDX toward Pseudomonas 
HK-9 has also been reported [126].  It could be concluded therefore, that the 
cytotoxicity of the products of RDX transformation may have exerted a negative 
selective pressure on the evolution of endogenous nitroreductase and Xen A/B genes. In 
Chapter 3, the challenge for RDX-degrading bacteria to successfully colonise explosive-
contaminated soil was discussed. The co-contaminating explosive TNT exerts negative 
effects on RDX-degrading bacteria in two ways: Firstly, TNT directly inhibits the RDX-
degrading enzyme, XplA. Secondly, TNT and its transformation products are toxic to 
the cells themselves. Studies using purified XplA demonstrated that while TNT inhibit 
the activity of XplA towards RDX, the chemically similar 2- and 4-ADNTs, as well as 
2,4- and 2,6-DNT compounds had no inhibitory effect on activity. These results show 
that the presence of a third nitro functional group is required for inhibition of XplA. 
Screening of mutated XplA libraries using Griess assays in 96-well formats to track 
RDX denitration activity in the presence of TNT could be used to find XplA variants 
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that are resistant to TNT-inhibition. However, it is possible that TNT-inhibition of XplA 
is intrinsically linked with the RDX-transforming ability of the enzyme. 
Although, R. rhodochrous 11Y has some TNT-transformation activity and reducing one 
of the nitro groups into amino groups or removing it is sufficient to stop the inhibitory 
effect of the compound towards XplA, this did not appear to be enough to overcome the 
toxicity of TNT towards growth. Therefore, it is likely that xplA-carrying bacteria are 
able to survive in TNT-contaminated sites by living in close association with TNT-
detoxifying bacteria such as Enterobacter cloacae. The findings presented in Chapter 3 
emphasise that TNT is a major environmental pollutant and more research is needed to 
identify low cost sustainable methods to decontaminate TNT-polluted sites.  
Chapter 4 contributes towards reconstructing the evolutionary origin of xplA by 
comparing sequences of xplA between eleven RDX-degrading bacteria belonging to 
four different genera.  The bacteria were isolated from distinct geographical sources at 
different times. Such an approach has successfully been used to estimate the 
evolutionary origin of the penicillin-binding protein (pbp) genes  from Streptococcus 
pneumoniae [17]. However, in the case of xplA, the gene was found to be so highly 
conserved that it was not possible to re-construct an ancestral gene. The highly 
conserved nature of xplA strongly supports its recent evolution, and there are many 
examples where near-identical genes involved in xenobiotic degradation from different 
bacteria have been reported [146, 148-153]. There are also examples for other highly 
conserved xenobiotic catabolic genes amongst Rhodococcus spp.: the gene encoding for 
haloalkane dehalogenase (dhaA) along with  a 12.5 kbp gene cluster flanking dhlA, has 
been shown to be highly conserved in six haloalkane-utilising Rhodococcus strains 
isolated in five distinct geographical locations, the Netherlands, the United Kingdom, 
Japan, Switzerland and the United States [187]. In addition, an operon of genes 
involved in naphthalene degradation (narAa,Ab,B) share greater than 90 % sequence 
identity between four naphthalene-degrading Rhodococcus strains, strains 
NCIMB12038, P400, P200, CIR2, and indene-converting Rhodococcus sp. strain I24 
[188]. Janssen et al. (2005) [151] proposed that finding near-identical genes either 
points to the sequence having been acquired originally from a “pre-industrial gene pool” 
and then distributed by horizontal gene transfer, or that they are continuously acquired 
from an identical pre-industrial sequence [151]. Mutation might also contribute to the 
evolution of xenobiotic degrading enzymes from previous functionally related or even 
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unrelated enzymes. Examples include the proposed evolution of atrazine 
chlorohydrolase (atzA) [16] and haloalkane dehalogenase (dhlA) [18]. In addition to 
highly conserved xplA/xplB genes, the other striking observation was that several genes 
surrounding xplA/xplB are almost identical amongst the four different genera examined. 
This is unusual considering that only xplA is required to denitrate RDX [96, 98, 105, 
144] and suggests that the whole region has a single evolutionary origin, which has 
subsequently been distributed by horizontal gene transfer. Up to now the fitness 
advantage resulting from the transmission of the genes alongside xplA/xplB is not well 
understood. Studies by Chong et al. (2014)  [144] showed that neither marR nor aroP, 
located upstream of xplA/B in R.rhodochrous 11Y, are directly involved in RDX-
degradation [144]. The experimental transfer of RDX-degradation by bacteria via 
conjugation suggests that conjugation could be a possible transmission route of this 
gene cluster. Additionally, it is proposed that the gene cluster is part of the genomic 
island rather than a Class-I transposable element as suggested by Andeer et al. (2009) 
[103]. As the xplA gene and its homologues described in Chapter 6 have only been 
found within the Actinomycetals group, this suggests a host-specific feature of the gene 
and it is tempting to propose that phage might have also had role in the transmission of 
this gene cluster.  Phage have been shown to be involved in the distribution of a 39.4 kb 
genomic island in Pseudomonas putida KT2440 and a 15 kbp pathogenicity island, 
SaPI1, in Staphylococcus aureus has already been reported [48, 189].  
One curious observation from the studies presented in Chapter 4 was the finding that the 
plasmid reduction, intragenomic rearrangement and gene shuffling in the xplA/xplB 
region of Gordonia sp. KTR9; particularly, the naturally fusion of xplB to glnA; a gene 
encoding glutamine synthetase, a key enzyme in nitrogen metabolism. Although xplB 
from Gordonia sp. KTR9 has 99.8 % amino acid sequence identity to XplB from R. 
rhodochrous 11Y, the Gordonia XplB was not able to retain the FAD-cofactor and thus 
was not functional as a reductase to XplA. The importance of the Trp residue in holding 
FAD in XplB was shown by creation of the XplB(W384S) mutant which resulted in the 
loss of FAD and subsequent loss of reductase activity. Interestingly, the corresponding 
residue was found to be conserved in a diverse range of FAD-containing proteins which 
share as low as 26 % sequence identity to XplB. This indicates that the corresponding 
Trp is involved in retaining FAD in these other, more distantly-related proteins too. 
Although homology modelling suggests that Trp does not appear to be directly involved 
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in FAD-binding in XplB, it would be interesting to have the crystal structure of XplB to 
to gain some insight on the role this residue plays in maintaining FAD in the active site 
of XplB. However, the poor solubility of XplB would make crystallising this protein 
challenging [98].   
The lack of activity by XplB as a result of single mutation might explain why the 
enzyme became fused to GS might. As it is proposed by Moran (2002) that “If gene 
functions are rendered useless, due to redundancy within the host environment, then 
mutations will inactivate the sequences, and the corresponding DNA will be eroded 
over time through mutational patterns favoring deletion” [21]. Thus, mutation is perhaps 
the evolutionary route in the bacterium to further reduce and lose xplB. This hypothesis 
can be further supported by the fact that RDX was not detected in the original 
ecological niche from which the bacterium was isolated [114]. Furthermore, the 
inactivity of the XplB portion of the XplB-GS fusion could be at least one of the 
reasons for low RDX-degrading capacity in Gordonia sp. KTR9, although additional 
factors such as XplA expression level and the ability of the bacterium to uptake RDX 
could contribute, and have yet to be tested. As discussed in Chapter 4, there is also a 
single nucleotide substitution which resulted in a mutation from Phe-172 to Iso-172 in 
Microbacterium sp. MA1. Microbacterium sp. MA1 also has a lower rate of RDX 
degradation compared to R. rhodochrous 11Y, and the Phe-172 to Iso-172 mutation 
could be the cause. While beyond the scope of the studies presented here, site-directed 
mutagenesis studies are underway on Microbacterium sp. MA1 to investigate this 
further. 
Sequence analysis of the GS portion of the Gordonia sp. KTR9 GS-XplB fusion 
revealed that it belonged to the Class-I α [155]. Although the truncated protein lacked 
15 % of the C-terminal region, spectrophotometric assays revealed that the protein is 
active. The nitrogen regulatory role of GSI-α from Bacillus subtilis through feedback-
inhibition of the glutamine mechanism has been reported [156, 158, 166]. Appearance 
of glnA in the same operon as xplB/xplA suggests a potential role for GS in the 
regulation of cellular nitrogen levels, something that could be investigated further by 
knock-out mutations of glnA. 
In Chapter 6, the evolutionary origin of xplA was further investigated. Three strategies 
were proposed to study the origin of gene; first, by comparing genes from different 
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bacterial species. Secondly by searching for homolouges of the gene in bacteria lacking 
the desire ability. Thirdly by searching for homologous genes in metagenomic libraries 
[151]. Using the first and third strategies was not possible as xplA was found to be too 
highly conserved amongst the studied RDX-degrading isolates (Chapter 4) and in the 
metagenomic database. However, the sequence analysis of the xplA homologues, gt-
xplA in Gordonia terrae strain NBRC 100016 and cypA and cypB from Gordonia 
polyisoprenivorans NBRC 16320 strongly suggested an evolutionary relationship 
between these putative cytochromes P450, particularly both GT-XplA and CYPA, with 
XplA. Despite technical obstacles in the expression of CYPA as a soluble protein, 
preliminary data from whole cell assays for CYPA as well as Gt-XplA mutant 
constructs gave an indication that there is indeed an evolutionary relationship between 
the putative cytochromes P450 and XplA, and that perhaps they share a common 
ancestor with XplA. It would be interesting to investigate potential natural substrates for 
GT-XplA and CYPA. Furthermore, the identity between these putative cytochromes 
P450 and XplA, perhaps not surprisingly, suggests that bacteria acquired RDX-
degrading capacity through the modification of xplA-like genes which might have had 
another cellular activity. Moreover, while RDX is a substrate for XplA, it may have 
activity towards other substrates, although none have yet been discovered despite 
extensive screening studies. It would not be surprising if closer XplA homologous 
appear in databases in the future. The question of whether there is a natural substrate for 
XplA therefore currently remains unanswered: Oxidation activity of XplA towards 
methyl tolyl and methyl phenyl sulfides, to produce sulfoxides has been reported [95].  
XplA was also reported to have activity towards the RDX denitration products MNX 
and TNX [190].  
In conclusion, the originality of the studies presented here can be summarised as 
follows:  
1- Although TNT is known to strongly inhibit XplA activity, dinitrotoluenes do not 
inhibit XplA activity.  
2- xplA is part of a large genomic island and the genomic island has a single 
evolutionary origin.  
3- XplB-GS from Gordonia sp. KTR9 is inactive as a reductase, as a result of both 
fusing the protein to GS and substitution of Trp to Ser. However, GS fused with 
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XplB is active; belong to Class I-α and perhaps works as a nitrogen regulatory 
protein.  
4- The evolutionary relationship between CYPA, Gt-XplA and XplA was shown 
through site-directed mutagenesis and strongly suggests an evolutionary 
relationship between all three enzymes, possibly sharing a common ancestor.   
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List of Abbreviations 
°C    degree(s) celsius 
µg    microgram 
µL    microlitre 
µM    micromolar 
2,4-DNT  2,4-dinitrotoluene 
2,6-DNT  2,6-dinitrotoluene 
2-ADNT  2-amino-4,6-dinitrotoluene  
4-ADNT  4-amino-2,6-dinitrotoluene 
ALA    5-aminolevulinic acid 
APS    Ammonium persulphate 
BLAST   Basic Local Alignment Search Tool 
BSA    Bovine Serum Albumin 
CO    Carbon Monoxide 
DMSO               Dimethyl sulfoxide 
DNA   Deoxyribonucleic acid 
dNTP    Deoxyribonucleotide triphosphate 
DNX   Hexahydro-1-3-dinitroso-5-nitro-1,3,5-triazine 
FAD   Flavin adenine dinucleotide 
GST   Glutathione S-transferase 
His-tag   Polyhistidine tagged 
HMX  Octahydro-1,3,5,7-tetranitro-1,3,5,7-tetrazocine,High melting explosive 
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HMX   High Melting Point eXplosive or Her Majesty's eXplosive 
HPLC    High Pressure Liquid Chromatography 
HS    High Spin 
IPTG   Isopropyl β-D-1-thiogalactopyranoside 
L    litre 
LB   Luria-Bertani medium 
M    molar 
mM    millimolar 
MNX   Hexahydro-l-nitroso-3,5-dinitro-1,3,5-triazine 
NADPH   nicotinamide adenine dinucleotide phosphate, reduced form 
NCBI   National Center for Biotechnology Information 
NDAP   4-nitro-2,4-diazabutanal 
NED    N-1-naphtylethylenediamine dihydrochloride  
OD    Optical Density 
ORF    Open Reading Frame 
PAGE    Poly-Acrylamide Gel Electrophoresis 
PBS    Phosphate Buffered Saline 
PCR    Polymerase Chain Reaction 
PDB    Protein Data Bank 
PMSF    Phenyl-Methane-Sulphonyl-Fluoride 
RDX   Hexahydro-1,3,5-trinitro-1,3,5-triazine, Royal Demolition Explosive 
RNA   ribonucleic acid 
rpm    revolutions per minute 
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SDS    Sodium Dodecyl Sulphate 
SNP    Single Nucleotide Polymorphism 
SOC    Super Optimal broth with Catabolite repression 
TCA    Trichloroacetic acid 
TNT    2,4,6-trinitrotoluene 
TNX    hexahydro-1,3,5-trinitroso-1,3,5-triazine 
TRIS    Tris(hydroxymethyl)aminomethane 
tRNA    Transfer RNA 
UV    Ultra Violet  
v/v    Volume/volume 
w/v    Weight/volume 
XplA    Explosive-degrading enzyme A, Cytochrome P450 (CYP177A1) 
XplA-heme  Heme domain of XplA 
XplB    Explosive-degrading enzyme B, flavodoxin reductase  
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